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Abstract 
Primary cilia are microtubule-based organelles on the apical surface of mammalian cells, 
and play a crucial role in vertebrate development and tissue homeostasis. Consequently, 
ciliary defects are associated with human disorders called ciliopathies. This organelle 
represents an organizing center for signaling pathways. In particular, in vertebrates, the 
Hedgehog (Hh) pathway controls embryonic development and adult homeostasis using the 
primary cilium to transduce its signal. Hh components localize to cilia and Kif7, a key 
player in cilia structure and length, controls the ciliary localization of Hh signaling 
molecules. Phenotypes associated to Hh signaling impairment are often observed in 
ciliopathies. Recent studies established a link between ciliary proteins and the Ubiquitin 
proteasome system (UPS) pathway, however much remains to be understood. The main 
role of the UPS is to mark proteins for degradation although it also functions in a wide 
variety of cellular processes. The aim of my PhD project was to investigate the association 
between cilioproteins and proteasomal functions, with particular emphasis on the cilia-
associated OFD1 protein, which is responsible for the rare OFD type I syndrome. The 
results obtained demonstrate that OFD1 controls proteasomal complex composition 
through direct binding with proteasomal components (see Liu et al. in appendix). Our 
results also demonstrate a role for Usp14, a deubiquitinating enzyme, in the control of 
ciliogenesis, cilia length and proper activation of the Hh pathway. We propose a new 
mechanism by which cilia maintenance and the Hh pathway are regulated by Usp14 via 
modulation of Kif7 proteasomal degradation (manuscript in preparation). This mechanism 
may be relevant not only in ciliopathies but also in other pathological conditions associated 
to Hedgehog signaling defects. Overall our results provide new insight into the spectrum of 
action of the UPS and may provide novel opportunities for therapeutic intervention in 
pathological conditions associated to cilia dysfunction. 
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Introduction 
 
1. The Primary Cilium  
 
1.1. Structure and functions of primary cilia 
Cilia are evolutionarily-conserved microtubule-based organelles that protrude from the cell 
surface of almost all mammalian cells and although exceptions have been described, can be 
classified into two main functional groups: motile (also called ﬂagella) and non-motile cilia 
(also called sensory or primary cilia). Motile and non-motile cilia are structurally related 
(see below) and have developed different functions (Keeling, Tsiokas et al. 2016). 
Numerous motile cilia are present on epithelial cells in various tissues, such as trachea, 
oviducts, and epididymis of the reproductive tracts. These cilia are used for cell 
locomotion or for the generation of ﬂuid ﬂow over the cell surface. One example is the 
beating on tracheal cells, which is important for pulmonary clearance (Stannard and 
O'Callaghan 2006, Roy 2009). In contrast to motile cilia, primary cilia are non-motile 
solitary organelles (Singla and Reiter 2006). They were long believed to be vestigial 
organelles without relevant biological functions. However, experimental evidence 
collected over the past twenty years revealed that primary cilia are essential sensory 
organelles functioning as cells’ antenna in many different instances: e.g. in signal 
transduction (Brown and Witman 2014); in mouse embryo patterning (Huangfu, Liu et al. 
2003, Goetz and Anderson 2010); for chemosensing in olfactory neurons (e.g. for detecting 
odorants), photo-sensing in rods and cones (e.g. for receiving and transducing the stimuli 
of light on the retina), and as mechanosensors in renal epithelia (e.g. for sensing fluid flow 
in kidney tubules) (Satir and Christensen 2007).  
Primary cilia consist of a microtubule-based core-skeleton, called axoneme, which is 
surrounded by a ciliary membrane (Breslow, Koslover et al. 2013). 
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The ciliary membrane (Figure 1), a specialized subdomain of the cell membrane, 
although continuous with the plasma membrane at the basal portion of the primary cilium, 
exhibits a distinct lipid and protein composition. Particularly, a specific portion of the 
ciliary membrane that extends from the axoneme (the ciliary tip) appears to have important 
roles for signals transduction (Rohatgi and Snell 2010) and in constrain of ciliary length. 
    
Figure 1. Structure of the primary cilium 
The primary cilium consists of a microtubule-based core-skeleton, called axoneme, which is surrounded by a 
ciliary membrane, which is continuous with the plasma membrane. The basal body is attached to the ciliary 
membrane by the transition fibers. Between the basal body and the axoneme of the primary cilia there is a 
substructural zone, named transition zone (TZ). IFT is carried out by the IFT-A and IFT-B complexes 
powered by dynein-2 and kinesin-2 motors, respectively (modified from (Bernabe-Rubio and Alonso 2017)). 
The localization of the Ofd1 protein at the basal body is also indicated. 
 
The core of cilia is the axoneme, which emanates from the basal portion of the cilium (the 
basal body) (Figure 1). It consists of nine outer microtubule doublets, termed 9+0 pattern, 
and lacks the central pair of microtubules typical of motile cilia (9+2 pattern) (Figure 2). 
Cilia localized at the embryonic node (nodal cilia) are an exception given that they are 
motile but lack a central pair of microtubules. The absence of the central microtubule 
doublet and of the accessory motility machinery (e.g., dynein arms, radical spokes, central 
pair projections) makes primary cilia non-motile. In place of this pair of microtubules, an 
electron-dense material, which varies from cell to cell, occupies the central portion of 
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primary cilia (Gluenz, Hoog et al. 2010). The outer axonemal microtubules doublets 
consist of a complete tubule (A microtubule) connected to an adjacent incomplete tubule 
(B microtubule), and lacking the third microtubule (C microtubule), which on the other 
hand, is present into the triplet microtubule pattern of the basal body of cilia (Gerdes, 
Davis et al. 2009) (Figure 2).  
 
 
Figure 2. Structures of motile and non-motile cilia. 
All cilia extend from a basal body that typically consists of triplet microtubules, and sub distal and distal 
appendages. Distal appendages (also known as transition fibers) tether the basal body to the base of the 
ciliary membrane. The axoneme is composed of doublet of microtubules. The transition zone, which contains 
doublet microtubules that are connected to the ciliary membrane via Y-shaped structures is localized between 
the basal body and the axoneme. In motile cilia, axonemes usually contain associated accessory proteins and 
structures (for example, the central pair and axonemal dyneins) that are required for cilia motility. Cilia may 
contain additional subdomains, including singlet microtubules at the distal end, and regions with specific 
protein composition or functions. Ciliary signaling functions, and roles in motility are summarized. PKD, 
polycystin (modified from (Reiter and Leroux 2017)) 
 
The microtubule subunits undergo post-translational modification for the establishment of 
functional microtubules (Janke and Kneussel 2010), such as acetylation (Piperno, LeDizet 
et al. 1987), detyrosination (Gundersen and Bulinski 1986), or glutamylation (Lee, Silhavy 
et al. 2012). These modifications are thought to be important for stability, motility, and 
formation, and function of primary cilia (Janke and Bulinski 2011, Konno, Setou et al. 
2012). Cilia are devoided of protein synthesis. The intraflagellar transport (IFT) machinery, 
a multiprotein complex responsible for transporting cargoes into the cilia (anterograde 
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transport) and out of the cilia (retrograde transport) runs along axonemal microtubules. It 
mediates both the assembly and resorption of the cilium, and the trafficking of key 
intermediates of signaling cascades. The anterograde transport is regulated by the IFT-B 
complex and the kinesin2 motor, whereas the retrograde transport is mediated by the IFT-
A complex and the dynein motor (Scholey 2008, Sasai and Briscoe 2012).  
At the base of the axoneme, under the cell surface, is located the basal body (Figure 1). It 
derives from the mother centriole, anchors the microtubules, and connects the axoneme to 
the rest of the cell (Dirksen 1991). 
Between the basal body and the axoneme of the primary cilia there is also another 
substructural zone, named transition zone (TZ) (Figure 1). Recent work has further 
defined this compartment near the base of the cilium as an important region for trafficking 
and ciliary gating, involved in the formation of a physical barrier that prevents free mixing 
of proteins between the plasma and the ciliary membranes (Czarnecki and Shah 2012). 
Several protein complexes, responsible for cilia formation as well as for selectively loading 
ciliary proteins to the IFT cargoes, localize at the transition zone (Nozawa, Lin et al. 2013). 
 
1.1.1. Cilia mediated signaling pathways 
Cilia act as complex sensory machines involved in transducing extracellular stimuli into 
cellular responses as they sense extracellular signals and transmit them from the cilium to 
the cytoplasm and nucleus in order to control gene expression and cell behavior, thereby 
playing several important roles in cell and developmental biology (Yuan, Serra et al. 2015). 
The extracellular sensory function of cilia is mediated by different signaling pathway 
receptors, ion channels, transporter proteins, and their downstream molecules located in the 
axoneme or in the basal body. A variety of signaling pathways are coordinated through this 
organelle during development, tissue homeostasis, cell migration, cellular differentiation, 
cell cycle, and apoptosis (Eggenschwiler and Anderson 2007, Satir, Pedersen et al. 2010). 
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Examples of signaling pathways that need intact cilia to properly transduce their signals 
include: the Hedgehog (Hh) pathway), involved in regulation of cell proliferation, cell fate 
determination, in the epithelial-to-mesenchymal transition and maintenance of homeostasis 
in adult cells (Simpson, Kerr et al. 2009, Briscoe and Therond 2013)(see also section 2); 
the PDGF pathway, which regulates cell proliferation, cell survival, and migration during 
embryogenesis and tissue homeostasis (Clement, Mally et al. 2013); the Wnt pathway, 
which is crucial during development and important for controlling cell proliferation, 
apoptosis, cell fate determination, microtubule stabilization, and cell polarization (Angers 
and Moon 2009), and the Ca2+ signaling cascade, which plays a key role in proper 
development of kidneys, by regulating the intracellular Ca2+ concentration (Kestler and 
Kuhl 2008, Angers and Moon 2009).  
 
1.2. Primary cilia biogenesis 
The formation of primary cilia is a process tightly linked to the cell cycle: as a matter of 
fact, the formation of the primary cilium is inversely correlated with cell cycle progression. 
The primary cilium assembles only when cells exit the cell cycle from mitosis, and for this 
reason it is considered an organelle of cells in quiescent or differentiated state. Therefore, 
when cells re-enter the cell cycle, cilium resorption occurs (Quarmby and Parker 2005). 
It has been proposed that formation of primary cilia proceeds by two distinct pathways 
(intracellular and extracellular/alternative pathways) (Sorokin 1962, Sorokin 1968). In the 
intracellular pathway the initiation of ciliogenesis is a well-orchestrated process where 
distal appendages vesicles (DAVs) originated from the Golgi attach to the distal ends of 
the mother centriole, which differentiates into a basal body. Ciliogenesis continues with 
fusion of DAVs to form the ciliary vesicle (CV), the basal body acquires positive 
regulators of ciliogenesis, as the Intraflagellar transport protein 20 (Ift20), and removes 
negative regulators, allowing docking and formation of the TZ. Once the basal body docks 
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at the plasma membrane (PM), the axoneme extends into the extracellular space. Thus, in 
this case, the basal body associates with a vesicle “en route” to the plasma membrane, and 
additional vesicles support the growing axoneme until the vesicular structure comes in 
contact and fuses with the plasma membrane (Sorokin 1962, Bernabe-Rubio and Alonso 
2017) (Figure 3).  
 
Figure 3. The intracellular pathway.  
Ciliogenesis initiates intracellularly with the formation of a large ciliary vesicle (CV) at the distal end of the 
appendages of the mother centriole by fusion of smaller distal appendages vesicles (DAVs). The axoneme 
starts forming intracellularly and, as it grows, deforms the CV and establishes an inner membrane (shaft) and 
an outer membrane (sheath). The incipient cilium is finally exocytosed and the cilium becomes exposed in 
the plasma membrane. The sheath gives rise to the ciliary pocket, and the shaft forms the ciliary membrane 
(modified from (Bernabe-Rubio and Alonso 2017)) 
 
Conversely, in the extracellular pathway, the basal body fuses with the apical surface of 
the plasma membrane and the cilium protrudes directly into the extracellular space where it 
elongates (Kobayashi and Dynlacht 2011).  
The use of a pathway rather than the other depends on the cell type and the position of the 
centrosome in the cell (Bernabe-Rubio and Alonso 2017). In non-polarized cells of 
connective tissues, as in the case of fibroblasts, where the centrosome is near the nucleus, 
ciliogenesis starts intracellularly and finishes at the plasma membrane, generating an 
invagination, known as the ciliary pocket; whereas, in polarized epithelial cells, the 
centrosome is close to the plasma membrane and the process takes place entirely at the 
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plasma membrane and no pocket appears (Rohatgi and Snell 2010, Benmerah 2013, 
Bernabe-Rubio and Alonso 2017)  (Figure 4). 
 
Figure 4. Routes of primary ciliogenesis.  
The position of the centrosome, near the nucleus or close to the plasma membrane, and the presence or 
absence of a ciliary pocket predicts the type of pathway used for primary ciliogenesis. Fibroblasts and 
polarized epithelial cells are cells that use the intracellular and alternative routes, respectively (modified from 
(Bernabe-Rubio and Alonso 2017)). 
 
The formation of the primary cilium is also induced by other conditions, such as starvation 
by using serum-free media and by cell confluency (Kiprilov, Awan et al. 2008), which 
forces the cell into a non-mitotic state. 
 
1.3 Control of ciliary length  
The primary cilium remains a highly dynamic organelle not only because it is assembled 
during specific phases of the cell life, but also because a dynamic turnover continually 
occurs at the distal tip of the axoneme (Satir and Christensen 2007, Pedersen and 
Rosenbaum 2008, Kobayashi and Dynlacht 2011). The ciliary axoneme is only ~0.25 μm 
in diameter, but it can reach up to 20 μm in length depending on the cell type. A precise 
balance between assembly and disassembly of the primary cilium is crucial for determining 
its length (Sanchez and Dynlacht 2016). When this balance is disrupted, cilia growth or 
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resorption will occur (Kozminski, Johnson et al. 1993, Marshall and Rosenbaum 2001, 
Marshall, Qin et al. 2005). It is believed that in all ciliated cells the regulation of the ciliary 
growth is mediated by IFT, which provides the necessary components, such as tubulins and 
other axonemal precursors, at the tips of the cilia and recycles ciliary turnover products at 
the base. Thus, a change in cilia length is considered to be indicative of a change in 
anterograde or retrograde IFT (Engel, Ludington et al. 2009). Moreover, there are 
emerging evidences that some kinesin motor proteins, well known for their roles in 
intracellular transport, can regulate the dynamics of tubulin polymerization. For example, 
KIF4A, a kinesin-4 protein, controls microtubule length during cell division (Hu, Coughlin 
et al. 2011) and another kinesin-4 protein, KIF21A, inhibits microtubule growth at the cell 
cortex (van der Vaart, van Riel et al. 2013). In K. Anderson’s laboratory it has been 
demonstrated that the Kinesin family member 7 (Kif7), a conserved regulator of Hh 
signaling (Tay, Ingham et al. 2005, Cheung, Zhang et al. 2009, Endoh-Yamagami, 
Evangelista et al. 2009, Liem, He et al. 2009), binds to microtubule plus ends at cilia tips to 
control cilia length, architecture, and stability, thus it organizes a specialized compartment 
that mediates Hh signaling (He, Subramanian et al. 2014). Recent genetic studies have also 
identified KIF7 mutations in patients with typical ciliopathy phenotypes (see below) 
(Dafinger, Liebau et al. 2011, Putoux, Thomas et al. 2011, Putoux, Nampoothiri et al. 2012, 
Walsh, Shalev et al. 2013). 
 
1.4. Ciliopathies 
Dysfunctions and malformations of motile or immotile cilia, due to mutations in genes 
encoding defective cilioproteins belonging to the different ciliary structures (primary 
cilium/basal body, axoneme, transition zone and fibers), are associated with a wide range 
of human diseases called ciliopathies (Badano, Mitsuma et al. 2006, D'Angelo and Franco 
2009) (Figure 5). These disorders show a broad spectrum of shared and overlapping 
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phenotypes involving various organ systems (Quinlan, Tobin et al. 2008), such as retinal 
degeneration, renal, hepatic and pancreatic cysts, skeletal defects, situs inversus, obesity, 
ciliary dyskinesia, mental retardation, and Central Nervous System (CNS) malformations 
(Davis and Katsanis 2012). These symptoms display different degrees of severity which 
also depend on whether ciliogenesis is affected or not and the disease is more severe if cilia 
architecture is compromised.  
  
Figure 5. Dysfunctions in motile and/or non-motile cilia affect most human organ systems and cause 
ciliopathies. 
Different organ systems or tissues affected in ciliopathies, and principle phenotypes in each organ are 
depicted. Ciliopathies caused primarily by defects in motile cilia (orange), those resulting from defects in 
non-motile primary cilia (blue) and those associated with defects in both types of cilia (green) are illustrated 
in the scheme. NPHP, nephronophthisis; PKD, polycystic kidney disease (modified from (Reiter and Leroux 
2017)). 
 
The number of reported ciliopathies is increasing, as well as the number of established and 
candidate ciliopathy associated genes. Moreover, ciliopathies that result from the 
disruption of proteins, which neither localize at, nor take part in cilia formation (non-
ciliary proteins), but which are required for ciliary functions, are occurring more frequently. 
Consequently, the range and the overlap between ciliopathy phenotypes is also increasing. 
Indeed, the relationship between a ciliary gene and a ciliopathy is often more complex than 
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a one-gene-to-one-phenotype relationship. Mutations in different cilia-associated 
transcripts result in defined ciliopathies (Novarino, Akizu et al. 2011, Waters and Beales 
2011), however multiple ciliopathies with no, or limited, phenotypic overlap are also 
caused by mutations in the same gene. A single gene can be linked to multiple phenotypes 
if the alleles differ in strength. In addition, different mutations in one gene can also result 
in ciliopathies that are associated with distinct phenotypes (for example: mutations in one 
gene encoding protein isoforms with different functions). Additionally, genetic modifiers 
present in different backgrounds can influence the clinical manifestation of mutations in 
ciliopathy-associated genes, partially explaining the pleiotropy of ciliopathies (Reiter and 
Leroux 2017). Therefore, although ciliopathies can be recognized as distinct clinical 
entities, it is becoming apparent that these are determined not only by the specific gene that 
is mutated, its biological role and pattern of expression, but also by the type and effect of 
the mutation on the function of the protein and by the total mutational load across different 
ciliary genes and ciliopathy-associated genes (Adams, Smith et al. 2008, Cardenas-
Rodriguez and Badano 2009, Deltas and Papagregoriou 2010). 
We can distinguish between ciliopathies caused by dysfunction of ciliary proteins of motile 
cilia (motile ciliopathies) and ciliopathies that result from the disruption of proteins that 
affect immotile cilia (sensory ciliopathies) (Figure 5). In addition, non-ciliary proteins can 
also contribute to ciliopathies influencing ciliary functions, and ciliary proteins can have 
extra-ciliary roles causing phenotypes that are unrelated to ciliopathies when they are 
impaired (Reiter and Leroux 2017). However, altered formation or function of motile cilia 
that doesn’t normally affect ciliary signaling almost exclusively results in motile 
ciliopathies. The most common of which is known as Primary Ciliary Dyskinesia 
(PCD). PCD is an inherited autosomal recessive disease characterized by chronic 
respiratory tract infections (attributable to defective clearance of lung mucus), abnormally 
positioned internal organs (different degrees of situs inversus), and male infertility (due to 
defective sperm locomotion) (Horani, Ferkol et al. 2016). On the other hand, sensory 
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ciliopathies result specifically from defects in the sensory and/or signaling functions of 
cilia, and are primarily caused by defects in non-motile cilia. Examples of ciliopathies 
caused by mutation in proteins affecting the primary cilium include: Bardet-Biedl 
Syndromes (BBS), a multisystemic disorder involving developmental abnormalities 
(polydactyly, mental retardation, and developmental delay) and degenerative phenotypes 
(retinal degeneration and renal cystic disease) (Forsythe and Beales 1993); Leber 
Congenital Amaurosis (LCA), a severe dystrophy of the retina that results in severe 
vision loss at an early age (McAnany, Genead et al. 2013); Oral-Facial-Digital type 1 
syndrome (OFDI), an X-linked dominant developmental disorder lethal to males. Female 
patients present malformations of the oral cavity, face, digits, renal cysts, and CNS 
malformations (Toriello, Franco et al. 1993)(see also section 1.4.1); autosomal dominant 
(ADPKD) (Harris and Torres 1993) or recessive (ARPKD) polycystic kidney disease 
(Sweeney and Avner 1993) characterized by the development of fluid filled cysts in the 
kidney, gradually leading to end-stage renal failure, and by extrarenal manifestations; 
Joubert Syndrome (JBTS) characterized by three primary findings: a distinctive 
cerebellar and brain stem malformation called the molar tooth sign (MTS), hypotonia, and 
developmental delays (Parisi and Glass 1993); Nephronophthisis (NPHP) associated to 
reduced renal concentrating ability, chronic tubulointerstitial nephritis, cystic renal disease, 
and progression to end-stage renal disease (ESRD) before the age of 30 (Stokman, Lilien et 
al. 1993); Meckel Grouber Syndrome (MKS) an autosomal recessive lethal condition 
characterized by occipital meningoencephalocele, polycystic kidneys, postaxial 
polydactyly, and ductal plate malformation of the liver (Henkel, Pfeiffer et al. 1993). 
Primary cilia have evolved several modes for sensing environmental and intercellular 
signals respect to motile cilia. Therefore, it is expected that defects in sensory cilia 
functions cause more varied sensory, physiological, and developmental anomalies 
compared to defects in motile cilia. Sensory ciliopathies have multiple possible molecular 
etiologies, including impaired cilium formation or maintenance, abrogation of ciliary 
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signaling pathway components, or trafficking defects that prevent the signaling machinery 
from being localized to, or removed from, cilia (Reiter and Leroux 2017)  
 
1.4.1 Oral-Facial-Digital syndrome type 1 (OFD1) 
Oral-facial-digital syndromes (OFDs) are a heterogeneous group of developmental 
disorders that feature malformations of the face, oral cavity, and digits. Other organ 
systems can also be involved, and the current classification has identified several different 
forms of OFDs (Franco and Thauvin-Robinet 2016, Bruel, Franco et al. 2017). 
Orofaciodigital syndrome type 1 (OFDS1, OMIM #311200), the most common type, 
occurs in 1:50000-1:250000 live births, and can be easily recognized for the typical X-
linked dominant male lethal transmission, even though few live males with mutations in 
OFD1 have been reported (Thauvin-Robinet, Thomas et al. 2013, Tsurusaki, Kosho et al. 
2013, Wentzensen, Johnston et al. 2016). OFD type 1 is caused by mutation of the OFD1 
(OMIM #300170) gene, located on the chromosome Xp22.2-Xp22.3 region (Feather, 
Winyard et al. 1997, Ferrante, Giorgio et al. 2001, Toriello 2009). To date, over 130 
different mutations have been identified in OFD1 with many truncating mutations (Franco 
and Thauvin-Robinet 2016).  
About 75% of cases with OFD1 are sporadic, and different papers exclude a convincing 
genotype/phenotype correlation (Stoll and Sauvage 2002, Macca and Franco 2009, 
Bisschoff, Zeschnigk et al. 2013). Mutations in the OFD1 gene have also been identified in 
association with four recessive X-linked phenotypes: Joubert syndrome, intellectual 
disability, type 2 Simpson-Golabi-Behmel syndrome, and retinitis pigmentosa (Budny, 
Chen et al. 2006, Coene, Roepman et al. 2009, Field, Scheffer et al. 2012, Webb, Parfitt et 
al. 2012, Tenorio, Arias et al. 2014). The cardinal clinical features of OFD1 syndrome 
include craniofacial abnormalities (facial asymmetry, hypertelorism, frontal bossing, 
microretrognathia, broadened nasal bridge, cleft palate, multi-lobulated tongue with 
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nodules, and abnormal dentition), and digital abnormalities (which affect the hands more 
often than the feet) including brachydactyly, syndactyly, clinodactyly, and pre- or post-
axial polydactyly (Figure 6).  
 
 
Figure 6. Clinical signs of OFDI syndrome. 
(A) Peculiar face of the patient and tooth abnormalities, (B) cleft palate, (C) lobulated tongue, (D) 
clinodactyly, (E and F) Brachydactyly, (G) Cystic kidney, (H) Hallux duplication, (I) Brachydactyly and 
syndactyly. (modified from (Toprak, Uzum et al. 2006, Macca and Franco 2009) 
 
About 60% of cases with OFD type 1 show brain structural abnormalities, developmental 
delay, and intellectual disabilities (Del Giudice, Macca et al. 2014), and most of the 
patients suffer from renal cystic disease (Feather, Woolf et al. 1997, Ferrante, Giorgio et al. 
2001, Prattichizzo, Macca et al. 2008). In addition, about 5% of OFDI affected females 
develop pancreatic, hepatic, and/or ovarian cysts (Ferrante, Giorgio et al. 2001, Macca and 
Franco 2009, Toriello 2009, Saal, Faivre et al. 2010). 
The OFD1 gene contains an open reading frame of 3033 base pairs (bp) spanning over 23 
coding exons and generates two main splice variants, OFD1a and OFD1b. OFD1b codifies 
for an unstudied putative protein of 367 aminoacids (aa) derived from exons 1–11 (de 
Conciliis, Marchitiello et al. 1998, Ferrante, Giorgio et al. 2001, Romio, Wright et al. 
2003), while OFD1a encodes for a 1012-amino acid protein (hereafter called OFD1) 
conserved among vertebrates (de Conciliis, Marchitiello et al. 1998, Ferrante, Giorgio et al. 
2001, Romio, Wright et al. 2003). This protein contains a Lis1 homology (LisH) motif in 
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its N-terminal region and six predicted coiled-coil (CC) domains distributed along the C-
terminal region (de Conciliis, Marchitiello et al. 1998, Emes and Ponting 2001, Budny, 
Chen et al. 2006). Interestingly, the OFD1 gene has been found to escape X-inactivation in 
humans while the murine counterpart is subjected to X-inactivation (Ferrante, Barra et al. 
2003). 
The OFD1 transcript is expressed in both human and murine structures, in all tissues 
affected by the disorder from early stages of development to adulthood. In particular, it is 
highly expressed during human organogenesis in the metanephros, gonads, brain, tongue, 
and limbs, and at lower levels in pancreas, kidneys, skeletal muscle, liver, lung, placenta, 
brain, and heart (de Conciliis, Marchitiello et al. 1998, Ferrante, Giorgio et al. 2001, 
Romio, Wright et al. 2003).  
 
1.4.1.1 The OFD1 protein: functions and animal models 
OFD1 is a centrosome-associated protein (Romio, Wright et al. 2003, Giorgio, Alfieri et al. 
2007) and it follows the dynamic distribution of the centrosome throughout the cell cycle 
(Romio, Fry et al. 2004). In post-mitotic cells, when the mother centriole forms the basal 
body to allow nucleation of the ciliary axoneme, OFD1 localizes at the basal body of 
primary cilia (Romio, Wright et al. 2003, Giorgio, Alfieri et al. 2007) (Figure 7A-C). More 
specifically, OFD1 localizes at the distal regions of centrioles and it appears to be 
important in the control of centriole length, centriole distal appendage formation, and 
centriolar recruitment of the Intraflagellar transport protein 88 (Ift88) (Singla, Romaguera-
Ros et al. 2010). Furthermore, OFD1, as well as CEP290, (a protein mutated in NPHP and 
Joubert syndrome), PCM-1 (pericentriolar material 1), and BBS4 (Bardet-Biedl syndrome 
4) is an important component of centriolar satellites, the particles surrounding centrosomes 
and basal bodies, whose integrity depends on each of these proteins (Lopes, Prosser et al. 
2011) (Figure 7D-E).  
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Figure 7. Subcellular localization of the endogenous OFD1 protein.  
OFD1 localization at primary cilia in MDCK cells. (A) Staining with the anti-acetylated α-tubulin to detect 
the primary cilium. (B) Staining with the anti-OFD1 C-ter antibody. (merge in C) OFD1 localizes at the basal 
body of the primary cilium. (modified from (Giorgio, Alfieri et al. 2007)) 
OFD1 localization at centriolar satellites in hTERT-RPE1 cells. (D) Staining with the anti-γ-tubulin to detect 
the centrosome, and with the anti-OFD1. (E) Staining with anti-OFD1, and anti-PCM-1 to identify centriolar 
satellites. Scale bars: 2 μm. (modified from (Lopes, Prosser et al. 2011)) 
 
 
Recently, it has been demonstrated that OFD1 at centriolar satellites has a crucial role in 
suppressing primary ciliogenesis: in fact, the selective degradation of OFD1 in this specific 
location promotes primary cilia biogenesis (Tang, Lin et al. 2013). Thus, while Ofd1 at 
centrioles is essential for primary cilia formation, the Ofd1 component associated to 
centriolar satellites inhibits ciliogenesis. 
Research with animal models has proved useful for better understanding of the role/s of 
Ofd1 in health and disease. Thus, to gain initial insight into the molecular role of Ofd1, a 
null murine model for OFD type I syndrome was generated using a Cre-loxP system 
(Ferrante, Zullo et al. 2006). The knockout mice displayed ubiquitous inactivation of Ofd1 
from early stages of development and reproduced the main features of the human disease, 
albeit with increased severity, probably due to differences between the X-inactivation 
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patterns observed in humans and mice (Ferrante, Barra et al. 2003, Morleo and Franco 
2008). The heterozygous females (Ofd1∆4-5/+) died at birth. The pups were small, with 
skeletal abnormalities as polydactyly or polysyndactyly, and craniofacial defects including 
cleft palate, which probably underlies the perinatal lethality (Ferrante, Zullo et al. 2006). 
The newborn heterozygous females also showed brain disorganization, reduced lung size, 
cardiac great vessel defects and cystic kidneys. In female mutants, cilia were missing from 
the cells within kidney cysts, whereas adjacent cells were ciliated, thus implicating 
ciliogenesis as a mechanism underlying cyst development in OFD1. It is likely that this is 
due to the X-inactivation phenomenon with the presence of both cells expressing the 
mutated X and cells expressing the normal wild-type allele on the X chromosome (Ferrante, 
Zullo et al. 2006). The majority of hemizygous male embryos (Ofd1∆4-5), completely 
lacking gene function, died by E12.5 with early developmental defects. The Ofd1∆4-5 
embryos are small and a striking pericardial edema is evident, accompanied by 
randomization or failure of heart looping, observed in about 50% of embryos, suggesting 
defective L-R patterning mediated by the absence of nodal cilia (Ferrante, Zullo et al. 
2006). These results are consistent with the subcellular localization of Ofd1 in the basal 
body and confirm that this protein is required for primary cilia formation and left right axis 
specification (Ferrante, Zullo et al. 2006).  
Ofd1 plays also a crucial role in forebrain development, and in particular, in the control of 
dorso-ventral patterning and early corticogenesis (D'Angelo, De Angelis et al. 2012). Due 
to X inactivation, Ofd1∆4-5/+ heterozygous females at E12.5 show a high degree of 
variability ranging from a mild to a severe neurological phenotype, characterized by 
enlarged heads and a disorganization of the brain architecture with affected dorsal-ventral 
patterning in the telencephalon and an abnormal activation of Sonic hedgehog (Shh) (see 
also section 2.2) throughout the forebrain (D'Angelo, De Angelis et al. 2012). 
Ultrastructural studies demonstrated that early Ofd1 inactivation results in the absence of 
ciliary axonemes, which most likely causes defects in cytoskeletal organization and apical-
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basal polarity, despite the mature basal bodies being properly orientated and docked 
(D'Angelo, De Angelis et al. 2012). To investigate whether Ofd1 has a developmental 
stage-dependent role in the forebrain, a conditional null mouse model, in which the Ofd1 
floxed allele was crossed with an inducible Cre-line expressing the Cre recombinase under 
the actin promoter (CAGG-creERTM), was generated (Ofd1-indKO). Ofd1 inducible-
tamoxifen mediated inactivation at birth does not affect ciliogenesis in the cortex, 
suggesting that Ofd1 is dispensable for ciliogenesis in post-natal stages. Therefore, Ofd1 is 
critical for forebrain development and plays a crucial developmental stage-dependent role 
in ciliogenesis that occur after docking and before axoneme elongation in vivo (D'Angelo, 
De Angelis et al. 2012).  
In addition, to bypass the male mortality and better study the possible correlation between 
the cysts formation in kidney and the dysfunction of primary cilia observed in Ofd1 null 
mice, a conditional mouse model with renal specific inactivation of Ofd1 was generated. 
Using the Ksp-Cre transgenic line in which the Cre recombinase is specifically expressed 
in renal tubular epithelial cells, a viable model characterized by renal cystic disease and 
progressive impairment of renal function was obtained (Zullo, Iaconis et al. 2010). In this 
model, primary cilia are present in all renal tubules of mutant animals (Ofd1fl;creKsp) at 
precystic stages (P7) and then disappear from cells lining the renal cysts, indicating that 
cilia form before the development of cysts and suggesting that the absence of primary cilia 
is a consequence rather than the primary cause of renal cystic disease (Zullo, Iaconis et al. 
2010). 
Moreover, another conditional model was generated to elucidate the role of the Ofd1 in 
limb development. The specific inactivation of Ofd1 in limb mesoderm results in mutant 
mice displaying polydactyly with loss of digit identity in the presence of shorter and 
malformed cilia, and shortened long bones accompanied by defects in chondrocytes 
organization, reduction in mineralization process, and defective Hh signaling (see also 
section 2.2) (Bimonte, De Angelis et al. 2011). The skeletal phenotype observed in these 
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Ofd1 mutant animals recapitulates the skeletal abnormalities observed in OFD type I 
patients, indicating that Ofd1 plays an important role in regulating digit number and 
identity during limb, and skeletal patterning. 
Finally, Ofd1 function was also studied during Zebrafish (Danio rerio) embryonic 
development (Ferrante, Romio et al. 2009). The Zebrafish homolog, ofd1, encodes a 
protein with a 29.6% identity with the human OFD1 and the same centrosome/basal body 
localization previously described in humans and mice (Ferrante, Romio et al. 2009). 
Injection of antisense morpholinos (MOs) in one-cell stage embryos determines a typical 
ciliary phenotype with bent body, laterality defects, and edema. In this model, cilia are 
shorter with altered ultrastructure, which causes alteration of the fluid flow and 
consequently laterality defects in the brain, heart, and viscera (Ferrante, Romio et al. 2009). 
Interestingly, ofd1 has also a role in convergent extension (CE) during gastrulation, 
consistent with other studies linking cilia and non-canonical, PCP, Wnt signaling (May-
Simera and Kelley 2012). However, while cystic disease was not observed, the described 
CE defects could also be responsible for the delayed glomerular fusion observed in ofd1 
morphants; the glomerular vascularization is also compromised (Ferrante, Romio et al. 
2009). Overall, the phenotype observed in the Zebrafish model together with the phenotype 
described in the murine models indicate that Ofd1 plays an important role in the 
pathogenesis of inherited renal cystic disease, and in proper brain and skeletal development.  
 
 
2. The Hedgehog (Hh) signaling pathway 
The Hedgehog (Hh) signaling pathway regulates many developmental processes in both 
vertebrates and invertebrates. The Hh gene was first discovered in a large-scale genetic 
screen for mutations that disrupt the Drosophila larval body plan. Hh was found to be one 
of several genes important for body segmentation in flies. The name of the pathway 
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originates from the short and “spiked” phenotype of the cuticle of the Hh mutant 
Drosophila larvae, which resembles the hedgehog animal (Ingham, Nakano et al. 2011). 
Years later, three vertebrate Hedgehog genes, Indian Hh (Ihh), Desert Hh (Dhh) and Sonic 
Hh (Shh), with conserved role in body organization, were identified (Robbins, Fei et al. 
2012). The Hh proteins codified from these genes act as morphogens and form a 
concentration gradient to direct tissue patterning. Their general physiological functions are 
the same but they differ in the pattern of expression. Ihh is important for bone and cartilage 
development, while Dhh is needed for germ cell development in the testis and peripheral 
nerve sheath formation (Burglin 2008). Shh is the most studied and best characterized 
component of this family. It is important for the specification of neuronal identities along 
the dorsal-ventral axis in the neural tube, as well as for the proper patterning of limbs 
(Briscoe and Therond 2013). The identification of these roles for Hh proteins matches the 
model of developmental biology, a model in which organizer tissues secrete the Hh 
morphogens whose cellular responses triggering action is dependent on their concentration.  
 
2.1. Hedgehog signaling and the primary cilium 
Overall, the key components of the Hh pathway are highly conserved from fruit flies to 
humans, although additional pathway mediators and the requirement of primary cilia have 
added complexity to this pathway in vertebrates (Varjosalo, Li et al. 2006). Underscoring 
the link between primary cilia and Hh signaling, it has been demonstrated that mutations 
affecting either formation or functionality of primary cilia prevent cellular responses to 
Hedgehog ligands. Additionally, most of the proteins required for vertebrate Hh signal 
transduction localize at the cilium and shift their localization in response to the ligand 
(Goetz and Anderson 2010), thus emphasizing the importance of primary cilia for proper 
Hh signaling transduction. 
In the absence of the Hh ligand, the pathway is inactive and the 12-transmembrane 
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receptor Patched1 (Ptch1) localizes within primary cilia where actively represses the 
accumulation of the 7-transmembrane protein Smoothened (Smo) (Rohatgi, Milenkovic et 
al. 2007). When Hh ligand binds Ptch1 on the receiving cells, Ptch1 is activated and de-
represses Smo, which is free to translocate into the primary cilia and initiates a signal 
transduction cascade that leads to the activation of Gli (Glioma-associated oncogene) 
family transcription factors (Corbit, Aanstad et al. 2005) (Figure 8). In this off state, the 
protein Suppressor of Fused (Sufu) that locates on the primary cilium in a Gli-dependent 
manner (Haycraft, Banizs et al. 2005, Zeng, Jia et al. 2010), negatively regulates the 
pathway by directly binding to Gli proteins and anchoring them in the cytoplasm thus 
preventing the activation of target genes, such as Gli1 and Ptch1(Kogerman, Grimm et al. 
1999, Paces-Fessy, Boucher et al. 2004, Chen, Wilson et al. 2009, Li, Wang et al. 2011).  
     
 
Figure 8. Hedgehog signaling and the primary cilium.  
In vertebrates, primary cilia can act as an organizing center for GLI proteins processing. a) In the absence of 
Hedgehog, PTCH1 (PTC) is localized to the cilium and prevents accumulation of SMO in the cilium through 
an undetermined mechanism. SUFU directly interacts with GLI2 and GLI3, enabling their phosphorylation 
by PKA, CKI and GSK-3, which promotes their proteolytic processing to GLI2Rep and GLI3Rep. b) 
Binding of hedgehog ligands to PTC promotes removal of PTC from the cilium. Enzymes (including CKI) 
phosphorylate SMO, which is activated thereby and accumulates in the primary cilium, resulting in 
translocation of SUFU–GLI protein complexes to ciliary tips. KIF7 acts through both SUFU-dependent and 
SUFU-independent mechanisms to control the ciliary localization and dissociation of SUFU–GLI protein 
complexes, which results in translocation of GLI2Act and GLI3Act into the nucleus, promoting GLI target 
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gene transcription. Abbreviations: Act, transcriptional activator; Rep, transcriptional repressor (modified 
from (Alman 2015)). 
 
As mentioned before, in vertebrates, there are three Gli transcription factors (Gli1, Gli2 
and Gli3). Gli1 is the main full-length transcriptional activator, whereas Gli2 and Gli3 act 
as either positive or negative regulators as determined by post-translational processing 
through the proteasome (Ruiz i Altaba 1997, Sasaki, Nishizaki et al. 1999). The functions 
of the three Gli proteins overlap but are also distinct. This is mostly determined by the 
intrinsic molecular nature of the proteins. In the absence of Hh signaling activation by the 
ligand, Gli proteins are present in low amount at the ciliary tip and the majority of full-
length Gli proteins (Gli2FL and Gli3FL) are proteolytically processed to the N-terminal 
transcriptional repressor forms (Gli2R and Gli3R) that translocate to the nucleus and 
inhibit the transcription of target genes (Wang, Fallon et al. 2000) (Figure 8). Cytoplasmic 
sequestration of Gli proteins by Sufu facilitates their processing to repressor forms and 
their degradation, thus inhibiting the Hh pathway (Kogerman, Grimm et al. 1999). Gli3 
processing depends on consecutive phosphorylation of multiple serine and threonine 
residues at its C-terminus by Protein Kinase A (PKA), Casein Kinase 1 (CK1), and 
Glycogen Synthase Kinase 3 (GSK3). The phosphorylated Gli3FL is bound and 
ubiquitinated by the SCFβTrCP ubiquitin E3 ligase and is consequently processed by the 
proteasome in a site-specific manner to generate Gli3R (Tempe, Casas et al. 2006, Wang 
and Li 2006). Hh signaling induction inhibits Gli3 processing and activates the Gli3FL, 
which leads to upregulation of target genes (Wang, Fallon et al. 2000, Huangfu and 
Anderson 2005). However, activated Gli3FL presents only a weak activator function 
(Wang, Ruther et al. 2007), working mainly as an inhibitor of Hh signaling. In contrast to 
Gli3, Gli1 is a potent transcriptional activator, and its transcription is directly regulated by 
Hh signaling (Dai, Akimaru et al. 1999, Bai and Joyner 2001). This is mostly due to the 
absence of the repressor domain and of proteolytic processing (Dai, Akimaru et al. 1999, 
Sasaki, Nishizaki et al. 1999, Kaesler, Luscher et al. 2000, Bai and Joyner 2001). 
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Nevertheless, Gli1 is not essential for the initial step of Hh signaling transduction, it 
appears to enforce the expression of Hh target genes after their initial activation mainly due 
by Gli2. Indeed, Gli2 acts as the primary transcriptional activator that mediates Hh 
signaling, and through Gli2FL is also processed to generate a repressor, although the extent 
of its processing is lower than what observed in Gli3 (Pan, Bai et al. 2006). However, the 
maintenance of a proper ratio of the Gli2/3FL to the Gli2/3R forms plays an essential role 
in Hh signaling (Goetz and Anderson 2010, Li, Wang et al. 2011). 
In conclusion, Hh pathway activation coincides with the exclusion of Ptch1 from, and 
concomitant accumulation of Smo, in the primary cilium (Corbit, Aanstad et al. 2005, 
Rohatgi, Milenkovic et al. 2007), which results in inhibiting of Gli2 and Gli3 proteolytic 
processing thus allowing their accumulation at the tip of primary cilia. At this point, Gli 
proteins are converted into transcriptional full-length activators (GliA), by a mechanism 
still unknown, most likely related to post-translational modifications of Gli2 sequence 
(Kim, Kato et al. 2009) (Figure 8). Specific regions of the Gli2 protein, that could be 
subjected to post-translational modifications, regulate the localization to distinct 
subcellular sites resulting in modulation of its activity. In fact, a domain required for ciliary 
localization is also essential for Gli2 transcriptional activity, suggesting that the primary 
cilium is required for its function (Santos and Reiter 2014) and that the ciliary localization 
is crucial for a cilium dependent activation of Hedgehog signaling (Liu, Zeng et al. 2015). 
Furthermore, Hh activation promotes the cilium dependent dissociation of Sufu from 
Gli2FL and Gli3FL (Humke, Dorn et al. 2010, Tukachinsky, Lopez et al. 2010), which 
migrate to the nucleus and induce the transcriptional outcome of Hh target genes (Figure 8). 
Hh-mediated dissociation does not occur in cells either lacking cilia or with activated PKA, 
suggesting that the dissociation of Sufu-Gli complexes is dependent on the cilium in 
response to PKA inactivation (Chen, Wilson et al. 2009, Jia, Kolterud et al. 2009, Humke, 
Dorn et al. 2010, Tukachinsky, Lopez et al. 2010).  
Another additional important player for regulating Gli activity is the kinesin family 
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member 7 (Kif7), a human ciliopathy protein (Dafinger, Liebau et al. 2011, Putoux, 
Thomas et al. 2011) which belongs to the kinesin-4 family. Beyond Sufu and Gli proteins, 
Kif7 also shows basal level of cilia localization in Mouse Embryonic Fibroblasts (MEFs), 
which enriches in cilia tips in response to Hh pathway activation (Liem, He et al. 2009). 
Recently, it has been demonstrated that Kif7 regulates Hh signaling by affecting Gli 
processing and activity (Liem, He et al. 2009, Maurya, Ben et al. 2013), however, the basic 
mechanisms of its function are still poorly understood. Solid experimental evidence 
demonstrates that its function in the Hh pathway depends strictly on the primary cilium 
(Endoh-Yamagami, Evangelista et al. 2009, Liem, He et al. 2009). In fact, Kif7 modulates 
the length of microtubules at the tip of primary cilia, and promotes the localization and 
appropriate regulation of Gli and Sufu in this location by controlling axonemal 
microtubules directly (He, Subramanian et al. 2014). In agreement, Gli2 and Sufu localize 
abnormally in puncta along the axoneme when Kif7 is absent or mutated, whereas in wild-
type cells they accumulate at ciliary tips, as expected (Briscoe and Therond 2013) (Figura 
9). Cilia on Kif7-mutant embryonic neural progenitor cells and cultured fibroblasts are 
longer, unstable and have structural defects at the axonemal tip, similarly to cilia 
fibroblasts from human patients with Kif7 mutations (Putoux, Thomas et al. 2011). Kif7 
increases the frequency of shrinkage at the distal end of axonemal microtubules, 
highlighting that it is important for the primary cilia integrity by regulating microtubule 
growth at the distal tip. This is the reason why Kif7-mutant cells have elongated cilia and 
mislocalization of Gli and Sufu to ectopic tip-like compartments along the axoneme, 
causing deregulation of Hh signaling (He, Subramanian et al. 2014) (Figura 9). Overall, the 
precise molecular and biochemical mechanism/s underlying the key role/s of Kif7 in 
affecting Gli localization, processing, and function to regulate expression of target genes 
remain unclear, but, researchers agree on the existence of a direct link between 
microtubule-regulation-dependent morphogenesis of primary cilia and the control of the 
Hh signaling pathway (Goetz, Ocbina et al. 2009, He, Subramanian et al. 2014, Gerhardt, 
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Leu et al. 2016). 
 
 
 
 
Figure 9. The primary cilium and regulation of Hedgehog signaling by Kif7.  
(a) In the absence of Shh, Ptc localizes to the ciliary membrane and inhibits Smo, located in vesicles in the 
cytoplasm. Kif7, Sufu and the Gli2 and Gli3 transcription factors are present in low amounts at the ciliary tip. 
Gli2 and Gli3 are processed to their repressor forms (Gli-R) and target gene transcription is turned off. (b) 
Shh binds to Ptc, causing the receptor to exit the cilium concomitantly with Smo ciliary entry and 
accumulation of Kif7 and Gli–Sufu complexes at the ciliary tip. Kif7 organizes ciliary tips for appropriate 
localization and regulation of Gli–Sufu complexes, and Gli2 and Gli3 are converted to their full-length 
activator forms (Gli-A) for target gene transcription in the nucleus. For simplicity, only the most relevant 
proteins are shown. For a detailed overview of Hedgehog signaling in cilia, see (Nozawa, Lin et al. 2013). (c) 
In Kif7-mutant cells, the ciliary tip compartment is disorganized. Axonemal microtubules are longer and of 
unequal length, leading to the formation of ectopic tip-like compartments where Gli–Sufu complexes become 
localized and inappropriately activated in the absence of Shh ligand (modified from (Pedersen and 
Akhmanova 2014)). 
 
Mutations in the KIF7 gene have recently been identified in patients with ciliopathies, such 
as hydrolethalus (HLS) and acrocallosal (ACLS) syndromes, characterized by polydactyly, 
brain abnormalities, and cleft palate (Putoux, Thomas et al. 2011, Putoux, Nampoothiri et 
al. 2012, Walsh, Shalev et al. 2013); Bardet-Biedl (BBS) (DeLuca, Weed et al. 2015) and 
Joubert syndromes (Dafinger, Liebau et al. 2011) with brain malformation, cerebellar 
hypoplasia, ataxia, psychomotor delay, retinal degeneration, renal cyst, and skeletal 
abnormalities. Thus, the interest in understanding the precise mechanism at the base of Gli 
regulation by Kif7 is growing more and more. 
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However, despite recent progress, the mechanisms by which the cilium regulates Hh 
signaling remain obscure, and still unanswered are many questions about the activation of 
Gli proteins, including how Glis are trafficked into the cilium, whether other ciliary events 
are required for their activation, and how they move from the cilium to the nucleus. 
 
2.2  Hedgehog signaling in health and disease 
The Hedgehog signaling pathway plays important roles in the embryonic development of 
multicellular organisms, while, in adults, it is required for tissue homeostasis, repair, and 
regeneration, and it is often abnormal in diseased states (Beachy, Karhadkar et al. 2004, 
Lum and Beachy 2004, Petrova and Joyner 2014). It controls the digit pattern in limbs and 
the organization of neuronal subtype identity in the CNS of vertebrates. Dysregulation of 
this pathway is responsible for congenital syndromes, such as holoprosencephaly (a rare 
congenital brain malformation resulting from incomplete separation of the two 
hemispheres); other developmental malformations (such as, neural tube disorders, axial 
skeleton and limb malformations) (Hui and Angers 2011); as well as carcinogenesis (Jacob 
and Briscoe 2003, Motoyama 2006). The Hh signaling cascade is activated in various types 
of human malignancies including basal cell carcinomas (BCC), the most common type of 
skin cancer, and the Shh subtype of medulloblastoma, the most common type of brain 
cancer (Ebrahimi, Larijani et al. 2013). 
In the vertebrate embryo, the Hedgehog ligand is initially expressed in the notochord, a 
mesodermal-derived structure that lies along the anteroposterior (A/P) axis of the body; it 
guides specification of all ventral cell types such as motor neurons in the developing neural 
tube, which will later on become the spinal cord (Jessell 2000). After birth, Shh continues 
to play important roles in the growth of the brain and in the maintenance of neural 
progenitors (Ruiz i Altaba, Palma et al. 2002). During skeletal development, it is required 
for limb formation and specification of digit number and identity in developing limb buds 
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(Johnson, Riddle et al. 1994). To be more precise, Hedgehog ligands are expressed by cells 
of the posterior portion of the limb bud mesoderm and diffuse across the developing limb 
bud, producing a concentration gradient that acts as a morphogen to specify digit 
development (Yang, Guillot et al. 1998). The repressor activity of Gli3 is especially 
important in embryonic patterning of limbs and also of the neural tube (Jiang and Hui 
2008). During limb buds development, Gli3R shows an A/P gradient inversely 
proportional to Shh levels. In the neural tube, Gli3 is critical to establish a double Gli 
gradient with opposite polarities of activators (high to low from ventral to dorsal) and 
repressors (high to low from dorsal to ventral) to regulate the specification of individual 
neural subtypes (Jiang and Hui 2008, Briscoe and Therond 2013). In addition to limb and 
neural development (Wang, Ruther et al. 2007), Gli3R is involved in the development of 
the vertebrate lung, kidneys, ureter, mammary gland, and ears (Lee, Zhao et al. 2016). Also, 
Gli2R takes part in the development of the brain and the limbs in mice as well as the neural 
tube in Zebrafish (Ke, Kondrichin et al. 2008, Bowers, Eng et al. 2012). Gli2R, together 
with Gli3R, controls anterior limb patterning and digit number. Overall, all three vertebrate 
Hh transcription factors (Gli1, Gli2 and Gli3 proteins) act together to integrate Hh 
signaling inputs, resulting in the regulation of tissue pattern, size, and shape (Ruiz i Altaba, 
Mas et al. 2007, Wang, Ruther et al. 2007, Hui and Angers 2011). 
Mutations that affect hedgehog signaling cause skeletal defects including polydactyly (the 
presence of extra digits) and neural tube defects.  Similarly, also mutations in cilia genes 
(e.g. the Ift mutants) associated to defective Hh pathway result in altered Hh-dependent 
digit development, polydactyly and abnormal dorso-ventral patterning of the neural tube 
(Goetz and Anderson 2010). In Shh mutants, ventral neural cell types fail to be specified 
and the limbs lack digits (Goetz and Anderson 2010); in anterograde IFT mutants (e.g. the 
IFT-B mutants Ift88 or Ift172) that lack cilia, the Hh signaling is reduced, the neural tube 
is dorsalized and polydactyly occurs, whereas IFT-A mutants (e.g. Ift139) exhibit 
phenotypes consistent with excessive Hh signaling and ventral cell types expand in the 
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neural tube (Goetz and Anderson 2010, Reiter and Leroux 2017) (Figure 10). 
 
                         
 
   
Figure 10. Neural and limb patterning phenotypes in hedgehog pathway and cilia mutants.  
a | In wild type embryos, ventral neural cell fates are specified by a gradient of sonic hedgehog (Shh). The 
number and identity of digits in the limb is established by an Shh gradient from the posterior limb bud to the 
anterior limb bud, where the repressor form of Gli3 (Gli3R) inhibits Shh. b | In the absence of hedgehog (Hh) 
(for example, in smoothened (Smo)–/– embryos) ventral neural cell fates are lost. The limbs of Shh–/– mutants 
lack digits. c | If the pathway is hyperactive (for example, in patched 1 (Ptch1)–/– embryos), ventral cell types 
expand in the neural tube. Activation of the pathway within the limb, such as in Gli3–/– mutants (which lack 
Gli3R), causes the formation of extra digits. d | Anterograde intraflagellar transport (Ift) mutants (for 
example, Ift88–/– or Ift172–/– embryos) lack cilia: Hh signaling is reduced, and the neural tube is dorsalized. 
This phenotype is milder than in b because cilia are also required for Gli3R processing, and cell types that 
require low levels of Hh signaling are specified. Reduced Gli3R results in polydactyly. Dynein motor 
mutants display a similar phenotype; however, they retain motor neurons in the caudal neural tube. e | IftA 
complex mutants (for example, Ift139–/– embryos) exhibit phenotypes consistent with excess Hh signaling 
(Modified from (Goetz and Anderson 2010)). 
 
Many clinical features seen in ciliopathies models can be attributed to abnormal Hh 
signaling. In fact, mouse mutants with Ofd1 inactivation that reproduces OFD type I 
syndrome display severe polydactyly with loss of A/P digit patterning and shortened long 
bones. These models show loss of digit identity associated with a progressive loss of Shh 
signaling and an impaired processing of Gli3. On the other hand, the defects in limb 
outgrowth observed in Ofd1 mutants are due to defective Ihh signaling and abnormal 
mineralization during endochondral bone formation (Bimonte, De Angelis et al. 2011).  
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Another important physiological role played by the Hh signaling pathway is the embryonal 
regulation of the early craniofacial development. Hh is essential for establishing 
subdivision of the eyefield, for bilateral patterning of the ventral forebrain (Chiang, 
Litingtung et al. 1996), and for early formation of the upper lip and palate. Many studies 
indicate that the concentration of ligand and the duration of Hh signaling are also important 
for the correct development of the face. Collectively, the time-space coordinated function 
of Hh signaling activity is essential for orchestrating fundamental organization of the 
craniofacial region (Xavier, Seppala et al. 2016). Mutations in many genes that encode Hh 
signaling proteins, or that cause impairment of the Hh pathway, are associated with 
craniofacial anomalies in the human population. Thus, mice with deletion of Shh have 
significant craniofacial defects, including alobar holoprosencephaly, cyclopia (Chiang, 
Litingtung et al. 1996), failure of the primary mouth opening (Tabler, Bolger et al. 2014), 
and hypoplasia of the first pharyngeal arch (Washington Smoak, Byrd et al. 2005, 
Yamagishi, Yamagishi et al. 2006). Moreover, a mouse model for MKS, caused by loss of 
Mks1, shows altered Hh signaling that underlies some of the defects, including craniofacial 
abnormalities (Weatherbee, Niswander et al. 2009).  
Finally, given the implications of the Hh pathway in human diseases, there is an evident 
interest in identifying small molecules capable to target and modulate this pathway and to 
develop pharmacologic strategies to apply in conditions where this pathway is impaired.  
 
 
3. Protein degradation and cilia 
Given that the diverse responses of the cell to the Hh pathway in different tissues during 
development depend on the duration of exposure to Hh ligand and on a proper gradient 
concentration of secreted Hh protein, several mechanisms that dynamically and tightly 
regulate the amount of Hh signaling mediators are necessary. A well-established 
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mechanism for limiting signal duration is the Hh induced ubiquitination and degradation of 
Gli proteins. The impairment of this process can lead to cell patterning disruption and 
uncontrolled cell proliferation (Di Marcotullio, Ferretti et al. 2006, Kent, Bush et al. 2006, 
Di Marcotullio, Ferretti et al. 2007, Ou, Wang et al. 2007). As mentioned before, the UPS 
also proteolytically processes Gli2 and Gli3 (Wang, Fallon et al. 2000). During this 
processing event, ubiquitination takes place immediately after phosphorylation of Gli2 and 
Gli3, but it is still unknown if this event occurs at the basal body. However, considering 
that the resulting truncated forms of both proteins play decisive roles during development 
of almost every vertebrate organ (Goetz and Anderson 2010, Waters and Beales 2011, 
Briscoe and Therond 2013), the correct functionality of the proteasome is really essential. 
In addition to Gli factors, a growing number of evidence suggests that ubiquitination also 
plays critical roles in modulating other Hh signaling components including Ptc, Smo, and 
Sufu, thus demonstrating that ubiquitination is an important mechanism in the regulation of 
Hh pathway dynamics and in the turnover of its mediators (Hsia, Gui et al. 2015).  
In general, intracellular protein turnover is essential for the regulation of cellular functions 
and maintenance of cellular homeostasis. Their levels within cells are determined not only 
by rates of synthesis, but also by rates of degradation. The rapid turnover of proteins is 
necessary to change quickly their levels in response to external stimuli (Lecker, Goldberg 
et al. 2006). This general mechanism for cellular protein is really important and also shared 
by ciliary proteins. In addition, also misfolded or damaged proteins are recognized and fast 
degraded within cells to avoid toxicity. Each protein is degraded at widely differing rates 
that vary from minutes to days or weeks. Overall, the rates of protein degradation in each 
cell must be precisely balanced because even a small acceleration of degradation can result 
in a marked loss of protein storages, with a consequential loss of protein which is not 
available for performing its cellular functions (Mitch and Goldberg 1996, Lecker, 
Goldberg et al. 2006).  
Cells contain multiple proteolytic systems to carry out degradation processes together with 
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complex regulatory mechanisms to ensure that the proteolytic processes are highly 
selective. Cells use two major protein degradation systems: the ubiquitin-proteasome 
system (UPS), which usually degrades the majority of proteins, and the autophagy-
lysosome pathway (ALP), primarily responsible for the degradation of most long-lived or 
aggregated proteins and cellular organelles (Lilienbaum 2013). 
 
3.1 The Ubiquitin-Proteasome System (UPS) 
The Ubiquitin Proteasome System (UPS) is a highly regulated mechanism responsible 
for degrading 80-90% of proteins. Considering that cells are permanently subjected to 
external and internal changes as well as stressful insults, a constant remodeling and repair 
or elimination of many regulated, short-lived, denatured, or damaged proteins is required 
(Dikic 2017). Ubiquitin-dependent degradation by the proteasomal machinery is involved 
in the regulation of several processes including maintenance of different aspects of cellular 
homeostasis (ATP balance, amino acid recycling, control of protein quality), regulation of 
gene transcription, antigen presentation, cell cycle progression, DNA repair, receptor-
mediated endocytosis, cell stress response, apoptosis, cell differentiation, and proper 
activity of pathways (Dikic 2017, Varshavsky 2017). The proteasome is a machine for 
efficient and automatic destruction of ubiquitin protein conjugates into oligopeptides and 
ubiquitin releasing and recycling, but it is also important for determining whether an 
ubiquitinated protein should undergo degradation or should survive intact (Collins and 
Goldberg 2017). Defects in UPS can result in the pathogenesis of relevant and common 
human conditions, such as neurodegenerative disorders and cancer. More recently, 
impaired UPS has also been associated to ciliopathies (Ciechanover, Orian et al. 2000, 
Gerhardt, Leu et al. 2016).  
UPS controls the activity of various cellular processes by covalently attaching ubiquitin to 
protein substrates. Proteins are initially tagged by a covalently linked poly-ubiquitin chain, 
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which is recognized as a degradation signal by the proteasome. As a result, the ubiquitin 
chain is removed and the protein is unfolded in an ATP dependent manner and translocated 
into the center of the proteasome complex, where it is degraded into small peptides 
(Kisselev and Goldberg 2001). The key factor in this process is the ubiquitin (Ub), which 
is an highly conserved, small (8.5kDa), regulatory, globular protein composed of 76 amino 
acids (Callis 2014). Ubiquitin is encoded by four different genes (UBB, UBC, UBA52, and 
UBA80 (RPS27A)) and is produced as a precursor that must be proteolytically processed to 
release mature ubiquitin (Bianchi, Giacomini et al. 2015). It is strongly expressed in cells 
and can be covalently coupled to the ε-amino group of a lysine (Lys) within a substrate 
protein. Ubiquitination is both an inducible and reversible signaling cascade used in all 
eukaryotic cells and requires the orchestration of three different classes of enzymes: 
ubiquitin activating enzymes (E1), ubiquitin-conjugating enzymes (E2), and ubiquitin 
ligases (E3), but a new class of ubiquitin elongation factors called ubiquitin ligases (E4) 
has been found (Callis 2014) (Figure 11). Each of these enzymes plays a different role in 
activating free ubiquitin and catalyzing its covalent addition for ubiquitin modification of 
protein substrates. Although ubiquitination can have many effects on the modified protein 
(such as in regulating the stability, function, and/or localization), its role as a signal for 
regulated protein degradation by proteasomal degradation is well established and 
characterized. Ubiquitination is mediated by an enzymatic cascade of three reactions. In 
the first step, the E1 catalyzes the ATP-dependent activation of ubiquitin resulting in the 
formation of a thioester bond between the C-terminus of ubiquitin and a cysteine residue in 
the E1 active site. Subsequently, activated Ub is transferred to an active cysteine residue of 
the E2 to generate again a new thiol ester intermediate. At the end, the E3, with 
cooperation of E2, attaches Ub to a Lys residue of a substrate protein. In some cases, the 
extension of short ubiquitin chains requires the action of additional elongation factors, the 
E4 enzymes (Callis 2014). (Figure 11). 
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Figure 11. Mechanism of ubiquitination. 
The ubiquitination process involves a three-enzyme cascade. The E1 enzyme first activates the carboxy 
terminus of the ubiquitin molecule, using the energy from converting an ATP molecule to AMP and 
pyrophosphate (PPi). The activated ubiquitin is attached to the sulfur of the E1 active-site cysteine residue. 
Ubiquitin is then transferred from E1 to E2, and E3 facilitates the transfer of ubiquitin from E2 to the 
substrate protein. In some cases, the extension of short ubiquitin chains requires additional elongation factors, 
termed E4 enzymes. (Modified from (Brinkmann, Schell et al. 2015)). 
 
There are approximately 600 ubiquitin E3 ligases identified, with variable specificities to 
individual protein-substrates (Komander 2009). The specificity and type of ubiquitination 
is generated from substrate recognition by the E3 and the formation of different E2–E3 
complex combinations that mediate ubiquitination (Weissman 2001). Ub itself contains 
seven lysine residues (Lys6, Lys11, Lys27, Lys29, Lys33, Lys48 and Lys63) that can be 
targeted in recurrent rounds of this cascade, giving rise to differently linked and branched 
Ub chains (polyUb). In this way, a complex Ub code can be generated. In fact, one 
ubiquitin C-terminus can be covalently linked to a second ubiquitin via one of the latter's 
seven Lys ε-amino groups or N-terminal amino group, forming ubiquitin chains. Thus, in 
addition to a single ubiquitin modification (monoubiquitination) or modification by one 
ubiquitin at multiple sites of the same substrate (multi-monoubiquitination or poly-
monoubiquitination), substrates can be modified by ubiquitin chains (polyubiquitination) 
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(Callis 2014). Ubiquitination plays additional roles depending on the chain configuration 
and linkage (Komander 2009). There is increasing evidence for the formation of more 
complex topologies with mixed linkages, so-called atypical chain types, with unknown 
functions (Li and Ye 2008). In fact, the Ub polymers can also contain several linkage types 
in mixed ubiquitin chains, or one ubiquitin can be modified on multiple sites to form 
branched ubiquitin chains (heterotypic chains), generating a huge number of possible chain 
topologies (Nakasone, Livnat-Levanon et al. 2013). These types of Ub chains provide new 
functionalities in cells and constitute seemingly independent signals in degradation and 
signaling (Michel, Elliott et al. 2015). Thus, different ubiquitin-ubiquitin linkages form 
distinct conformations and consequently regulate different cellular processes (Haglund and 
Dikic 2005). Monoubiquitination may facilitate protein recognition, complex formation, or 
allosteric regulation, while most substrates require poly-ubiquitination to be delivered to 
the proteasome. Usually, the attachment of a Lys 48-linked polyUb chain to a protein is 
required for an efficient degradation, whereas the Lys 63-linked polyUb chain is mainly 
involved in non-proteolytic processes such as transcription, intracellular protein trafficking, 
autophagy, DNA-damage response, cellular signaling, and others (Komander and Rape 
2012, Swatek and Komander 2016, Yau and Rape 2016).  However, recent studies have 
added another level of complexity to this general process by demonstrating also the 
involvement of polyUb chains linked through Lys6, Lys11, Lys27, Lys29, Lys33 or Lys63 
in targeting proteins to the proteasome for degradation (Saeki, Kudo et al. 2009).  
 
3.1.1 Structure and function of the 26S proteasome 
The degradation of the vast majority of intracellular mammalian proteins is performed 
mainly by the proteasome, also called 26S proteasome in eukaryotes. The 26S proteasome 
is a cylinder-shaped multicatalytic ATP-dependent protease complex present in all 
eukaryotic cells. It consists of two subcomplexes: a central 20S core particle (CP, about 
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700 kDa), capped with one or two 19S regulatory particles (RP the most abundant form 
in mammals is called PA700, about 900 kDa) on one or both ends of the CP (Budenholzer, 
Cheng et al. 2017) (Figure 12).  
 
 
Figure 12. Scheme of 26S proteasome. 
a | The 26S proteasome consists of the catalytic 20S proteasome (a barrel of four stacked rings: two outer 
alpha-rings and two inner beta-rings) and the 19S regulatory particle (RP, also known as PA700). b | Subunit 
composition of the 26S proteasome. The regulatory particle is further divided into the base and the lid 
subcomplexes, which are composed of regulatory particle triple-A (RPT) and regulatory particle non-ATPase 
(RPN) subunits. RPN10 is colored in yellow since it is thought to be located at the base–lid interface 
(modified from (Murata, Yashiroda et al. 2009)).  
 
The 20S core particle is responsible for the degradation of proteins into short peptides. It 
is composed of four stacked rings, two outer α-rings and two inner β-rings, forming a 
central cavity of 2-nm diameter. The two outer rings consist of seven different α subunits 
(α1- α7) that cap the two inner rings formed by seven different β subunits (β1-β7) 
(Budenholzer, Cheng et al. 2017). Only three β subunits (β1, β2 and β5) contain 
catalytically active sites, with threonine residues at their N-termini, that face the interior 
space of the 20S CP, while the other β-subunits, (β3, β4, β6 and β7) are catalytically 
inactive. The β catalytic subunits are associated with caspase-like, trypsin-like, and 
chymotrypsin-like activities, respectively, which confer the ability to cleave peptide bonds 
at the C-terminal side of acidic, basic, and hydrophobic aminoacid residues, respectively 
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(Budenholzer, Cheng et al. 2017). Different proteasome inhibitors have been developed 
that target these activities (Groll and Huber 2003). While β rings possess proteolytically 
active sites, the outer α rings forms a narrow channel (~ 13Å in diameter), mainly 
composed of α2, α3, and α4 subunits, which controls the access of substrates to the 
catalytic chamber and provides attachment sites for the 19S RP. In order to be degraded 
into peptides of 2–24 amino acids, substrate proteins must first be unfolded and then 
translocated into the proteolytic chamber via the narrow gate to access the active sites of 
catalytic enzymes at the center of the α-ring (Budenholzer, Cheng et al. 2017). Thus, UPS 
provides an essential source for aminoacids, and if the proteasome activity is inhibited, 
increased cell lethality due to severe storage of aminoacids occurs (Suraweera, Munch et al. 
2012). 
The 19S regulatory particle is the key regulatory component of the 26S proteasome. It is 
responsible for recognition of ubiquitinated substrate followed by the removal of the 
ubiquitin chain via deubiquitinating enzymes, substrate unfolding, and translocation into 
the 20S catalytic chamber for degradation (Bar-Nun and Glickman 2012). The 19S RP is 
composed of at least 19 subunits that can be divided into two sub-complexes: the base and 
the lid (Lander, Estrin et al. 2012). The central part of the RP base consists of six AAA 
ATPases (Rpt1–Rpt6), Rpt1/S7, Rpt2/S4, Rpt3/S6, Rpt4/S10b, Rpt5/S6 and Rpt6/S8, 
which form an hesameric ring (Tomko, Funakoshi et al. 2010). The base also includes four 
non-ATPase subunits: Rpn1/S2, Rpn2/S1, Rpn10/S5a, and Rpn13/hRpn13 (Elsasser, Gali 
et al. 2002, Tomko, Funakoshi et al. 2010, Rosenzweig, Bronner et al. 2012). The 
hydrolysis of ATP provides the energy to unfold the substrates and translocate them into 
the 20S CP catalytic chamber (Smith, Chang et al. 2007). Significantly, the functions of the 
six ATPases are not redundant; in fact, they have to work together and coordinately. The 
non-ATPase proteins of the RP base, Rpn13, and Rpn10 possess ubiquitin-binding 
domains, and function as receptors for ubiquitinated substrates (Finley 2009). In addition, 
shuttling factors (Rad23, Dsk2, and Ddi1), members of the UBL/UBA protein family, 
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deliver ubiquitinated proteins to the proteasome for degradation. These proteins contain an 
ubiquitin-like (UBL) domain for binding to proteasome and one or more ubiquitin 
associated (UBA) domains for binding to poly-ubiquitinated chains (Wilkinson, Seeger et 
al. 2001, Elsasser, Gali et al. 2002). The lid complex includes also 9 non-ATPase subunits, 
Rpn3, Rpn5–Rpn9, Rpn11, Rpn12, and Sem1 (Lander, Estrin et al. 2012). It is connected 
to the base complex by interactions between Rpn12 and Rpn2, Rpn11 and Rpn1, and 
Rpn10 might be involved in stabilizing these interactions (Boehringer, Riedinger et al. 
2012). One of the main functions of lid and base is proposed to be the removal of ubiquitin 
signals (a process called deubiquitination), carried out by specific enzymes, the 
deubiquitinases or deubiquitinating enzymes (DUBs) (Reyes-Turcu, Ventii et al. 2009). 
 
3.1.2 Deubiquitinating enzymes 
DUBs are a class of the human family of proteases that catalyse the removal of ubiquitin 
from target proteins and are also involved in ubiquitin maturation, recycling, and editing 
(Reyes-Turcu, Ventii et al. 2009, Clague, Barsukov et al. 2013). In particular, they produce 
free ubiquitin by releasing single molecules of Ub from the multiple fused ubiquitin 
moieties transcribed by ribosomes during the generation of de novo Ub. Another way to 
maintain the pool of free Ub is recycling ubiquitin from ubiquitin-protein conjugates. This 
process is vital for keeping sufficient levels of free ubiquitin that can be used for ubiquitin 
chain assembly. Deubiquitinating enzymes also cleave polyubiquitinated chains in specific 
locations inducing differential effects on the fate of the ubiquitinated proteins (Reyes-
Turcu, Ventii et al. 2009). Moreover, DUBs can completely remove ubiquitin chains from 
ubiquitinated proteins and consequently stabilize proteins by preventing their degradation 
(Komander, Clague et al. 2009, Farshi, Deshmukh et al. 2015). Most DUBs regulate only a 
limited number of proteins and pathways, indicating that they operate with a limited 
number of specific target substrates (Hu, Li et al. 2005). In fact deubiquitinases exhibit 
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strong substrates specificity by using their ubiquitin-binding domain (UBD) (Nijman, 
Luna-Vargas et al. 2005, Komander, Clague et al. 2009). The number of known 
deubiquitinases is growing and varies depending on different organisms; for example, ~20 
DUBs exist in Saccharomyces cerevisiae, while in humans there are ~100 enzymes 
(Clague, Barsukov et al. 2013) which are divided into six classes: ubiquitin-specific 
proteases (USPs, the largest family in human: about 60 members), ubiquitin carboxy-
terminal hydrolases (UCHs), ovarian-tumour proteases (OTUs), Machado–Joseph disease 
protein domain proteases (MJD), JAMM/MPN domain-associated metallopeptidases 
(JAMMs) and monocyte chemotactic protein-induced protein (MCPIP) (Fraile, Quesada et 
al. 2012). Among the DUBs, three are associated with proteasome in humans to rescue 
ubiquitin chains before the degradation of the substrate protein: Rpn11/POH1 (Verma, 
Aravind et al. 2002), Ubp6/USP14 (Borodovsky, Kessler et al. 2001, Leggett, Hanna et al. 
2002), and Uch37/UCHL5 (Lam, Xu et al. 1997) (yeast/human nomenclature) (Figure 13).  
Rpn11 is a metalloprotease, precisely a Zn2+-dependent DUB, which belongs to the 
JAMM domain family and is an integral part of the lid complex in 19S RP (Ambroggio, 
Rees et al. 2004), while Uch37 and Usp14 are cysteine proteases and members of the 
UCHs and USPs families, respectively. Both Usp14 and Uch37 are proteases reversibly 
associated to the base complex of the 19S RP: they release the ubiquitin chain from the 
substrate of proteasome and disassemble it. For an efficient proteolysis, the substrate has to 
be deubiquitinated. The covalently linked poly-ubiquitin chains of substrates sterically 
prevent the access to the opened channel into the 20S CP, thus the cleavage and removal of 
the ubiquitin chain is required for substrate translocation and degradation. 
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Figure 13. Proteasome bound deubiquitinating enzymes.  
Deubiquitinating enzymes are indicated by red crescents, the substrate as a green line, and ubiquitin as blue 
ovals. POH1 catalyzes the release of a polyubiquitin chain “en bloc” as the substrate is engaged and 
translocated through the gated pore of the 20S protease. RPN10 (yellow) binds the polyubiquitin chain and 
the distal end of the chain can be removed by the action of UCH37 bound to ADRM1 (orange). USP14 is 
bound to the proteasome via interactions with RPN1 (purple) and probably removes mono ubiquitin attached 
to the substrate (modified from (Reyes-Turcu, Ventii et al. 2009)).  
 
Rpn11 is the essential DUB for this aim: as a matter of fact, while Rpn11 promotes 
substrate degradation by removing the ubiquitin moiety as en bloc from the base of the 
chain, Uch37 and Usp14 are believed to antagonize substrate degradation. Both Usp14 and 
Uch37 trim the polyubiquitin chain to regulate the time of interaction between substrate 
and proteasome and the resulting rate of degradation (Leggett, Hanna et al. 2002, Stone, 
Hartmann-Petersen et al. 2004, Lee, Lee et al. 2011). Thus, the discrimination between 
these three DUBs resides in their proteolysis promoting activity. 
 
3.1.3  Ubiquitin-Specific Protease14 (USP14) 
USP14, the mammalian homolog of yeast Ubp6, is a cysteine protease that belongs to the 
ubiquitin specific proteases (USP) family. It is encoded by the USP14 gene, located on 
chromosome 18p11.32, which is highly expressed in several mammalian tissues. 
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Alternative pre-RNA splicing results in two isoforms of USP14 but only one of them gives 
rise to a fully operative enzyme (Crimmins, Jin et al. 2006). 
 
3.1.3.1.  Structure and functions of USP14 
USP14 encodes a protein that consists of 494 amino acids (about 60 kDa), composed of a 9 
kDa N-terminal UBL domain (Wyndham, Baker et al. 1999), conserved between many 
eukaryotic species, and followed by a 45 kDa catalytic domain (Hu, Li et al. 2005). The 
UBL domain has a folding pattern similar to that observed in ubiquitin (Wyndham, Baker 
et al. 1999). It was first identified in USP14, but now it is known to be present in several 
members of the USP family (Komander, Clague et al. 2009). The UBL domain of Usp14 is 
critical for its reversible association with the Rpn1 subunit of the base in the 19S 
regulatory particle (Hu, Li et al. 2005). This association with the proteasome increases 
USP14 catalytic activity several hundredfold. In fact, USP14 is activated upon binding to 
the proteasome and catalyzes the cleavage of ubiquitin subunits from substrates before 
degradation by the proteasome (Borodovsky, Kessler et al. 2001, Hu, Li et al. 2005, Hanna, 
Hathaway et al. 2006), but it is also likely that free USP14 could have other proteasomal 
independent functions (Jung, Kim et al. 2013). The favourite substrates for USP14 are 
Lys48-linked polyUb chains which are cleaved from their distal end or within the chain 
(Hu, Li et al. 2005, Hanna, Hathaway et al. 2006), but recently, it has also been 
demonstrated an involvement of Usp14 in the regulation of the autophagy pathway by 
negatively controlling K63 ubiquitination of Beclin1, an important player of autophagy 
(Xu, Shan et al. 2016). Therefore, regulation of Usp14 activity provides a mechanism to 
control both proteasomal and autophagic degradation. Inhibition of Usp14 has been 
proposed as a strategy to promote both UPS and ALP for developing novel therapeutic 
approaches to use in neurodegenerative disease. The activity of Usp14 in deubiquitinating 
K63 Ub linkage is likely of physiological relevance given that inhibition of Usp14 in vivo 
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leads to enhanced K63-linked Ub conjugates in both spinal cord and neurons (Vaden, 
Bhattacharyya et al. 2015). However, the mechanism by which Usp14 regulates K63 
ubiquitination in controlling cellular processes and its functional significance is not well 
characterized. 
Beyond its function in controlling protein degradation, Usp14 has a critical role in 
ubiquitin recycling. Loss of ubiquitin pools severely impairs the ability of the proteasome 
to degrade unwanted proteins, being dependent on ubiquitin for tagging, thus resulting in 
protein accumulation. Depletion of free ubiquitin upregulates proteasome bound Usp14, 
while loss of Usp14 results in increased degradation of ubiquitin and decreased levels of 
monomeric ubiquitin (Hanna, Leggett et al. 2003, Hanna, Hathaway et al. 2006, Hanna, 
Meides et al. 2007). This specific role of Usp14 in stabilizing cellular ubiquitin levels was 
demonstrated in Usp14 deficient mice with spontaneous ataxia mutation (axJ) which 
display decreased ubiquitin levels in all tissues with the most evident depletion observed at 
synaptic terminals (Wilson, Bhattacharyya et al. 2002, Anderson, Crimmins et al. 2005). 
The axJ mutation reduces dramatically the levels of Usp14 in both neuronal and non-
neuronal tissues, resulting in severe tremors at 2–3 weeks of age followed by paralysis of 
hindlimbs and finally death in 2–3 months. This mutation consists in the insertion of an 
intracisternal A-particle (IAP), into intron 5 of the Usp14 gene (Wilson, Bhattacharyya et 
al. 2002). axJ mice are characterized by defects in synaptic transmission in both the central 
and peripheral nervous systems rather than the ubiquitin-positive protein aggregates or 
neuronal cell loss observed in other neurodegenerative diseases. (Wilson, Bhattacharyya et 
al. 2002). Therefore, Usp14 regulates synaptic activity and neuronal development, and its 
massive reduction causes ataxia, but the neuronal specific expression of Usp14 can restore 
viability and motor system function. The ubiquitin monomer levels are also restored by 
Usp14 expression indicating that proteasome dysfunction could contribute to the 
neurological dysfunction in axJ mice (Crimmins, Jin et al. 2006, Chen, Bhattacharyya et al. 
2011). Afterwards, Usp14 has been found to be essential for synaptic development and 
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function at neuromuscular junctions. In contrast to reduced levels of Usp14 in axJ mice, 
loss of Usp14 causes developmental defects at motor neuron endplates which correlate 
with observed ubiquitin loss (Chen, Qin et al. 2009). Moreover, a study with a novel 
induced mutation (nmf375) in Usp14, indicates that Usp14 is also needed in adulthood. 
This mutation causes aberrant Usp14 mRNA splicing with a dramatic reduction of Usp14 
amount, causing ubiquitin depletion and adult-onset motor endplate disease without 
reduced ubiquitin levels and neuromuscular junction abnormalities during the first 4-6 
weeks of life, and early postnatal lethality characteristic of axJ mutation (Marshall, Watson 
et al. 2013). Overall, different genetic backgrounds have a great impact on the ubiquitin 
expression and influence the phenotypes caused by Usp14 deficiency. 
Interestingly, recent studies suggest that a number of DUBs plays a prominent role in 
cancer development and progression (D'Arcy, Wang et al. 2015). Also, USP14 is thought 
to be involved in different cancers including, but not limited to, ovarian and colorectal 
cancer (Farshi, Deshmukh et al. 2015). High expression of USP14 has been found in 
several hematopoietic and solid tumor cell lines (for example: leukemic, colon cancer, and 
multiple myeloma cells) (Ishiwata, Katayama et al. 2001, Ishiwata, Ozawa et al. 2004, 
Tian, D'Arcy et al. 2014). Another engaging discovery is the identification of Usp14 
among the candidate primary cilia proteins identified by proteomic analysis of mammalian 
primary cilia (Ishikawa, Thompson et al. 2012). Usp14 has never been implicated in cilia 
biology until now and this new evidence suggests a possible functional role of Usp14 in 
regulating ciliogenesis and maintenance of primary cilia, and a possible involvement of 
cilia in deubiquitination process.  
 
3.1.3.2. IU1: a specific inhibitor of Usp14 deubiquitinating activity  
Proteasome inhibitors are becoming attractive therapeutic agents. Researchers now propose 
that targeting specific aspects of the ubiquitin–proteasome pathway upstream of the 20S 
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proteasome (e.g. DUBs) might be advantageous with regards to efficacy as well as adverse 
effects. The main aspect that makes DUBs an attractive therapeutic target for diseases is 
the ability to modulate protein fate in a specific or selective manner (Farshi, Deshmukh et 
al. 2015). Therefore, targeting DUBs can modulate the status of the cell by modifying 
specific key aspects of pathological pathways to selectively direct the cell towards death or 
recovering from the pathological state. The importance of DUBs for proteasomal 
degradation has enhanced the interest in development of selective and specific DUBs 
inhibitors (Farshi, Deshmukh et al. 2015). Several inhibitors of pan-DUB that target both 
proteasomal and non-proteasomal DUBs have been described and the Usp14 inhibitor 
belongs to these. Thousands of compounds have been screened and 1-[1-(4-fluorophenyl)-
2,5-dimethylpyrrol-3-yl]-2-pyrrolidin-1-ylethanone (IU1) represents the first small 
molecule we know that selectively, specifically and reversibly binds the proteasomal-
associated form of USP14, thus inhibiting its deubiquitinase activity. The structure of IU1 
is an active-site-directed thiol protease inhibitor which binds only the active form of Usp14 
(Figure 14). 
 
   
Figure 14. Chemical structures of IU1.  
IU1 structure is an active-site-directed thiol protease inhibitor 
 
IU1 increases proteasomal substrates degradation by enhancing proteasome activity and 
produces sharp reduction in the chain-trimming rate on ubiquitin chains of proteins 
associated with proteasomes through Usp14. Thus, inhibition of Usp14 has been proposed 
as a therapeutic strategy to accelerate proteasomal function in neurodegenerative diseases 
that are associated with the accumulation of misfolded and aggregated proteins such as tau 
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in Alzheimer’s Disease and TDP-43 in Amyotropic lateral sclerosis (Lee, Lee et al. 2010). 
 
3.2 Crosstalk between protein degradation and cilia 
In recent years, the interest in understanding the correlation between primary cilia and 
degradative pathways has been exponentially growing, also because it has been found an 
intriguing crosstalk between ciliary growth and proteasome/autophagy activity. Changes in 
length and formation of cilia have been directly related to changes in functioning of 
degradative mechanisms. However, the regulatory role of degradation processes for the 
control of primary cilia is much more complex than it would appear, and for this reason 
there have been several conflicting reports. Indeed, blockage of autophagic or proteasomal 
pathways can either increase or decrease ciliary length. Part of these opposite effects are 
due to the fact that autophagy and proteasome can degrade proteins that contribute to 
ciliary growth (e.g. IFT20 essential for ciliogenesis) as well as regulatory proteins that 
inhibit ciliogenesis (e.g. Ofd1 associated to centriolar satellites) (Pampliega and Cuervo 
2016, Shearer and Saunders 2016). The additional fascinating demonstrations that 
ciliopathy proteins can regulate signaling cascades by modulating proteolytic degradation 
(Liu, Tsai et al. 2014), together with the finding of proteasomal and autophagic 
components in proximity or into the primary cilia (Dikic 2017), have emphasized the 
interest for the relationship between ciliary proteins and degradation pathways. 
 
3.2.1 Proteasome and cilia  
The presence of functional proteins in appropriate quantities, maintained through balanced 
protein synthesis and degradation pathways, is necessary for viability of the cell. There are 
now various evidences that the primary cilium has a role in regulating protein homeostasis 
by influencing the ubiquitin-proteasome system (Malicki and Johnson 2017).  
In the last years, interactions of different ciliary proteins with proteasomal components 
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were identified indicating a possible link between cilia and the proteasome. In line with 
this observation, we also demonstrated that cilioproteins play a crucial role in the 
regulation of paracrine signal transduction interacting directly with different proteasomal 
components and coordinating proteolytic degradation of signaling mediators (Liu, Tsai et 
al. 2014). Indeed, Ofd1 controls the composition of the proteasome components and its 
loss leads to a reduced proteasomal activity affecting the stability of proteins involved in 
Hh signaling (Liu, Tsai et al. 2014). The absence of other cilioproteins, such as Bbs4 and 
Bbs7, implicated in two forms of Bardet-Bield syndrome, is also associated with a 
decreased activity of the proteasome that leads to dysregulation of different cilia-related 
signaling pathways (Gerdes, Liu et al. 2007, Gascue, Tan et al. 2012, Liu, Tsai et al. 2014). 
The effect of these ciliary proteins has been referred to the proteasome localized at the 
centrosome, but only recently it has been demonstrated the real existence of a cilia-
regulated proteasome. Three components of the 19S proteasomal subunit (Psmd2, Psmd3, 
and Psmd4, respectively) have been detected at the basal body of MEF cilia, and one 
component of the 20S proteasomal subunit (Psma5) along the entire cilium, thus 
supporting the likelihood of a ciliary involvement in proteasome assembly and/or function 
(Gerhardt, Lier et al. 2015). Moreover, the transition zone protein Rpgrip1l binds the 
ciliary regulatory proteasomal subunit Psmd2, and its depletion results in reduced 
proteasomal activity, specifically and exclusively at the ciliary base (Gerhardt, Lier et al. 
2015), confirming the existence of a ciliary localization for the proteasome. In summary, 
some ciliary genes, whose mutations give rise to very severe ciliopathies, encode ciliary 
proteins that regulate proteasomal activity. Considering that the proteasome is involved in 
the formation, maintenance and function of several organs and structures of the human 
body, it is possible that proteasome dysfunction contributes to the manifestation of 
ciliopathies, and potentially, its decreased activity may influence the severity of the 
phenotypes observed in ciliopathies. Overall, all these discoveries suggest that the 
enhancement of proteasomal function might benefit ciliopathy patients. Additionally, using 
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a system biology approach, we also found that proteasomal components represent the 
largest community of “cilia/centrosome complex interactome (CCCI)” (Amato, Morleo et 
al. 2014), supporting that the close association of UPS with primary cilia may be 
functionally relevant.  
Interestingly, protein degradation via UPS is also essential for regulating ciliogenesis, cilia 
disassembly and maintenance of cilia length during cell cycle. As said before, the primary 
cilium protrudes directly from the distal end of the mother centriole. In this context, UPS 
regulates the amount and availability of players involved in cilia formation localized to 
centrioles or close to these organelles. For examples, ciliogenesis is inhibited by Aurora A 
(AurA), a protein belonging to a repressor complex of cilia formation, which is bound and 
activated by the keratin-binding protein trichoplein at the centriole, preventing axoneme 
extension. The ubiquitin-proteasome system results indispensable to initiate ciliogenesis by 
removing trichoplein from the mother centrioles, thus causing inactivation of centriolar 
AurA, which promotes ciliogenesis. Therefore, degradation of polyubiquitinated 
trichoplein results in disassembly of the repressor complex, critical for the initiation of 
axoneme extension (Kasahara, Kawakami et al. 2014). Moreover, the E3 ubiquitin ligase 
Mindbomb 1 (MIB1), a new component of centriolar satellites, ubiquitinates Cep131 (also 
known as AZI1) and PCM1, and suppresses primary cilium formation (Villumsen, 
Danielsen et al. 2013). The E3 Ub ligase von Hippel-Lindau tumor suppressor (VHL) 
localizes to primary cilia and directly ubiquitinates Hypoxia-Inducible Factor-1α (HIF-1α), 
a transcriptional regulator of AurA, thus playing an indirect role in regulating ciliogenesis 
(Patil, Pabla et al. 2013). The activity of E3 ubiquitin ligase Anaphase-promoting complex 
(APC) controls the proper length of preformed cilia as well as the timely resorption of the 
cilium after serum induction. It also ubiquitinases Nek1, a ciliary kinase, and stimulate its 
proteolysis for regulating the stability of axonemal microtubules (Wang, Wu et al. 2014). 
Additionally, NDE1, a suppressor of the later stages of cilium formation, is also 
ubiquitinated and degraded through the UPS increasing ciliary length (Kim, Zaghloul et al. 
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2011, Maskey, Marlin et al. 2015). Altogether these results indicate that ubiquitination 
occurs during both the initiation and elongation stages of ciliogenesis, and it is important 
for controlling of cilia length.  
Apart from the evident role of ubiquitination in the maintenance of centriolar satellites and 
cilium assembly, protein deubiquitination is also involved in ciliogenesis, correctly 
regulating protein levels. For example, cylindromatosis tumor suppressor gene (CYLD) 
encodes a deubiquitinating enzyme, and its mutation results in defects of cilium formation 
(Eguether, Ermolaeva et al. 2014). Ubiquitin-specific protease 8 (USP8) functions as a 
deubiquitinase of HIF1α by counteracting the VHL-mediated ubiquitination, and maintains 
basal expression levels of HIF1α, critical for ciliogenesis mediated by endosome 
trafficking (Eguether, Ermolaeva et al. 2014). Another study shows that Ubiquitin specific 
peptidase 21 (USP21) localizes strongly to the centrosome and microtubules, and its 
depletion greatly reduces cilia formation in human Retinal pigment epithelial (RPE) cells 
(Urbe, Liu et al. 2012). In summary, UPS results necessary to maintain the right balance of 
proteins involved in controlling primary cilia formation, length and function, by regulating 
both ubiquitination and deubiquitination mechanisms.  
Based on these results, we can assume that ubiquitination, deubiquitination, and 
proteasomal degradation of key regulators of ciliogenesis represent mechanisms for 
controlling cilia formation, maintenance and length, and consequently all the sensory 
function played from primary cilia. To date the biological significance of the changes in 
cilia length during cellular processes it is not completely clear, but it is possible that 
primary cilia modify their sensing ability when they change their length, and, by doing so, 
subsequently sensitize and adapt cells to different metabolic, pathologic or physiologic 
necessities. 
In conclusion, all these studies demonstrate that cilia and degradative pathways 
reciprocally affect each other. It seems that UPS is activated or inhibited to control primary 
cilia length both positively and negatively depending on the context. This highlights the 
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need for a fine-tune regulation of this processes to assure rapid adaptation of ciliary length 
to the cellular requirements. On the basis of the existing interplay across ubiquitin 
mediated degradation pathways, primary cilia, and ciliopathies, both academic laboratories 
and pharmaceutical companies are developing compounds that target specific components 
of this degradative system. Useful drugs have been already developed for clinical 
applications, but further studies on the crosstalk between cilia and proteasomal pathway 
are required thus continuing the production of conventional inhibitors or activators of 
specific enzymes, as well as supplying drugs able to direct the ubiquitin system to target, 
destroy, and thereby downregulate any specific protein. The result from these studies will 
lead to a better understanding of the pathophysiological implications derived from the 
perturbation of this interplay, and may lead to the identification of modulators capable to 
influence ciliary signaling pathways in order to improve the phenotype observed in 
ciliopathies. 
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MATERIALS AND METHODS 
 
1. Cell culture 
Usp14+/+ and Usp14-/- MEFs (Mouse Embryonic Fibroblasts) were a gift provided by Dr. 
Scott Wilson and were previously described (Wilson, Bhattacharyya et al. 2002). MEFs 
were cultured in Dulbecco’s Modified Eagle Medium (Gibco) containing 10% fetal bovine 
serum (FBS), 1% l-glutamine (Gibco), 1% sodium pyruvate (Gibco), and 1% antibiotics 
(penicillin/streptomycin) (Gibco) at 37oC and 5% CO2. HEK-293 or HEK- 293-FT cells 
and human dermal fibroblasts were grown in DMEM (Invitrogen) containing 10% FBS 
(Invitrogen) and 2 mM L-glutamine (Invitrogen). All cells were splitted upon reaching of 
confluence, by rinsing the monolayer twice with sterile filtered Phosphate-Buffered Saline 
(PBS, Gibco) and exposing cells to 0.25% Trypsin-EDTA for 2-3 minutes. Detached cells 
were centrifuged to eliminate Trypsin from the media and then plated at a density of 104 
cells/cm2. To induce ciliogenesis, confluent MEFs were serum starved with medium 
containing 0.5% FBS for ≥30h. 
 
2. Cell treatments 
Shh, SAG, IU1 and MG132 treatments in MEFs cells were performed in DMEM Glucose 
Free (Gibco) supplemented with 0,5% FBS (Life Technologies). Hh signaling activation 
was performed by treatment with either Shh-N recombinant protein at a final concentration 
of 100ng/ml (R & D Systems (464-SH)) or SAG 200nM (Millipore) for 24h. IU1 (Cayman 
Chemical) was dissolved in DMSO at final concentration of 100mM and stored at -20°C. 
IU1 treatment was carried out at a final concentration of 40 μM for 6 or 24h. MG132 
(Calbiochem) was dissolved in DMSO at a concentration of 10 mM and stored at -20°C. 
MG132. Drug treatment with MG132 was carried out at a final concentration of 30 μM for 
6h, while SFN (Sigma-Aldrich) was used at a final concentration of 10 μM for 6h. 
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3. In vitro differentiation of ES cell–derived neurons 
The Ofd1-deficient E14Tg2A.4 KOES line was obtained from BayGenomics. Both WT 
and Ofd1 KOESs were maintained in an undifferentiated state by culture on a monolayer 
of mitomycin C–inactivated fibroblasts in the presence of leukemia-inhibiting factor (LIF). 
To induce neural differentiation, we followed previously described protocols (Fico, 
Manganelli et al. 2008). Briefly, 48h after ES cells were seeded on gelatin-coated plates, 
they were dissociated and plated on gelatin-coated plates at 1,000 cells/cm2 on day 0 (T0). 
The culture medium for neuronal differentiation (serum-free KnockOut Serum 
Replacement–supplemented medium; Invitrogen) contained knockout DMEM 
supplemented with 15% KSR (Invitrogen), 2 mM L-glutamine, 100 U/ml penicillin-
streptomycin, and 0.1 mM β-mercaptoethanol and was replaced daily during the 
differentiation process. 
 
4. Constructs and Transfections  
Full-length murine Usp14 were tagged at the C terminus with a 3xFLAG tag by cloning it 
into the 3xFLAG-pCMV vector. The generated plasmid was verified by sequencing. 
pEGFP-N3-Kif7 construct was a gift from Kathrin Anderson’s lab. pCDNA-HA-Ubiquitin 
construct was a gift provided by Di Marcotullio’s lab. 
The same number of MEFs were transfected in suspension with TransIT®-LT1 
Transfection Reagent (Mirus) with a 3:1 ratio of TransIT-LT1 Reagent to DNA and 
following manufacture’s instruction.  Cells were starved for 30h, treated with Shh/SAG for 
24h and collected 48h after transfection in two samples for RNA extraction and Western 
Blot analysis, respectively. 
FuGene6 Transfection Reagent (Roche) was used for transfection of expression constructs, 
shRNA-expressing plasmids, in HEK293 cells. Then cells were cultured for 72h.  
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5. RNAi 
To silence Usp14, MEF cells were transfected using siRNAs ON-TARGET plus smart 
pool against the murine Usp14 and ON-TARGET Non-Targeting (Darmachon) as control 
to a final concentration of 100 nM. The transfection reagent was INTERFERIN (409–10, 
Polyplus). Equal numbers of MEFs transfected with siRNAs against murine Usp14 and 
Non-Targeting RNA were plated. After 48h cells reached the confluence and were 
incubated in medium containing 0.5% FBS to induce ciliogenesis. 24h before harvesting, 
MEFs were treated with Shh-N or SAG to induce Hedgehog pathway activation. Silenced 
cells were used for RNA extraction, Western Blot and IF analyses 96h after transfections. 
 
6. RT-PCR and qReal-Time PCR 
Total RNA extracted from MEF cells, was isolated by using RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s instructions. During the extraction protocol, RNAs were 
digested with DNaseI (Qiagen) to remove DNA contaminating. Total RNA was then 
reverse-transcribed into cDNA by QuantiTect Reverse Transcription Kit (Qiagen) with 
random hexamers oligo. For quantitative real time PCR analysis (qRT-PCR), cDNAs were 
analysed with Roche Light Cycler 480 system using a LigthCycler 480 SYBR Green I 
Master (Roche). The final concentration of primers was of 0.8 μM. The ΔCT method was 
used for statistical analysis to determine gene expression levels. All experiments contained 
three technical replicates and were performed at least three times. The Hprt transcript was 
used as endogenous reference. The results are shown as means ± SEM of three independent 
biological replicates. 
 
7. Western blot (WB) analysis  
MEFs were lysed in RIPA buffer (Tris-HCl 50mM, pH 8, NaCl 150 mM, EDTA 1mM, 
NP-40 1%, SDS 0,1%, C₂₄H₃₉NaO₄ 0,5%) containing protease inhibitors (Sigma-Aldrich), 
phosphatase inhibitors (PhosSTOP, Roche) and proteasome inhibitor (Calbiochem), and 
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sonicated at appropriate intervals, followed by centrifugation at 4°C for 15 minutes. 
Protein concentrations in all lysates were measured using PierceTM BCA Protein Assay Kit 
(Thermo Fisher) and a spectrophotometer reader (Biorad) at a wavelength of 595 nm. 
Protein samples were separated by 5% SDS-PAGE or 4-15% Precast Protein gel (Bio-Rad), 
and transferred to ImmunoBlot Polyvinylidene difluoride (PVDF) membranes (Millipore, 
US, Immobilon-P). Membranes were blocked in TBS containing 5% Non-Fat Dry Milk 
(Cell Signaling) and incubated with the following commercial primary antibodies:  
Ab Company Catalog number Dilution 
anti-β-tubulin Sigma T 4026 1:5000 
anti-GAPDH Santa Cruz Biotechnology Inc. sc-32233 1:10000 
anti- HSP90 Cell Signaling  4874S 1:1000 
anti-GLI2 R&D Systems AF3635  1:200 
anti-GLI3 R&D Systems AF3690 1:400 
anti- Flag Sigma-Aldrich F3165 1:1000 
anti- Sp1 Santa Cruz Biotechnology Inc. sc-14027 1:500 
anti-Kif7 Abcam ab95884 1:1000 
anti- Usp14 Bethyl Laboratories A300-920A 1:3000 
anti-Ubiquitin Santa Cruz Biotechnology Inc Sc-8017 1:500 
anti-Ubiquitin-
Lys48-Specific 
Merck Millipore 05-1307 1:3000 
anti-GFP Abcam ab290 1:1000 
anti-SUFU Santa Cruz Biotechnology Inc sc-10934 1:500 
anti- mmOFD1 Antisera against a portion of  murine 
OFD1 NM_177429 aa 461-884 
 1:200 
anti- hsOFD1 antisera against human 
full-length OFD1 NM_003611 
 1:1000 
anti-RPN10 Santa Cruz Biotechnology Inc sc-10934 1:500 
anti-20S Novus NB600-1016 1:400 
anti-PA28γ  Novus NBP1-54587 1:400 
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anti-RPT2 Boston Biochem AP-107 1:1000 
anti-RPT6 Enzo Life Sciences BML-PW9265 1:400 
anti-PA28γ  Novus NBP1-54587 1:500 
 
Proteins of interest were detected with horseradish peroxidase-conjugated goat anti-mouse 
or anti-rabbit IgG antibody (1:3000, GE Healthcare) and rabbit anti-goat IgG antibody 
(1:3000, Calbiochem), visualized with the Luminata Crescendo substrate (Millipore) or the 
Super Signal West Femto substrate (Thermo Scientific), according to the manufacturer’s 
protocol. WB images were acquired using the Chemidoc-lt imaging system (UVP) and 
densitometric analysis was performed with ImageJ software.  WB studies were performed 
at least in triplicate and representative images are shown. 
 
8. Nuclear-Cytoplasmic Extraction 
Nuclear-Cytoplasmic extractions were performed on ice with freshly harvested cells. 
Nuclear and Cytoplasmic fractions from MEF cells were isolated using NE-PER Nuclear 
and Cytoplasmic Extraction Kit (Thermo Scientific) according to the manufacturer’s 
instructions. Each fraction for all samples was quantified before taking samples for gel 
electrophoresis to ensure that equal amounts of each fraction were loaded on the gel. 
 
9. Affinity purification of proteasome complex 
The 26S proteasome complex was purified following a previously described protocol 
(Wang, Chen et al. 2007) with modifications. Briefly, HEK-293-FT cells expressing stable 
HTBH-tagged hRPN11 (a gift from Lan Huang, University of California, Irvine, California, 
USA) were transfected with either pSuper control plasmid or pSuperOFD1 to knock down 
OFD1 expression. Seventy-two hours after transfection, cells were lysed in buffer A (100 
mM NaCl, 50 mM Tris-HCl [pH 7.5], 10% glycerol, 2 mM ATP, 1 mM DTT, and 5 mM 
MgCl2) with 1× proteasome inhibitor (Roche). Lysates were centrifuged at 4°C for 15 
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minutes to remove cell debris. To purify proteasomes, an aliquot of the supernatant was 
incubated with streptavidin beads at 4°C overnight to precipitate HTBH-RPN11. The 
beads were then washed with buffer A three times, followed by one washing with TEB 
buffer (50 mM Tris-HCl, pH 7.5 and 10% glycerol). Finally, the beads were incubated in 
TEB buffer containing 1% TEV protease at 30°C for 1h, before SDS-PAGE and 
immunoblotting with anti-RPN11 (ab20239; Abcam). 
 
10. Sucrose gradient sedimentation 
HEK-293-FT cells were transfected and treated with nocodazole (10 μg/ml) and 
cytochalasin B (5 μg/ml) for 1h after 72h of transfection. To collect cytoplasmic lysates, 
cells were harvested in lysis buffer (1 mM HEPES [pH 7.3], 0.5% NP-40, 0.5 mM MgCl2, 
0.1% β-ME, and 1× protease inhibitor), followed by centrifugation at 2,500 g for 10 
minutes. After 10 mM HEPES and 5 U/ml DNase treatment for 30 minutes on ice, 1 ml of 
cytoplasmic lysates was layered on a discontinued sucrose gradient (70%, 50%, and 40% 
sucrose in the buffer containing 10 mM PIPES [pH 7.2], 0.1% NP-40, and 0.1% β-ME) 
and centrifuged for 1h at 195,000 g; 2% of lysates were kept before ultracentrifugation and 
served as an input. After ultracentrifugation, 13 fractions were collected and analysed by 
immunoblotting. 
 
11. Generation of Ofd1fl/y CAG-Cre-ERTM mice by tamoxifen injections 
Ofd1fl/+ females were crossed with CAG-Cre-ERTM mice, a general deletor Cre line in 
which Cre-ER is ubiquitously expressed after tamoxifen injection. We treated pregnant 
mothers with a single intraperitoneal injection of 100 μg tamoxifen/g of weight at E18.5. 
Tamoxifen (Sigma-Aldrich) was diluted in 10% ethanol and 90% sesame oil at a final 
concentration of 10 mg/ml. 
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12. Primary cilia biogenesis assay 
Equal numbers of MEFs transfected with siRNAs against murine Usp14 and Non-
Targeting RNA were seeded into 6-well dishes containing slides. When cells were attached 
on the slides, they were incubated in fresh complete medium. 96h after transfection slides 
were transferred into 24-well dishes and cells were fixed for immunofluorescence staining. 
The remaining cells from 6 wells were used for western blot analysis to evaluate silencing 
efficiency. Cells were seeded at different confluency to ensure that the cells reached the 
same confluence 96h after transfection. The same analysis was performed for MEFs after 
treatment with DMSO or IU1.  
 
13. Immunofluorescence and image acquisition 
MEFs were plated to be confluent after 24h and treated according to protocols described 
above with or without serum starvation or drug treatments. Cells were fixed with PFA 4% 
for 10 minutes at room temperature. Cells were then washed three times with PBS and then 
blocked with blocking buffer (2.5% BSA + 0.2% Triton X-100 in PBS) at room 
temperature for 45 minutes. Cells were incubated with primary antibodies either at 4°C 
overnight or at room temperature for 2h, washed three times with PBS and then incubated 
with the appropriate secondary antibodies conjugated to Alexa Fluor 488 or Alexa Fluor 
568 (Invitrogen) for 1h at room temperature. DNA was stained with Hoechst. After three 
washings with PBS, slides were mounted on coverslips with Mowiol.  
Images were acquired using LSM700 or LSM800 High-resolution confocal microscopes 
(Zeiss) and examined and processed using ZEN (Zeiss), ImageJ and Photoshop (Adobe) 
software. To quantify cilia length and localization of proteins to the cilia, images were 
taken as Z-stacks and rendered as maximum intensity projections. Fluorescence intensity at 
cilia was quantified by the ImageJ software and by measuring the sum of intensities in 
compressed z stacks images. The average intensities along the axoneme were measured 
and plotted against cilia length. 
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IF experiments were performed at least three times and representative images were shown. 
For analysis of IF data more than 100 cells were counted for each experiment. The 
significance of the results was calculated by Student’s t-test and reported as p-value. 
HEK-293 cells cultured on coverslips were fixed in methanol, blocked in normal goat 
serum (1:10 in PBS containing 5% BSA), and then probed with anti-RPN10 and anti–γ-
tubulin, followed by secondary antibodies Alexa Fluor 488 IgG and Alexa Fluor 568 IgG. 
Finally, nuclei were visualized with Hoechst 33258 (Sigma-Aldrich). Images were 
captured with a Zeiss LSM 710 confocal microscope and analyzed with ImageJ software. 
 
14. Ubiquitination experiments and IP 
For Ubiquitination experiments, MEFs transfected with both the pEGF-Kif7 and HA-
Ubiquitin plasmids were starved for 30h, treated with MG132 and DMSO or IU1 for 6h 
and collected 48h after transfection for IP experiments. For IP, approximately 1 mg of 
whole-cell was incubated with anti-OFD1, anti-Flag, or anti-GFP at 4°C overnight, 
followed by incubation with protein G–coupled agarose beads (Santa Cruz Biotechnology 
Inc.) at 4°C for 1 hour, or directly with anti-Flag M2 beads (A2220 Sigma-Aldrich). The 
beads were collected and washed with IP buffer (10% glycerol, 50 mM Tris-HCl [pH 7.5], 
2.5 mM MgCl2, 1% NP40, and 200 mM NaCl). Proteins conjugated with the beads were 
then denatured and separated from the beads by boiling at 95°C to 100°C for 5 minutes 
before processing for immunoblotting. Proteins were resolved by SDS-PAGE, transferred 
onto PVDF membrane, and probed with the indicated antibodies. 
 
15. Statistical analysis 
In ciliary counts experiments the likelihood ratio test for Negative Binomial generalized 
linear models was applied. In all the remaining experiments, the statistical significance 
between two groups was evaluated by Student’s t-test, p<0.05 was considered significant. 
Quantitative data are presented as the mean ± SEM (Standard Error of the Mean).  
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Results 
 
1. Loss of Ofd1 causes accumulation of Hh signaling mediators 
 
In vertebrates, the cilium and the basal body are key components of signal transduction, 
and different phenotypes of ciliopathy patients have been attributed to defective paracrine 
signaling (Hildebrandt, Benzing et al. 2011), including polydactyly and neural tube defects 
due to defective Hh signaling (Eggenschwiler and Anderson 2007).  
The increasing association of ciliary and basal body proteins with proteasomal functions; 
the involvement of proteasomal degradation in Hh signaling cascades; and the presence of 
proteasomal components to the primary cilium, led us to ask whether the ubiquitin-
proteasome system could be a mechanism that contributes to the Hh signaling defects seen 
in OFD1 syndrome. We thus considered the possibility that loss of the basal body protein 
Ofd1 leads to changes in the stability of signaling mediators.  
We examined the Hedgehog signaling, an established cilium-dependent signaling pathway 
(Eggenschwiler and Anderson 2007) which plays a critical role in determining proper 
embryonic patterning and cell fate determination in the CNS. We developed an in vitro 
neural differentiation model, in which embryonic wild type murine stem cells (WT ESs) 
and Ofd1-knockout murine embryonic stem cells (KO ESs) were cultured to generate 
neural progenitors (Figure 15). This model recapitulates the multi-step process of neural 
development in embryos (Fico, Manganelli et al. 2008). We used this method to 
differentiate ES cells in neurons and glial cells for studying the impact of Ofd1 inhibition 
in proteasomal degradation of Hh signaling components.  
ES cells were maintained in an undifferentiated state by culturing them in the presence of 
leukemia-inhibiting factor (LIF). To induce neural differentiation the culture medium for 
neuronal differentiation was daily replaced during the whole process. From day 8 (T8) to 
day12 (T12) of differentiation it is possible to observe the emergence of a rosette 
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conformation typical of neuronal precursors and, as time goes by, the presence of cells 
with neuronal morphology. 
 
Figure 15. A model that recapitulates the multi-step process of neural development in embryos 
 
KO ESs are male murine cells containing a gene trap mutation in Ofd1. As Ofd1 is located 
on the X chromosome, Ofd1 KO ESs are hemizygous for Ofd1 and do not produce the 
protein (Singla and Reiter 2006).  
To establish if the stability of Hh signaling mediators is altered upon depletion of Ofd1, we 
performed WB analysis and compared the total protein lysates obtained from Ofd1 WT 
neurons differentiated from WT ESs to the total protein lysates obtained from Ofd1 KO 
differentiated neurons derived from KO ESs. We found a significant increase in protein 
levels of Gli2FL and Sufu at the T8 time point in Ofd1-depleted neurons (Figure 16A). We 
also analyzed total lysates from Ofd1Δ4–5/y hemizygous male mouse embryos and WT 
littermates and we observed increased levels of Gli2FL and Sufu in Ofd1Δ4–5/y embryos 
compared to WT embryos (Figure 16B). In addition, also Gli3FL increased both in Ofd1 
KO neurons (Figure 16A) and in Ofd1Δ4–5/y mutant embryos (Figure 16B), with a 
concomitant decrease in Gli3R levels (Figure 16A and B), suggesting an involvement of 
Ofd1 in the regulation of the Hh pathway.  
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Figure 16. Accumulation of Shh signaling mediators upon Ofd1 depletion  
(A) Immunoblots show accumulation of Gli2FL, Gli3FL, and Sufu as well as reduction of Gli3R in T8-
derived Ofd1KO neurons. (B) At E10.5, accumulation of Gli2FL, Gli3FL, and Sufu as well as reduction of 
Gli3R were detected in protein lysates from Ofd1Δ4–5/y mice. Ofd1+/y mice are used as controls. Samples in 
each panel in B were run on the same gel but were noncontiguous. Bar graphs showing the SEM are plotted 
adjacent to each blot. *P < 0.05; **P < 0.01 
 
Therefore, the perturbation of the Ofd1 ciliopathy protein alters the stability of Hh 
signaling mediators, such as Gli2, Gli3 and Sufu, demonstrating a role for Ofd1 in 
regulating proteasome-mediated degradation. 
 
2. Loss of Ofd1 selectively disrupts the UPS 
Given our data on Hh mediators and the fact that the processing of components from this 
pathway is known to be mediated by the proteasome (Haycraft, Banizs et al. 2005), we 
asked whether proteasomal agonists could ameliorate the phenotypes observed in Ofd1 
depleted cells. The expression levels of three catalytic subunits of the proteasome, namely, 
proteasome subunit β types 5, 6, and 7 (PSMB5, PSMB6, and PSMB7, respectively), as 
well as the corresponding peptidase activities, increase upon treatment with sulforaphane 
(Kwak, Cho et al. 2007) [SFN; 1-isothiocyanato-4(R)-methylsulfinylbutane], an 
isothiocyanate extracted from cruciferous vegetables, rendering this compound an 
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attractive substrate for our studies. To address our hypothesis, we thus treated WT and T8 
derived-Ofd1 KO neurons with this drug and performed WB analysis to evaluate the 
amounts of Hh mediator proteins. We found that treatment with SFN reduced the protein 
levels of Gli2FL, Gli3FL, and Sufu when Ofd1 is lost, in comparison with the untreated 
Ofd1 KO counterpart (Figure 17A), thus rescuing the previously observed accumulation of 
these mediators in the absence of Ofd1. Consistent with the participation of the proteasome 
in both processing and degradation of Gli2/3, treatment with SFN also reduced Gli3R 
protein levels (Figure 17A).  
 
 
Figure 17. Disruption of proteasomal degradation caused by loss of Ofd1  
(A) Treatment of proteasomal agonist SFN ameliorated the accumulation of Gli3FL, Gli2FL, and Sufu in T8-
derived Ofd1KO neurons. Bar graphs showing the SEM are plotted adjacent to each blot. *P < 0.05; **P < 
0.01; ***P<0.001 
 
Therefore, defects in proteasome-dependent processing and degradation of Gli2/3, and 
Sufu in Ofd1 depleted neurons can be ameliorated by increasing the expression of the 
corresponding proteasomal subunits through SFN treatment as this treatment improves the 
ability of the cell to eliminate proteins targeted for degradation. 
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3. Ofd1 regulates the proteasome complex 
Our observations in differentiated neurons suggested that Ofd1 is responsible for 
regulating proteasomal degradation of Hh mediators but the mechanism is still unclear. We 
therefore explored the possibility of a direct biochemical relationship between OFD1 and 
the proteasome. 
First, an unbiased mass spectrometry screen was conducted to identify putative OFD1-
interacting proteins. This experiment uncovered a spectrum of different UPS components 
including the regulatory proteasome ATPase subunit 6 (RPT6). To confirm this putative 
interaction, we performed a semiendogenous coimmunoprecipitation. We transfected 
3xFlag-RPT6 expressing vector or 3xFlag empty vector in WT cells. RPT6 or OFD1 were 
immunoprecipitated with Flag antibody, or OFD1 antibody that recognized the endogenous 
protein, respectively, and the immunoblot confirmed the interaction between OFD1 and the 
Flag-tagged RPT6 (Figure 18A). 
To probe the relevance of these interactions, we asked whether loss of OFD1 alters the 
composition of the proteasome respect to its subunits and the association of deubiquitinase 
enzymes to the proteasome. Using a stable HEK-293 cell line expressing tagged regulatory 
proteasome non-ATPase subunit 11 (RPN11) (Lee, Lee et al. 2010), we suppressed OFD1 
by transfection with short hairpin RNA (shRNA)-expressing plasmids, purified 26S 
proteasome complexes, and analyzed the binding of some proteasomal subunits and 
deubiquitinases. We observed a robust reduction (60% ± 8%) of 26S-bound regulatory 
proteasome ATPase subunit 2 (RPT2) in OFD1-depleted cells compared to controls, while 
total RPT2 protein abundance was not affected by OFD1 depletion (Figure 18B). We also 
found increased levels of USP14 deubiquitinase bound to proteasome in OFD1 depleted 
cells, while the binding of the other proteasomal DUB, UCH37, did not change (Figure 
18B). Therefore, the depletion of OFD1 alters the association of some UPS components to 
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the proteasomal complex, such as RPT2 and USP14, demonstrating a role for OFD1 in 
regulating proteasome composition. 
Given that the centrosome was identified as a site for concentration of the proteasome and 
associated regulatory proteins, we also tested the localization of some regulatory subunits. 
We analyzed the regulatory proteasome non-ATPase subunit 10 (RPN10) around the 
centrosome in OFD1 HEK-293 depleted cells by quantifying the RPN10 signal that 
localized around centrosomal γ-tubulin. We performed immunofluorescence (IF) analysis 
and observed a 43% ± 2% reduction of pericentriolar RPN10 levels (normalized to 
cytoplasmic RPN10 levels) in OFD1-depleted cells (Figure 18C), suggesting that OFD1 is 
necessary for the proper localization of the centrosomal proteasome. 
On the basis of these data, we also tested whether loss of OFD1 altered the composition of 
RPN10, RPT2, and other proteasomal components by sucrose gradient sedimentation. 
Based on the commercial availability of reliable antibodies against proteasomal subunits, 
we found that RPN10, RPN13, RPT2, and RPT6 were enriched in γ-tubulin–enriched 
fractions in cells transfected with pSuper control plasmid. Depletion of OFD1 by 
transfecting pSuperOFD1 plasmid to knock down OFD1 expression, resulted in a shift in 
the peak expression of the proteasomal subunits with a decrease in the overlap between γ-
tubulin–enriched fractions and 19S subunit–enriched fractions (Figure 18D), indicating an 
involvement of the basal body OFD1 protein in the regulation of proteasome composition 
at the centrosome. 
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Figure 18. OFD1 interacts with proteasomal components and regulates proteasome composition 
(A) Immunoblots of immunoprecipitation analysis show interaction between endogenous OFD1 and Flag-
tagged RPT6. (B) Immunoblots show that suppression of OFD1 in HEK-293 cells reduced RPT2 and 
increased USP14 protein levels in purified 26S proteasome. Densitometry measurements of proteasomal 
RPT2 (n = 3) and USP14 protein levels were plotted (n = 2), and no significant difference in total RPT2 and 
Usp14 abundance was detected. Coomassie blue staining were carried out as a loading control to measure the 
efficiency of the 26S proteasomal purification process. (C) Suppression of OFD1 in HEK-293 cells result in 
the reduction of pericentriolar RPN10 levels (normalized to cytoplasmic RPN10 levels). RPN10 in green, γ-
Tubulin marks centrosome (red) and DAPI for nuclei (blue). Scale bar: 10 μm. (D) HEK-293 cells 
transfected with pSuper control and pSuperOFD1 were subjected to sucrose gradient centrifugation. 
Fractions (fractions 6–12 of 13 fractions) were then analyzed by immunoblotting with antibodies against γ-
tubulin and proteasomal subunits.  
**P < 0.01; ***P < 0.001. 
 
Taken together, these data suggest that OFD1 regulates the composition of the centrosomal 
proteasome, likely through direct biochemical interactions with specific regulatory 
subunits and that its depletion perturbs the cilia-associated Hedgehog signaling pathway 
due to impaired proteasome-mediated degradation of signaling mediators. 
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Our observations led us to conclude that the relationship between ciliary proteins and the 
proteasome is of relevant functional importance. In support of this idea, the two main 
proteomic studies on mammalian primary cilia, performed by different approaches 
(Ishikawa, Thompson et al. 2012, Mick, Rodrigues et al. 2015), show common UPS 
components, and in particular, one of them is Usp14, suggesting a relationship between 
primary cilia functions and deubiquitination process. Furthermore, given the importance of 
protein degradation mediated by the ubiquitin-proteasome system on cilia formation, cilia 
elongation and ciliary signal transduction we decided to investigate the involvement of 
Usp14 in cilia biology.  
 
4. Usp14 controls ciliogenesis and cilia length 
First, we hypothesized that inhibition of Usp14 may have an effect on ciliogenesis in vitro. 
To test this hypothesis Usp14 was silenced in cycling mouse embryonic fibroblasts (MEFs) 
in complete medium. The transfection efficiency of small interfering RNA targeting Usp14 
(Usp14 siRNA) was confirmed by WB analysis of Usp14 protein levels. We observed 
about 80% reduction of relative Usp14 levels in Usp14-depleted cells respect to cells 
transfected with non-targeting control siRNAs (control) (Figure 19A), thus ensuring an 
efficient decrease of Usp14 expression. 
The effects of Usp14 silencing on ciliogenesis were determined by IF analysis 96h after 
siRNAs transfection. Surprisingly, despite the cells being cultured in 10% FBS medium, 
knockdown of Usp14 had a strong effect on cilium formation. About 14% of silenced cells 
had visible cilia, labeled with an antibody that recognizes Arl13b, a protein specifically 
localized at primary cilia; while the cycling serum-stimulated control MEFs remained 
mostly unciliated, as expected for not quiescent cells, with about 4% of ciliated cells 
(Figure 19B). Our results indicate that the Usp14 depletion induces formation of primary 
cilia, demonstrating a role for Usp14 in regulating ciliogenesis.  
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To provide evidence that Usp14 inhibition promotes cilia formation through its 
deubiquitinase activity we treated WT MEFs with IU1, an inhibitor of the catalytic activity 
of Usp14 that reduces the trimming of ubiquitin chains and enhances the proteasome 
degradation activity of specific targets (Lee, Lee et al. 2010). Cells were scored for the 
presence of cilia under serum stimulus, at 6h and 24h of IU1 treatment: the number of 
ciliated cells increased over time (~15% at 6h and 20% at 24h), while DMSO treated 
controls remained unciliated (~5-7% at 0, 6 and 24h) (Figure 19C). Then, to verify the 
suppression of ubiquitin removal by IU1 we performed WB analysis which showed 
increased ubiquitination levels of total protein lysates after 6h of treatment, which was 
even more evident after 24h (Figure 19D). 
Proteasomal activity seems to impact different stages of ciliogenesis, allowing for proper 
cilia biogenesis and elongation (Kim, Zaghloul et al. 2011, Kasahara, Kawakami et al. 
2014, Maskey, Marlin et al. 2015), we thus next examined whether depletion of Usp14 
may influence axoneme elongation. Usp14 siRNA-treated MEFs were analyzed by IF 
analysis 48h after serum starvation and displayed increased ciliary length compared to 
controls (Figure 20A). Using Arl13b as a cilia marker, we found that the length of cilia 
from control MEFs was ~2.8µm, whereas the length of mutant cilia was ~3.6µm in Usp14 
depleted MEFs. Thus, Usp14 mutant cilia were ~30% longer, on average, and more 
variable in length, compared to controls. 
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Figure 19. Usp14 controls ciliogenesis  
(A) WB analysis of Usp14-depleted MEFs that were transfected with Usp14 specific or control siRNAs. 
(B) Representative confocal images of cycling MEFs in complete medium (with FBS), transfected with 
siRNA targeting Usp14 (Usp14 siRNA) and non-targeting negative control siRNA (control) for 96-hours. 
Acetylated-α-tubulin (red) marks cilia. Hoechst (blue) labels nuclei. (C) Representative confocal images of 
primary cilia in cycling MEFs in complete medium (with FBS), treated with IU1 or DMSO for 0, 6 and 24h. 
Acetylated-α-tubulin (red) marks cilia. Hoechst (blue) labels nuclei. (D) WB analysis of the suppression of 
ubiquitin chain trimming by IU1 was verified at 6 and 24h. 
Bar graphs showing the SEM are plotted adjacent to each panel. *P < 0.05; **P < 0.01; ***P<0.001. Scale 
bar = 5μm. More than 100 cells were analyzed per sample. 
 
To supply an independent evidence, Usp14 WT and knockout MEFs (Usp14+/+ and Usp14-
/-, respectively) were plated in complete medium and serum-starved (0,5% FBS) for 48h to 
induce cilia formation. Cilia of Usp14-/- MEFs showed morphological defects similar to 
those observed in Usp14 silenced cells, with an average length remarkably increased 
compared to WT MEFs (Figure 20B). An increased ciliary length was also observed in WT 
MEFs that were plated in complete medium, serum-starved for 48h and treated with IU1 
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for 24h, suggesting that the Usp14 catalytic proteasome inhibitor activity acts also on cilia 
elongation (Figure 20C). Consistent with these observations, transfection of Usp14-/- MEFs 
with the 3xFLAG-Usp14 construct rescued the cilia length (Figure 20D), confirming that 
Usp14 acts as inhibitor of cilia elongation.  
 
 
 
Figure 20. Usp14 controls cilia length 
(A) Representative confocal images of primary cilia in Usp14-siRNA depleted and control MEFs, after 48h 
of serum starvation. Arl13b marks primary cilia (red) and Hoechst labels nuclei (blue). (B) Primary cilia 
stained with Arl13b (green) and Hoechst in blue, in 48h FBS starved WT Usp14+/+ and knockout Usp14−/− 
MEFs. (C) Primary cilia stained with Arl13b (red) and Hoechst in blue, in 48h starved WT MEFs treated 
with IU1 and DMSO for 24h. (D) Primary cilia stained with Arl13b (red) and Hoechst in blue, in 48h starved 
WT and Usp14−/− MEFs transfected with the empty vector (EV) and Usp14−/−  expressing 3xFlag-Usp145 
vector (left). WB analysis of Usp14 expression in Usp14−/− MEFs transfected with either the empty vector 
(EV) or the 3xFlag-Usp14 construct (right). 
The histograms on the right of each panel show the quantification of primary cilia length. Scale bar = 5μm. 
More than 100 cells analyzed per sample. Data are expressed as mean +/- SEM (n=3); *P < 0.05; **P < 0.01.  
 
Taken together, our results reveal a role for Usp14 in the control of ciliogenesis in vitro 
and indicate that pharmacological induction of proteasomal activity positively affects cilia 
formation and elongation. 
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5. Usp14 is required for the proper localization of Hh components to 
primary cilia 
 
In order to evaluate the functionality of abnormally long primary cilia observed when 
Usp14 is inhibited, we decided to analyze the signaling cascade of the Hh pathway which 
needs cilia to properly transduce its signals and activate the transcription of target genes in 
order to exert its physiological functions (Nozawa, Lin et al. 2013). A major event 
associated with active Hh signaling is the increased levels of pathway mediators along the 
primary cilium under Hh stimulus. In basal conditions, Gli proteins are present in low 
amounts at the ciliary tip where enriched after Hh signaling activation. We thus determined 
whether the levels/localization of Hh signaling components were affected in longer cilia of 
Usp14-/- embryonic fibroblasts. We assayed the ciliary localization of Gli2 and Gli3 by 
fluorescence staining with endogenous antibodies, whereas anti Arl13b/Acetylated tubulin 
antibodies were used for labeling of primary cilia. We then bordered the perimeter of each 
cilium and measured fluorescence intensity to quantify the total ciliary amounts of Gli2 
and Gli3 in unstimulated conditions or after 24h of stimulation either with the Smoothened 
agonist (SAG) or the ligand Sonic Hedgehog (Shh) recombinant protein. 
We rarely observed Gli2 staining in the tips of WT cilia in unstimulated conditions (NT), 
while the staining significantly enriched upon induction either with SAG or Shh in Usp14-/- 
cilia. Gli2 also shifted localization, and many Usp14 mutant cells showed multiple sites of 
concentrated Gli2 under the tip and throughout the axoneme, compared to WT MEFs 
(Figure 21A). Moreover, the analysis of Gli3 ciliary localization revealed a pattern similar 
to that observed for Gli2. The fluorescence intensity of Gli3 was significantly stronger 
along Usp14-/- cilia compared to WT cells under Hh pathway activation (Figure 21B), 
suggesting that Usp14 is essential for controlling the proper localization of Gli proteins at 
the primary cilia. To provide independent evidence and support these findings, Usp14 was 
silenced using specific siRNA directed against Usp14 in WT MEFs and the cells were 
stimulated with SAG for 24h. Immunofluorescence experiments showed that also the 
 79 
transient silencing of Usp14 had a strong effect on Gli2 ciliary localization compared to 
controls, as demonstrated by quantification of ciliary fluorescent intensity (Figure 21C). 
We then asked whether Usp14 inhibition promotes recruitment of Hh signaling effectors to 
cilia through its catalytic activity. WT MEFs were plated in complete medium, serum-
starved for 48h and treated with IU1 inhibitor for 24h. Confocal analysis revealed 
increased ciliary fluorescence intensity for Gli2, confirming that the catalytic proteasome 
inhibitor activity of Usp14 acts also on the ciliary localization of Hh signaling components 
(Figure 21D).  
 
Figure 21. Usp14 controls localization of Hh mediators at cilia 
(A) Representative confocal images of endogenous Gli2 (green) and (B) Gli3 (green) localization at cilia in 
Usp14+/+ and Usp14-/- starved MEFs in basal condition (NT) and under SAG/Shh stimuli. Arl13b marks 
primary cilia (red) and Hoechst in blue. Gli2 and Gli3 staining were rarely observed in WT cilia in 
unstimulated conditions while they were significantly enriched in cilia in Usp14-/- MEFs upon induction both 
with SAG or Shh compared to Usp14+/+ cells. The histograms show the quantification of the fluorescence 
intensity of ciliary Gli2 (A) and Gli3 (B), respectively, for NT, SAG and Shh stimulated MEFs. (C) IF 
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staining of the endogenous Gli2 (green) on Usp14 siRNA depleted MEFs and control under SAG stimulus 
for 24h. Acetylated tubulin marks primary cilia (red). The histogram shows the quantification of Gli2 
fluorescence intensity on cilia which increased in Usp14 depleted cells compared to controls. (D) IF staining 
of the endogenous Gli2 (green) on WT MEFs treated with IU1 inhibitor and DMSO for 24h, under SAG 
stimulus for 24h. Acetylated tubulin marks primary cilia (red). The histogram shows the quantification of 
Gli2 fluorescence intensity on cilia which increased in IU1 treated cells compared to controls.  
Data are expressed as mean+- SEM (n=3); *P < 0.05; **P < 0.01; ***P < 0.001. Scale bar = 5μm. More than 
100 cells analyzed per sample. SAG= Smoothened agonist, Shh=recombinant N-Shh 
 
 
Consistent with these observations, transfection of Usp14-/- MEFs with the 3xFLAG-
Usp14 construct rescued the Gli2 ciliary localization compared to cells transfected with 
the empty vector (Figure 22A), thus proving the specificity of action of Usp14.  
On the basis of these observations, we treated Usp14-/- MEFs with MG132, a proteasome 
inhibitor, to establish if the observed ciliary phenotypes can be modulated by regulating 
proteasomal activity. We found that the MG132 treatment was able to rescue the ciliary 
fluorescence intensity of Gli2 and Gli3 in Usp14-/- MEFs, compared to DMSO treated 
cells (Figure 22B), confirming an involvement of the proteasomal activity in modulating 
the localization of Gli proteins at the primary cilia.  
In order to demonstrate that the enhanced recruitment of Gli2/3 to cilia, consequent to 
inhibition of Usp14, does not depend on increased levels of total Gli proteins, we 
performed WB analysis and compared the total protein lysates obtained from WT and 
Usp14-/- MEFs. We didn’t find a significant increase in protein levels of Gli2 and Gli3 in 
Usp14-/- cells, as well as in Usp14 silenced and IU1 treated cells (Figure 22C), confirming 
that the enhanced ciliary localization of Hh mediators is not due to increased protein levels. 
Therefore, our observations suggest that the efficiency of the ciliary recruitment and 
transport of Hh regulatory proteins, and perhaps other cargos, is controlled by Usp14, 
putting forward the possibility of an ‘ubiquitin-dependent’ regulation. 
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Figure 22. Proteasomal activity regulates localization of Hh mediators at cilia 
(A) IF in 48h starved WT and Usp14−/− MEFs transfected with the empty vector (EV) and Usp14-/- cells 
transfected with the 3xFlag-Usp14 construct. Primary cilia stained with Arl13b (red), endogenous Gli2 in 
green and Hoechst in blue. Scale bar=5µm. (B) Representative confocal images of endogenous Gli2 (green in 
upper panel) and Gli3 (green in lower panel) localization at cilia in WT and Usp14-/- MEFs treated with 
DMSO or MG132 under SAG stimulus. Arl13b marks primary cilia (red) and Hoechst in blue. (C) WB 
analysis of Gli2 and Gli3 protein levels in Usp14−/− MEFs, Usp14 siRNA depleted MEFs and IU1 treated 
cells, compared to their controls. 
 
6. Loss of Usp14 enhances migration of Gli2 to the nucleus 
The Hh phenotype observed in Usp14 depleted models could also be associated to 
defective retrograde transport. We thus evaluated whether Gli proteins normally 
translocated to the nucleus to activate transcription of target genes.  
To analyze the nuclear migration of Gli2 we decided to employ a subcellular fractionation 
analysis. We plated WT MEFs at confluency. The cells then underwent serum starvation 
for 48h and the Hh pathway was activated by SAG treatment. Finally, the cells were 
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treated with IU1 in order to inhibit the catalytic activity of Usp14. At this point we 
separated the nuclear fractions from the cytoplasmic fractions and measured the amounts 
of Gli2 protein in DMSO or IU1 treated samples. IU1 treatment of SAG stimulated WT 
MEFs revealed an increased nuclear amount of Gli2, the main Hh transcriptional activator, 
compared to the amount detected in untreated cells. On the contrary, IU1 treated cells 
displayed lower amount of cytoplasmic Gli2 protein compared to untreated MEFs (Figure 
23A, left panels). Nuclear and cytoplasmic fractions obtained were not cross-contaminated, 
as indicated by the absence of Gapdh and Sp1, used as controls, in nuclear and cytoplasmic 
extracts, respectively. The same findings were observed for SAG stimulated Usp14 
siRNA-treated and Usp14-/- MEF cells (Figure 23A, central and right panels, respectively). 
Conversely, transfection of 3xFLAG-Usp14 in Usp14-/- SAG stimulated MEFs resulted in 
increased cytoplasmic levels and reduced nuclear amounts of Gli2 compared to cells 
transfected with the empty vector, as the protein is retained in the cytoplasm (Figure 23B). 
 
 
Figure 23. Usp14 controls migration of Gli2 to the nucleus 
(A) WB analysis of Gli2 protein levels in cytoplasmic and nuclear fractions from IU1 or DMSO treated 
MEFs (left), Usp14 siRNA depleted MEFs and control (center), and Usp14+/+ and Usp14-/- MEFs lysates 
(right). In all conditions, nuclear amounts of Gli2 are increased, and cytoplasmic amounts of Gli2 are 
decreased in Usp14 depleted cells compared to the respective control. (B) WB analysis of Gli2 protein levels 
in cytoplasmic and nuclear fractions from Usp14-/- cells transiently transfected with the EV or p3xFlag-
Usp14 for 48h. In Usp14-/- cells transfected with the p3xFlag-Usp14 construct, the Gli2 cytoplasmic levels 
resulted increased, while the nuclear amounts of Gli2 resulted decreased compared to cells transfected with 
the EV. For all experiments MEFs were stimulated with SAG for 24h. Gapdh and Sp1 were used as control 
for the quality of cytoplasmic and nuclear fractions. TL=total lysate.  
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To evaluate the functionality of the increased nuclear amounts of Gli2 observed in the 
absence of Usp14, we analyzed the expression levels of Gli1, the main downstream direct 
target gene, used as readout of the Hh pathway activation. For this purpose, we exposed 
starved MEF cells to both SAG and Shh stimulus for 24h and then monitored the Gli1 
transcriptional levels by quantitative Real-Time PCR (qPCR). We found that the mRNA 
levels of Gli1 were significantly higher in IU1 treated cells (Figure 24A, top left panel), as 
well as in Usp14-/- MEFs and Usp14 siRNA depleted cells (Figure 24A, right and bottom 
left panels, respectively), demonstrating that genetic or pharmacological inhibition of 
Usp14 resulted in enhanced activation of the Hh signaling pathway. Consistent with these 
observations, to demonstrate the specificity of action of Usp14, we transfected 3xFLAG-
Usp14 in Usp14-/- MEFs and rescued Gli1 mRNA expression levels compared to cells 
transfected with the empty vector (Figure 24B), confirming an inhibitory role of Usp14 in 
Hh signal transduction pathway. 
 
 
 
Figure 24. Usp14 controls activation of Hedgehog signaling 
(A) qRT-PCR analysis. The transcriptional levels of Gli1 are increased in IU1, Usp14-/- or Usp14 siRNA 
depleted MEFs under SAG treatment compared to the corresponding control. The levels of Gli1 are also 
increased in Usp14-/- cells under Shh treatment (bottom right). (B) Conversely, Gli1 transcriptional levels are 
decreased in Usp14-/- cells transiently transfected for 48h with the p3xFlag-Usp14 construct under SAG and 
Shh treatment. Data are expressed as mean+- SEM (n=3); *P < 0.05; **P < 0.01; ***P < 0.001 
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The above-described results reveal a critical role for Usp14 and proteasomal activity not 
only in the control of ciliogenesis and cilia elongation, but also in Hedgehog signaling. 
On the basis of these data, at this point, we also wondered whether the suppression of 
Usp14’s deubiquitinase activity altered the stability of specific regulator of cilia 
maintenance and functionality.  
 
7. Usp14 inhibition promotes Kif7 degradation 
We reasoned that Kif7, a kinesin-4 family protein, could be an interesting putative target of 
Usp14, since Kif7 has been shown to inhibit Hh signaling, to control localization of Hh 
mediators and axonemal length. In particular, depletion of Kif7 causes a relatively mild 
activation of Hh signaling, induces elongation and instability of cilia, and ectopic puncta of 
Hh signaling components along Kif7 mutant cilia (Ingham and McMahon 2009, He, 
Subramanian et al. 2014). We thus hypothesized that Usp14 may act on cilia and Hh 
signaling through the Kif7 protein.  
In order to evaluate whether Kif7 is target of the proteasome, we treated WT MEFs with 
the proteasome inhibitor MG132, and analyzed whole-cell lysates by WB analysis. We 
observed a time dependent accumulation of Kif7 protein levels after MG132 treatment, 
indicating a degradation of Kif7 mediated by UPS (Figure 25A). Then we evaluated the 
effect of genetic and pharmacological inhibition of Usp14 on Kif7 stability. We first 
treated WT MEFs at different time points with IU1 and we quantified the protein amounts 
of Kif7 after 24h of MG132 treatment by WB analysis. In addition, we also analyzed 
lysates from Usp14 silenced and KO cells. We found that protein amounts of endogenous 
Kif7 were dramatically decreased in IU1 treated WT cells (Figure 25B), Usp14 siRNA-
treated MEFs (Figure 25C), and Usp14-/- MEFs (Figure 25D) compared to the respective 
controls. Conversely, 3xFLAG-Usp14 overexpression increased Kif7 protein levels in WT 
MEFs compared to cells transfected with the empty vector (Figure 25E).  
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Given that Usp14 is a deubiquitinating enzyme we further investigated whether Usp14 may 
regulate the ubiquitination status of Kif7. WT MEFs were transfected with a GFP-Kif7 
construct and treated either with IU1 or DMSO. The exogenous tagged Kif7 was 
immunoprecipitated using the GFP antibody. Then, samples from Usp14-inhibited or -not 
inhibited MEFs were immunoblotted with an antibody specifically recognizing the K48 
ubiquitin chains that mediate the degradation of proteins by the UPS. In order to detect 
specifically the ubiquitination on Kif7 and not on non-covalently interacting proteins, we 
used a stringent condition for cell lysis, immunoprecipitation and washing (see methods). 
Our results indicated that inhibition of the catalytic activity of Usp14 increased the levels 
of ubiquitination of Kif7 as demonstrated by the stronger smear of high molecular weight 
observed in IU1 treated cells compared to DMSO treated controls (Figure 25F). Taken 
together these findings strongly suggest that Kif7 is a target of Usp14. 
Furthermore, we asked whether Kif7 instability could be connected to the cellular 
phenotypes observed in Usp14 depleted cells. Usp14-/- MEFs were transfected with the 
empty vector alone or the GFP-Kif7 plasmid for 48h, followed by nuclear and cytoplasmic 
fractionation to study Gli2 migration into the nucleus. Immunoblotting showed that Kif7 
overexpression rescued the Gli2 nuclear accumulation observed in Usp14 depleted 
conditions (Figure 25G), suggesting that Usp14 has a role in regulating Gli2 nuclear 
translocation trough Kif7. In addition, we also evaluated activation of the Hh pathway. We 
thus performed qPCR on extracts of Usp14-/- cells transfected either with pGFP-Kif7 or EV. 
We found a downregulation of Gli1 expression levels in Usp14 mutated cells 
overexpressing tagged Kif7 (Figure 25H), confirming an action of Kif7 downstream of 
Usp14 and demonstrating the ability of Kif7 overexpression to rescue the iper-activation of 
the Hh signaling pathway caused by Usp14 inhibition. 
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Figure 25. Usp14 inhibition promotes Kif7 degradation 
(A) WB analysis of Kif7 protein levels from WT MEFs cells treated with MG132 at different time points. 
(B) WB analysis of Kif7 protein levels from WT MEFs cells treated with IU1 at different time points. The 
histogram shows quantification of band intensities for relative Kif7 levels after 24h of treatment. (C-E) WB 
analysis of Kif7 protein levels from Usp14 siRNA depleted MEFs and control (C), Usp14+/+ and Usp14-/- 
MEFs lysates (D) and Usp14-/- MEFs transiently transfected with the EV or the p3xFlag-Usp14 construct for 
48h (E). For all three conditions, MEFs are stimulated by SAG for 24h. Histograms show quantification of 
band intensities for relative Kif7 levels (C-E). (F) MEFs were transfected with the pEGFP-Kif7 construct 
and treated with IU1 or DMSO for 6h in the presence of MG132. Protein extracts were immunoprecipitated 
in denaturing conditions using an antibody against GFP, and Ubiquitin-K48 and GFP-Kif7 were analyzed by 
WB. (G) WB analysis on Gli2 protein levels in cytoplasmic and nuclear fractions from Usp14-/- cells 
transiently transfected with EV or pGFP-Kif7 for 48h, under SAG stimulus. Gapdh and Sp1 were used as 
controls for the quality of cytoplasmic and nuclear fractions. TL=total lysate. (H) qPCR analysis on mRNA 
expression levels of Gli1 under SAG treatment in Usp14-/- cells transiently transfected for 48h with the EV 
vector or the pGFP-Kif7 construct. 
 
These findings suggest a new mechanism by which cilia maintenance and the Hh pathway 
are regulated by Usp14, a major inhibitor of proteasome degradation, via modulation of the 
stability of the ciliopathy protein Kif7. 
 
 
 87 
8. Inhibition of Usp14 rescues Hh related phenotypes in Pkd1-/- MEFs  
The Hh signaling pathway is essential for embryonic development in vertebrates. 
Consequently, impaired Hh signaling results in severe human diseases, and is responsible 
for some of the clinical signs observed in ciliopathies (Wong and Reiter 2008). We thus 
tested if Usp14 may play a role in Hh-related phenotypes observed in ciliopathies cellular 
models. We analyzed Usp14 and Kif7 protein amounts in in vitro models (MEFs) depleted 
for the Intraflagellar transport 20 (Ift20-/-), Ofd1 (Ofd1-/-), and Pkd1 (Pkd1-/-) transcripts. 
WB analysis showed increased protein levels of Usp14 and Kif7 in all the three ciliopathy 
models analyzed (Figure 26A), suggesting an involvement of Usp14 and Kif7 in the 
manifestations of the Hh phenotypes observed in ciliopathies.  
Mutations in Ift20 and Ofd1 disrupt assembly of cilia and result in Hh signaling 
impairment (Clement, Kristensen et al. 2009, Liu, Tsai et al. 2014), while Pkd1 mutations 
are not associated to defects in cilia formation (Lee and Somlo 2014). Polycystin-1 and -2 
localize at the primary cilium of diverse cell types, but vertebrates lacking functional 
polycystins do not have structurally abnormal cilia, suggesting that polycystins, may 
modulate sensory functions of cilia, rather than proper cilia formation (Gascue, Katsanis et 
al. 2011, Lee and Somlo 2014). We thus decided to perform IF analysis in order to 
evaluate Gli2 ciliary localization in Pkd1-/- cells. Our results showed a proper localization 
of endogenous Gli2 to cilia in WT and Pkd1-/- MEFs, although the Gli2 fluorescence 
intensity resulted fainter on the ciliary tips of Pkd1 mutant MEFs compared to WT (Figure 
26B). We then wondered whether inhibition of Usp14 could promote recruitment of Gli2 
to cilia in Pkd1-/- MEFs, and could improve the Gli proteins translocation defects observed 
in Pkd1-/- cells. IF experiment showed rescued amount of Gli2 protein on ciliary tips of 
Pkd1-/- MEFs transfected with siRNA against Usp14 (Figure 26C), confirming the role of 
Usp14 in regulating the ciliary localization of Gli2 also in the Pkd1 cellular model. We 
then exposed WT and Pkd1-/- MEFs to SAG treatment and evaluated Hh signaling 
activation by Real Time PCR. Our results indicated that Gli1 transcriptional levels, as 
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already shown in other ciliopathies models (Clement, Kristensen et al. 2009, Liu, Tsai et 
al. 2014), were downregulated in Pkd1-/- cells compared to WT, in basal condition and 
after Hh pathway activation (Figure 26D). We thus hypothesized that by inhibiting the 
activity of Usp14 we could also modulate the activation of the Hh signaling. Consistent 
with these idea, silencing of Usp14 in Pkd1-/- MEFs enhanced Gli1 mRNA expression 
levels compared to cells transfected with the empty vector (Figure 26E), demonstrating the 
role of Usp14 on the proper activation of the Hh signal transduction pathway. We also 
enhanced the ciliary amount of Gli2 and the mRNA expression levels of Gli1 in Pkd1-/- 
MEFs after treatment with IU1, confirming the role of Us14deubiquitinase activity in Hh 
signaling pathway (Figure 26F-G). 
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Figure 26. Usp14 inhibition rescues Hh related phenotypes of Pkd1-/- MEFs  
(A) WB blot analysis of Ift20-/-, Pkd1-/- and Ofd1-/- MEFs show increased protein levels of Usp14 and Kif7 
in all models analyzed. (B) Representative confocal images of endogenous Gli2 (green) localization to cilia 
in Pkd1+/+ and Pkd1-/- starved MEFs in basal condition (NT) and under SAG stimulus. Arl13b marks primary 
cilia (red) and Hoechst labels nuclei (blue). Scale bar=5µm. (C) IF experiments in 48h starved WT and 
Pkd1−/− MEFs transfected with non-targeting siRNA (control) and Pkd1-/-  cells transfected with siRNA 
directed against Usp14. Primary cilia are stained with Arl13b (red), endogenous Gli2 is in green and Hoechst 
in blue. Scale bar=5µm. (D) qPCR analysis on mRNA expression levels of Gli1 in basal condition and under 
SAG treatment in Pkd1+/+ and Pkd1-/- starved MEFs, (E) and in Pkd1-/- cells transfected with Usp14 siRNA 
under SAG stimulus. (F) IF experiments in 48h starved WT and Pkd1−/− MEFs treated with DMSO and 
Pkd1-/-  cells treated with IU1. Primary cilia are stained with Arl13b (red), endogenous Gli2 is in green and 
Hoechst in blue. Scale bar=5µm. (G) qPCR analysis on mRNA expression levels of Gli1 under SAG stimulus 
in Pkd1-/- cells treated with DMSO or IU1. 
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Discussion 
In recent years primary cilia have become the focus of intensive studies for their 
importance in development, inherited human disease and cancer (Brown and Witman 
2014). Since most mammalian cells have cilia, loss of primary cilia or defects in ciliary 
functions affect different organ systems, and are associated with severe developmental 
diseases, collectively called ciliopathies (Hildebrandt, Benzing et al. 2011). It is well 
established that primary cilia act as the cell’s antenna and play important roles in the 
correct transmission of several signal transduction pathways. One of the most convincing 
and solid experimental evidence in cilia biology is that vertebrate cells require intact and 
functioning primary cilia to respond to Hh family ligands (Lee, Zhao et al. 2016). 
Moreover, many important aspects of the phenotypes observed in ciliopathies, such as 
neural tube defects, polydactyly skeletal defects and craniofacial malformations, which 
include also the classical clinical features of OFD type 1 syndrome (Toprak, Uzum et al. 
2006, Macca and Franco 2009), can be explained by misregulation of the Hh signaling 
(Toprak, Uzum et al. 2006, Macca and Franco 2009). Mutations in ciliary genes result in 
either loss or increase of Hh signaling. This is particularly evident in craniofacial structures, 
where cilia impairment can lead to both narrowing of the head with incomplete separation 
of the forebrain hemispheres (holoprosencephaly, associated with loss of Hh signaling) and 
widening of the mid-face (associated with gain of Hh signaling) (Cordero, Marcucio et al. 
2004, Brugmann, Allen et al. 2010). 
The study of the connections between cilia and developmental signaling has begun to 
clarify the basis of human diseases associated with ciliary dysfunction. The proper course 
of several cilia-associated signaling pathways is also mediated by ubiquitin-dependent 
proteolysis. In particular, besides the ubiquitin-dependent protein degradation, the 
proteasome is able to proteolytically process proteins. A well-designed processing event is 
the transformation of full-length activating Gli proteins into their shorter repressor forms 
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(Gerhardt, Leu et al. 2016), highlighting the possibility of regulating the Hh pathway 
activity through UPS modulation. Despite significant advances in identifying ciliopathy 
genes, the causative mechanisms at the base of ciliopathies are still poorly understood. To 
better understand the processes of Hh signal transduction related to the cilium, we directed 
our study towards the analysis of the relationship between ciliary function and the 
ubiquitin proteasome pathway. Our hypothesis is grounded on the previously cited 
observations and on the presence of several regulatory subunits of the proteasome in the 
available ciliary proteome databases (Ishikawa, Thompson et al. 2012, Goel, Murthy et al. 
2013). In addition, the proteasome is known to alter its composition under certain 
conditions, such as cellular stress (Schmidt and Finley 2014). Conversely, it has been 
shown that in response to cellular stress primary cilia length and ciliogenesis are affected 
(Keeling, Tsiokas et al. 2016). Therefore, we wondered whether loss of the OFD1 
ciliopathy protein affects proteasome composition, and performed functional evaluation of 
appropriate degradation/processing of Hh mediators; and we also asked whether the 
modulation of UPS components or proteasomal activity could ameliorate ciliary 
dysfunctions. Our data suggest a simple model, in which the Ofd1 centrosomal/basal body 
protein plays a role in Hh signal transduction regulation through a direct interaction with 
regulatory subunits of the proteasome, and by controlling the context-dependent 
proteolytic degradation. We tested the robustness of this model by demonstrating that cells 
ablated for Ofd1 show defects in proteasomal clearance of specific Hh signaling 
components including Gli2, Gli3, and Sufu. An altered composition of multiple subunits in 
the proteasome occurs during cellular stress (Hanna, Meides et al. 2007), and it is plausible 
that alteration of ciliary signaling can have a similar effect. Thus, we evaluated whether the 
ablation of the centrosomal OFD1 protein, which causes impairment of Hh signaling, can 
affect the proteasomal composition. The centrosome is a site of action for the UPS (Vora 
and Phillips 2016), and in the absence of OFD1, the centrosomal proteasome is 
mislocalized and changes its composition, as demonstrated by the reduction of RPT2 
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regulatory subunit and increased levels of USP14 deubiquitinase, which is a major 
inhibitor of proteasomal activity. Furthermore, we demonstrated that enhancement of the 
proteasomal activity, by SFN treatment, has an ameliorative effect by improving the Hh 
signaling defects through the chemical upregulation of proteasomal components. Notably, 
we observed sucrose fraction sedimentation changes in multiple proteasomal subunits in 
the absence of OFD1, suggesting that ciliopathy phenotypes are unlikely to be driven by 
specific defects in only one subunit, consistent with the observation that mice 
haploinsufficient for the subunit Rpn10 are phenotypically normal, at least by looking at 
the gross pathology, while homozygous Rpn10–/– mutants are embryonic lethal (Hamazaki, 
Sasaki et al. 2007). Ciliopathy proteins also play a central role in the regulation of the actin 
cytoskeleton and in the control of cilia length (Hernandez-Hernandez, Pravincumar et al. 
2013, Keeling, Tsiokas et al. 2016). Defects in ciliary length are in fact associated with 
ciliopathies. It is intriguing to note that several renal cystic diseases have been associated 
with long cilia. Kidney tubules and cultured renal tubular cells from Bbs4-null mice 
displayed elongated cilia with an intact microtubular structure following prolonged culture 
(Mokrzan, Lewis et al. 2007), and Juvenile cystic kidneys (jck) mice (carrying a mutation 
in Nek8) also displayed long cilia (Smith, Bukanov et al. 2006, Sohara, Luo et al. 2008). 
Kidney tissues from a fetus affected with mutations in MKS3 displayed longer cilia 
compared to the control tissue, as measured by alpha-acetylated tubulin staining 
(Tammachote, Hommerding et al. 2009). Cells depleted for three genes responsible for 
three different forms of Joubert syndrome (JBTS): KIF7 (JBTS12) (He, Subramanian et al. 
2014), KIAA0556 (JBTS26) (Sanders, de Vrieze et al. 2015) and TMEM67 (JBTS6) also 
have abnormally long cilia (Stayner, Poole et al. 2017). 
Research on the UPS has demonstrated that proteins involved in ubiquitin-dependent 
signaling and proteolysis are important for a variety of cellular functions (Dikic 2017, 
Varshavsky 2017). Indeed, it has recently been suggested that the ubiquitin proteasomal 
system is one of the core mechanisms in regulating the formation and maintenance of 
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primary cilia (Malicki and Johnson 2017). Moreover, results from functional genomics and 
proteomics screen indicate that many UPS components may play a role in ciliogenesis. 
Although a large body of evidence indicated the potential importance of UPS in the 
dynamic profile of cilia, the role of the proteasome complex in ciliogenesis has been 
poorly studied and needs to be fully understood. Here, we report that a specific DUB, 
Usp14, reveals a novel signaling mechanism in both ciliogenesis and the control of the Hh 
pathway. We provide evidence that both genetic and pharmacological inhibition of Usp14 
promotes ciliogenesis and cilia length elongation. Since the control of primary cilia length 
is an important and dynamic process, intimately related to ciliary signaling (Goetz and 
Anderson 2010), it is clear that alterations of cilia morphology and/or length can have 
dramatic functional implications. In order to evaluate the functionality of the abnormally 
long observed cilia, we studied the Hedgehog pathway, as its signal transduction is closely 
related to cilia integrity and is mediated by Gli proteins translocation to the cilia tip 
(Robbins, Fei et al. 2012). Strikingly, here we report that both genetic and pharmacological 
modulation using a drug that activate proteasome by Usp14 inhibition not only influenced 
ciliogenesis but also promoted translocation of Gli proteins to the cilia, into the nucleus 
and activation of the Hh pathway.  
Recent studies of ciliary regulators and components have uncovered multiple mechanisms 
that control the movement of Hh players and the activation of the pathway (Goetz, Ocbina 
et al. 2009). IFT is integral for Hh transduction by trafficking signaling components within 
cilia: loss of most IFT complex B proteins, which mediate anterograde IFT, causes the 
absence of cilia and the inability to transduce Hh signals (Huangfu, Liu et al. 2003, 
Huangfu and Anderson 2005). In contrast, loss of IFT complex A proteins, Thm1 and 
Ift122, which largely mediate retrograde IFT, sequesters proteins in bulb-like structures at 
the distal tip of shortened cilia and causes inappropriate activation of the Hh pathway (Tran, 
Haycraft et al. 2008, Qin, Lin et al. 2011). Unlike most complex B proteins, Ift25 and Ift27 
are not essential for ciliogenesis but form a subcomplex which is critical for ciliary import 
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of Gli2. As a result, loss of Ift25 or Ift27 does not alter cilia structure but disrupts 
activation of the Hh pathway (Keady, Samtani et al. 2012, Eguether, San Agustin et al. 
2014, Liew, Ye et al. 2014). More recently, the phospholipid content of the ciliary 
membrane has also been shown to be a critical regulator of the pathway. INPP5E encodes 
for a phophoinositide phosphatase that creates a distinct phosphoinositide distribution in 
the ciliary membrane. Mutations in INPP5E cause Joubert syndrome, a well-known 
ciliopathy (Jacoby, Cox et al. 2009), and increase ciliary localization of Hh negative 
modulators, resulting in inactivation of the pathway. Furthermore, the transport of proteins 
in the ciliary axoneme is also driven by microtubule-dependent motors, the kinesins (Kif 
proteins). A null mutation in Kif3a has also been shown to disrupt Hh signaling (Goetz, 
Ocbina et al. 2009), while pathogenic mutations of KIF7, show not only upregulation of 
direct targets of Hh signaling but also elongation of primary cilia (Putoux, Thomas et al. 
2011). KIF7 is the only evolutionarily conserved component of the core Hh signal 
transduction pathway that controls the axoneme length and the ciliary localization of Hh 
signaling molecules (He, Subramanian et al. 2014). Mutations in human KIF7 have been 
reported in several classes of severe ciliopathies associated with perinatal lethality, 
including fetal hydrolethalus, acrocallosal syndrome, and Joubert syndrome (Dafinger, 
Liebau et al. 2011, Putoux, Thomas et al. 2011, Ali, Silhavy et al. 2012, Barakeh, Faqeih et 
al. 2015:Walsh, 2013 #76, Ibisler, Hehr et al. 2015, Karaer, Yuksel et al. 2015, Tunovic, 
Baranano et al. 2015). Affected individuals show a spectrum of developmental defects 
including brain abnormalities, skeletal malformations, and craniofacial dysmorphisms, 
consistent with a role for KIF7 in the mammalian Hh pathway. Based on these 
observations, we propose a model where Usp14-mediated degradation of Kif7 regulates 
both ciliogenesis and Hh signaling. Consistent with our model, the levels of both Usp14 
and Kif7 were increased in three different types of ciliopathies, confirming that Usp14 is 
intimately related to cilia biology. The mechanistic cause of this elevation has not yet been 
determined, and it is necessary to understand whether the increased Usp14 levels influence 
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or simply accompany the progression of the ciliopathies cellular phenotype. Moreover, we 
evaluated the effects of Usp14 inhibition on Hh signaling in Pkd1-/- MEFs, that do not 
display altered cilia formation. At the molecular level, one of the evident differences 
between proteins codified by genes responsible for ADPKD and proteins codified by 
transcripts mutated in other forms of inherited polycystic kidney disease is that while most 
cilioproteins responsible for renal cystic diseases have a fundamental role in ciliogenesis, 
polycystins (involved in ADPKD) do not seem to be essential for cilia formation and both 
Pkd1 and Pkd2, when inactivated, are not associated to cilia impairment (Gascue, Katsanis 
et al. 2011, Lee and Somlo 2014). Surprisingly, we showed that loss of Pkd1 is associated 
to a dramatic decrease of Hh signaling and to impaired Gli2 ciliary localization following 
Hh activation, which was rescued by IU1 treatment even in the presence of apparently 
normal cilia (as in the case of the Pkd1-/- model) suggesting that Hh signaling may be 
involved in renal cytogenesis independently from the normal length of cilia. Additional 
experiments in the different available ADPKD in vitro and in vivo models accompanied by 
ultrastructural analysis of cilia will help in clarifying this hypothesis. Evidence that Hh 
signaling is involved in renal cystogenesis in animal models not due to mutations in the 
ADPKD loci are recently emerging (Attanasio, Uhlenhaut et al. 2007, Tran, Haycraft et al. 
2008, Jonassen, SanAgustin et al. 2012, Tran, Talbott et al. 2014). On the basis of these 
considerations one of the challenges in understanding the molecular mechanisms of 
ADPKD is to discover the specific ciliary signaling process/es regulated by polycystins. In 
this regard, the mammalian Hh pathway may be a good starting point. As mentioned above, 
to the best of my knowledge a detailed analysis of the Hh signaling in PKD mouse models 
in vivo has not been reported yet and it will be needed to determine a possible functional 
role for Hh signaling in the renal cystic disease observed in ADPKD. 
Therefore, our findings not only support the previously reported suggestion of an 
involvement of the UPS in cilia signaling and biogenesis but also contribute to the 
understanding of the role of the catalytic activation of proteasomal degradation in linking 
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ciliogenesis and Hh signaling transduction. To the best of our knowledge, this is the first 
example in which activation of proteasomal degradation has been shown to lead to an 
elongation of cilia, and to Hh signaling activation. Our results linking ciliopathy proteins, 
proteasomal function, cilia maintenance and Hh signaling represent a significant advance 
in the understanding of this organelle and indicate new potential therapeutic applications. 
In contrast to proteasome inhibitors, small molecules that can activate or enhance 
proteasome activity are rare and not well studied. Intriguingly, Lee et al. demonstrated that 
IU1, the selective small-molecule inhibitor of Usp14, accelerates proteasomal degradation 
of specific targets (Lee, Lee et al. 2010).  Since we demonstrated that IU1 promotes 
ciliogenesis and Hh signaling, the activation of the proteasome could become a useful 
therapeutic strategy in ciliopathies. Our findings may therefore provide interesting new 
insights to better understand the spectrum of actions of proteasome activating compounds 
and may warrant further investigation into application of some of these compounds in 
treatment. Therefore, although the proteasomal dysfunction is just one of the contributor to 
the pathology of ciliopathies, our results can help in the design of future UPS-related 
therapies aimed at improving Hh-mediated phenotypes. 
 
 
Conclusions 
In conclusion, we demonstrated, both in vitro and in vivo, that loss of Ofd1 causes 
accumulation of Hh signaling mediators that is rescued by enhancing proteasomal activity. 
We also demonstrated that OFD1, as well as other cilioproteins, regulates the proteasomal 
composition at the centrosome through a direct interaction with specific regulatory 
proteasomal subunits. This part of the thesis was published in 2014 (Liu, Tsai et al. 2014), 
and is reported in the appendix.  
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Our observation led us to further investigate USP14, a proteasomal deubiquitinase 
identified in mammalian primary cilia through proteomic approaches that was found more 
bound to the proteasome in Ofd1-depleted models. Indeed, our results indicate that USP14 
controls ciliogenesis and cilia length and has also a role in Hh signaling. Indeed Usp14 
inactivation, depletion or inhibition by using a specific small molecule, modulate 
localization of Hh signaling components to primary cilia and activation of the pathway. 
Our results were also tested and validated in other ciliopathy models.  
In summary, our studies support the involvement of the Ubiquitin Proteasome System in 
cilia signaling and biogenesis and contribute information to the emerging data linking 
proteasomal degradation, ciliogenesis and Hh signal transduction. Our findings may also 
provide insights for the potential therapeutic use of UPS-related therapies aimed at 
improving Hh-mediated ciliopathy phenotypes.  
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Ciliopathy proteins regulate  
paracrine signaling by modulating 
proteasomal degradation of mediators
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Cilia are critical mediators of paracrine signaling; however, it is unknown whether proteins that contrib-
ute to ciliopathies converge on multiple paracrine pathways through a common mechanism. Here, we show 
that loss of cilopathy-associated proteins Bardet-Biedl syndrome 4 (BBS4) or oral-facial-digital syndrome 1 
(OFD1) results in the accumulation of signaling mediators normally targeted for proteasomal degradation. 
In WT cells, several BBS proteins and OFD1 interacted with proteasomal subunits, and loss of either BBS4 
or OFD1 led to depletion of multiple subunits from the centrosomal proteasome. Furthermore, overexpres-
sion of proteasomal regulatory components or treatment with proteasomal activators sulforaphane (SFN) 
and mevalonolactone (MVA) ameliorated signaling defects in cells lacking BBS1, BBS4, and OFD1, in mor-
phant zebrafish embryos, and in induced neurons from Ofd1-deficient mice. Finally, we tested the hypothesis 
that other proteasome-dependent pathways not known to be associated with ciliopathies are defective in the 
absence of ciliopathy proteins. We found that loss of BBS1, BBS4, or OFD1 led to decreased NF-κB activity and 
concomitant IκBβ accumulation and that these defects were ameliorated with SFN treatment. Taken together, 
our data indicate that basal body proteasomal regulation governs paracrine signaling pathways and suggest 
that augmenting proteasomal function might benefit ciliopathy patients.
Introduction
In vertebrates, the cilium and the basal body are key components of 
paracrine signaling transduction. This has, in turn, suggested that 
phenotypes of ciliopathy patients might be attributed to defective 
paracrine signaling (1), including polydactyly due to defective sonic 
hedgehog (Shh) signaling (2) and renal cysts attributed to unbal-
anced Wnt signaling (3). Some data have raised the possibility that 
a fraction of these defects, especially Wnt, are driven by nonciliary 
functions of ciliary and basal body proteins (2, 4); other findings 
have indicated that the cilium/basal body Wnt roles are likely spe-
cific to discrete spatiotemporal contexts (5–9).
Although basal body and ciliary proteins are not signaling 
molecules per se, these structures are thought to operate as a 
hub for coordinating networks of signaling cascades. Compo-
nents of various signaling pathways localize to basal body and 
cilium (10–13). Moreover, mutations in a single basal body or 
ciliary gene can lead to defects in more than one signaling path-
way (11, 14), while loss-of-function mutations in signaling mol-
ecules such as the Shh regulator kinesin family member 7 (KIF7) 
(15, 16) and the Wnt/planar cell polarity (PCP) effector Fritz 
(17) cause ciliopathies in some families.
The increasing association of ciliary and basal body proteins 
with signaling defects led us to ask whether a common mecha-
nism might account for the convergence of multiple pathways. 
One candidate, the ubiquitin-proteasome system (UPS), is 
attractive for three reasons. First, the basal body is known to be 
a proteolytic center (18–21). Second, we reported previously that 
disruption of some basal body proteins results in loss of proteasome- 
dependent degradation of β-catenin (5), a phenotype reproduced 
subsequently (22). Finally, we noted that, in addition to Wnt, 
proteasomal degradation is implicated in most paracrine signal-
ing cascades known to be defective in basal body mutants. For 
example, in Notch-mediated lateral inhibition, a transmembrane 
ligand of the Delta-Serrate-LAG2 (DSL) family binds a transmem-
brane Notch receptor in the adjacent target cells (23). To reduce 
Notch signaling, DSL ligands are ubiquitinated, internalized, 
and degraded by the proteasome (24); similarly, the intracellular 
domain of the Notch receptor is degraded by the proteasome to 
reduce Notch signaling (25). Likewise, when Shh ligand is pres-
ent, glioma-associated oncogenes 2 and 3 (GLI2/3) exist in their 
full-length activator forms, whereas they are truncated by protea-
some-mediated proteolysis to their repressor forms when Shh is 
removed (26); both the activator and repressor forms of GLI2/3 are 
also degraded by the proteasome (27). Besides GLI2/3, suppressor 
of fused homolog (SUFU), a negative regulator of Shh signaling 
that physically localizes at the cilium, is also degraded in a protea-
some-dependent manner (28).
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Given these observations, we wondered whether basal body 
and ciliary proteins might regulate multiple signaling pathways 
by controlling proteasome-mediated degradation of signaling 
mediators. We show that suppression of basal body–localized 
ciliopathy proteins led to defective proteasomal degradation of 
such mediators, which in turn caused dysfunction in three major 
cilia-associated signaling pathways (Shh, Wnt, and Notch) in 
vitro and in vivo. These observations are unlikely to reflect non-
specific cellular malaise; not only could the ciliopathy proteins 
tested here interact with specific regulatory subunits of the pro-
teasome holoenzyme, but also depletion of each of Bardet-Biedl 
syndrome 4 (BBS4) and oral-facial-digital syndrome 1 (OFD1) 
selectively perturbed the subunit composition of the centroso-
mal proteasome. Further, signaling phenotypes due to depletion 
of BBS1, BBS4, and OFD1 could be rescued by activating protea-
somal function. Finally, because the model predicts that other 
proteasome-dependent paracrine signaling pathways should also 
be defective in the absence of basal body proteins, we examined 
NF-κB signaling, a pathway that has not been linked previously 
to basal body (dys)function. Consistent with our prediction, loss 
of each of BBS1, BBS4, and OFD1 repressed NF-κB activity, which 
could be restored by activating the proteasome. Taken together, 
these findings suggest that proteasome-mediated basal body reg-
ulation might be a common mechanism for a multitude of signal-
ing cascades and that proteasomal activation might be a potential 
treatment paradigm for ciliopathies.
Results
Accumulation of signaling mediators upon depletion of ciliopathy proteins. 
We and others have reported previously that perturbation of some 
ciliopathy proteins alters the stability of Wnt signaling mediators 
such as β-catenin and Dishevelled (5, 8, 21, 29, 30). To study the 
physiological relevance of these findings in vivo, we mated Bbs4–/– 
mice with a transgenic proteasome reporter mouse line expressing 
unstable ubiquitin–tagged GFP (31) to generate UbG76V-Gfp Bbs4–/– 
mice. As a hallmark of potential proteasomal dysfunction, we 
examined GFP levels in a broad range of tissues with known pathol-
ogy in BBS and observed no aberrant GFP accumulation in the kid-
ney and liver of UbG76V-Gfp Bbs4–/– mice (Figure 1A; full uncut gels 
are shown in the Supplemental Material.) and modest increases in 
components of the central nervous system (hippocampus, cortex, 
and cerebellum; Figure 1A). By contrast, we detected significant 
accumulation of GFP from P14 onward in the retinas of UbG76V-Gfp 
Bbs4–/– mice (Figure 1B). To identify which cell types were account-
ing for the GFP signal, we performed immunohistochemical anal-
yses of retina from three UbG76V-Gfp WT and three UbG76V-Gfp Bbs4–/– 
 mice (masked to the genotypes). Cryosections from UbG76V-Gfp 
Bbs4–/– mice revealed significant aggregation of GFP in the rod and 
cone photoreceptor layers consisting of the outer segment, inner 
segment, and outer nuclear layer (Figure 1C). This phenotype was 
restricted to photoreceptors (Figure 1C) and was unlikely to be 
secondary to retinal degeneration, as we observed no anatomical 
photoreceptor defects on P14, consistent with reported findings 
for other Bbs mouse mutants (29).
Given the specificity of GFP degradation defects in the photore-
ceptors of Bbs4–/– mice and previous data on the abnormal stabil-
ity of β-catenin in BBS4-depleted cells (5), we next asked whether 
proteasomal dysfunction might be more broadly relevant to basal 
body–mediated paracrine signal regulation. If this is true, then: (a) 
other basal body proteins should have similar functions; and (b) 
other known basal body–mediated pathways should also be per-
turbed. To evaluate functional links between basal body proteins, 
we first conducted an in silico study to analyze a network of coex-
pressed basal body and ciliary genes through a publicly available 
online tool (http://netview.tigem.it), which reconstructs the regu-
latory interactions among genes from genome scale measurements 
of gene expression profiles (32). This analysis revealed a subset of 
centrosomal transcripts (P = 3.5 × 10–7) including BBS1, BBS4, and 
OFD1 (Supplemental Figure 1; supplemental material available 
online with this article; doi:10.1172/JCI71898DS1). We thus con-
sidered the possibility that loss of OFD1 also leads to changes in 
the stability of signaling mediators.
We turned to an established cilium-dependent paracrine signaling 
pathway, Hedgehog signaling (Hh) (2), and developed an in vitro 
neural differentiation model, in which the embryonic WT murine 
stem cells (WTESs) and Ofd1-deficient murine embryonic stem cells 
(KOESs) were cultured to generate neural progenitors (Supplemen-
tal Figure 2), a model that recapitulates the multi-step process of 
neural development in embryos (33). KOESs are male murine cells 
containing a gene trap mutation in Ofd1. As Ofd1 is located on the 
X chromosome, Ofd1 KOESs are hemizygous for Ofd1 and do not 
produce the protein (34). Comparing Ofd1WT neurons derived from 
WTESs and Ofd1KO neurons from KOESs, we found a significant 
increase in GLI2FL (full-length GLI2) and SUFU at the T8 time 
point in Ofd1-depleted neurons (Figure 2A). We also found increased 
levels of GLI2FL and SUFU in lysates from Ofd1Δ4–5/+  heterozygous 
female mouse embryos (data not shown) and Ofd1Δ4–5/y hemizygous 
male mouse embryos (Supplemental Figure 3A) compared with 
levels observed in WT littermates (Figure 2B). In addition, GLI3FL 
(full-length GLI3) increased both in Ofd1KO neurons (Figure 2A) and 
in Ofd1Δ4–5/+  (data not shown) and Ofd1Δ4–5/y mutant embryos (Fig-
ure 2B), with a concomitant decrease in glioma-associated oncogene 
3 repressor (GLI3R) levels (Figure 2, A and B, and Supplemental Fig-
ure 3, B and C).
Similar to Hh and Wnt signaling, Notch signaling is regulated 
through the cilium (13), and if the overarching hypothesis is correct, 
this pathway should also be perturbed in our mutants. As a first 
test, we cotransfected Flag-tagged Notch1 intracellular domain 
(NICD) into HEK-293-FT cells depleted of BBS4 by shRNA- 
mediated gene silencing (pSuperBBS4) (5). Immunoblot analysis of 
transfected cells revealed an elevation of NICD protein levels upon 
knockdown of BBS4 (Figure 2C). Further, we asked whether loss 
of BBS4 modulates the protein levels of a DSL ligand, Jagged 1 
(JAG1). We therefore assayed GFP-tagged JAG1 in BBS4-depleted 
and control cells. Similar to our findings with NICD, knockdown 
of BBS4 also resulted in an elevation of GFP-JAG1 (Figure 2D).
Selective disruption of UPS caused by loss of ciliopathy proteins. Given 
our data on Wnt, Shh, and Notch and the fact that the processing 
of components from these paracrine signaling pathways is known 
to be mediated by the proteasome (11, 35), we asked whether pro-
teasomal agonists could ameliorate the signaling phenotypes of 
basal body mutants.
The expression levels of three catalytic subunits of the protea-
some, proteasome subunit β types 5, 6, and 7 (PSMB5, PSMB6, 
and PSMB7), as well as the corresponding peptidase activi-
ties, increase upon treatment with sulforaphane (36) [SFN; 
1-isothiocyanato-4(R)-methylsulfinylbutane], an isothiocyanate 
extracted from cruciferous vegetables, rendering this com-
pound an attractive initial substrate for our studies. We found 
that treatment with SFN rescued the accumulation of GLI2FL, 
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GLI3FL, and SUFU in T8-derived Ofd1KO neurons (Figure 3A). 
Consistent with the participation of the proteasome in both 
the processing and degradation of GLI2/3, treatment with SFN 
reduced GLI3R protein levels (Figure 3A and Supplemental 
Figure 3D). Moreover, SFN treatment of cells depleted of BBS4 
also revealed a reduction in β-catenin protein levels relative to 
vehicle-treated cells (Figure 3B), suggesting that defects in pro-
teasome-dependent processing and degradation of GLI2/3, 
SUFU, and β-catenin can be ameliorated.
Taken together, our data argue for a role of basal body pro-
teins in regulating proteasome-mediated degradation and that 
we should observe a reciprocal signaling/proteasomal phenotype 
upon overexpressing our pro-
teins of interest. We therefore 
overexpressed BBS4 in cells 
and observed a depletion of 
both NICD (Figure 3C and 
Supplemental Figure 3E) 
and JAG1 (Supplemental Fig-
ure 3F); further, we treated 
BBS4-overexpressing cells 
with two proteasome inhib-
itors, N-carbobenzoxyl-L- 
l e u c i n y l - L - l e u c i n y l - L - 
norleucinal (MG132) and 
lactacystin as well as DMSO 
vehicle as a control. While 
cells overexpressing BBS4 
showed a 21%–50% reduction 
in total NICD levels (Fig-
ure 3C and Supplemental 
Figure 3E) and an approxi-
mately 50% ± 16% reduction 
in total JAG1 levels (Supple-
mental Figure 3F), treatment 
with MG132 and lactacystin 
restored NICD protein levels 
to 93% (Figure 3C) and 138% 
(Supplemental Figure 3E) of 
basal levels, respectively, and 
restored JAG1 levels to 99% ± 
38% of basal levels (Supple-
mental Figure 3F), suggest-
ing that BBS4 can facilitate 
the degradation of Notch 
signaling mediators in a pro-
teasome-dependent manner.
Regulation of the proteasome 
complex by ciliopathy proteins. 
Although our observations 
in mouse mutants, zebrafish 
embryos (5), and cultured 
cells argue that the basal 
body proteins we studied are 
responsible for regulating the 
proteasome, the mechanism 
of that action is unclear, leav-
ing the possibility that the 
observed phenotypes are sur-
rogate effects of generalized 
cellular “malaise.” We therefore explored the possibility of direct 
biochemical relationships between BBS1, BBS4, and OFD1 and 
the proteasome.
First, we conducted an unbiased mass spectrometry screen to 
identify putative OFD1-interacting proteins. This experiment 
uncovered a spectrum of proteasomal subunits including regula-
tory proteasome ATPase subunit 6 (RPT6), a finding confirmed 
by semiendogenous coimmunoprecipitation (Figure 4A). Inde-
pendently, we tested for protein-protein interactions between 
multiple BBS proteins (BBS1, 2, 4, 5, 6, 7, 8, and 10) and several 
proteasomal subunits (proteasome subunit β type 1 subunit in the 
20S particle [PSMB1], regulatory proteasome non-ATPase subunit 
Figure 1
Accumulation of GFP in Bbs4–/– mice. (A and B) Immunoblotting with anti-GFP to examine the kidney (P80), 
liver (P144), several brain components (P80), and retina (P12–P126) (B) of UbG76V-Gfp Bbs4–/– mice, with 
UbG76V-Gfp WT littermates used as controls. Samples in each panel for the brain were run on the same gel but 
were noncontiguous. (C) Immunohistochemistry of retinal sections of P23 and P126 UbG76V-Gfp transgenic 
mice. Progressive retinal degeneration and GFP accumulation in photoreceptors (OS and IS, and ONL) were 
observed in Bbs4–/– mice, but not in WT littermates. OS was immunolabeled with anti–s-opsin; ONL and INL 
were labeled with DAPI staining. RPE, retinal pigment epithelium; OS, outer segment of the photoreceptors; 
IS, inner segment; ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner 
plexiform layer; GCL, ganglion cell layer. White boxes delimit the enlarged images, showing OS and IS. HP, 
hippocampus; CX, cortex; CB, cerebellum. White boxes delimit the enlarged images, showing OS and IS. 
Scale bar: 25 μm in images and inserts. Bar graphs showing standard error of the mean are plotted adjacent 
to each blot. *P < 0.05; **P < 0.01.
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10 [RPN10],  regulatory proteasome non-ATPase subunit 
13 [RPN13], RPT6, and non-19S regulatory subunit [PA28γ], 
selected based on antibodies available for subsequent experi-
ments). Under stringent detergent conditions (1% Triton X-100), 
we confirmed the previously reported interaction between BBS4 
and RPN10 (5) by semiendogenous coimmunoprecipitation (Fig-
ure 4A) and also observed a biochemical interaction of some BBS 
proteins (BBS1, BBS2, BBS4, BBS6, BBS7, and BBS8) with protea-
somal components, while BBS5 and BBS10 did not interact with 
any tested proteasomal subunits (Supplemental Figure 4A). To test 
the physiological relevance of a BBS-proteasome interactome, we 
determined that BBS1 and RPN10 interacted at endogenous levels 
in protein lysates isolated from C57BL/6 mouse testes (Figure 4A).
To probe the relevance of these interactions, we asked whether 
loss of OFD1 or BBS4 alters the composition of the proteasome 
with respect to its subunits. Using a stable cell line expressing 
tagged regulatory proteasome non-ATPase subunit 11 (RPN11) 
(37), we suppressed OFD1, purified 26S proteasome complexes, 
and observed a robust reduction (60% ± 8%) of 26S-bound regu-
latory proteasome ATPase subunit 2 (RPT2) in OFD1-depleted 
cells in comparison with that in control, while total RPT2 protein 
abundance was not affected by OFD1 depletion (Figure 4B). We 
also assayed the fraction of 26S-bound RPN10 in BBS4-depleted 
cells and observed a modest but significant reduction (20% ± 3%) 
in RPN10 (Supplemental Figure 4B). Furthermore, we also tested 
the localization of RPN10 around the centrosome in HEK-293 cells 
depleted of BBS4 and OFD1 by quantifying the RPN10 signal that 
localized around centrosomal γ-tubulin; we did not observe appre-
ciable changes in BBS4-depleted cells (data not shown), possibly 
because of a lack of spatial resolution. By contrast, we observed 
a 43% ± 2% reduction of pericentriolar RPN10 levels (normalized 
to cytoplasmic RPN10 levels) in OFD1-depleted cells (Figure 4C). 
Given these data, we tested whether loss of OFD1 or BBS4 altered 
the composition of RPN10, RPT2, and other proteasomal compo-
nents by sedimentation. Based on the commercial availability of 
reliable antibodies against proteasomal subunits, we found that 
RPN10, RPN13, RPT2, and RPT6 were enriched in γ-tubulin–
enriched fractions in control cells (Figure 4D and Supplemental 
Figure 4C). Depletion of OFD1 or BBS4, however, resulted in a shift 
in the peak expression of the proteasomal subunits (Figure 4D and 
Supplemental Figure 4C). Taken together, these data suggest that 
BBS proteins and OFD1 regulate the composition of the centroso-
mal proteasome, likely through direct biochemical interactions.
Activation of proteasomal components ameliorates signaling defects caused 
by loss of ciliopathy proteins that reside at the basal body. Our observa-
tions next led us to speculate that (a) if reduction of proteasomal 
Figure 2
Accumulation of Shh and Notch signaling mediators upon depletion of ciliopathy proteins. (A) Accumulation of GLI2FL, GLI3FL, and SUFU as well 
as reduction of GLI3R in T8-derived Ofd1KO neurons. (B) At E10.5, accumulation of GLI2FL, GLI3FL, and SUFU as well as reduction of GLI3R 
were detected in protein lysates from Ofd1Δ4–5/y mice, with Ofd1+/y mice used as controls. (C) Suppression of BBS4 increases Flag-tagged NICD 
levels compared with those in pSuper controls. (D) Suppression of BBS4 led to a 2-fold increase in GFP-tagged JAG1. The samples in each panel 
in B and C were run on the same gel but were noncontiguous. Bar graphs showing the SEM are plotted adjacent to each blot. *P < 0.05; **P < 0.01.
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subunits in the centrosomal fraction of BBS4- or OFD1-depleted 
cells results in hampered degradation of signaling mediators, then 
increasing expression of the corresponding proteasomal subunits 
may ameliorate defective signaling phenotypes; and (b) activation 
of the proteasome might compensate for signaling defects.
We and others have reported previously that loss of ciliopathy 
proteins produces defects in convergent extension (CE) move-
ments during gastrulation in zebrafish embryos (5, 29, 30). In 
addition to and independent of these phenotypes, we observed 
defects in the definition of somite boundaries in zebrafish 
embryos injected with morpholinos against bbs genes (bbs mor-
phants [bbs MO]) (Supplemental Figure 5A and ref. 38). In ver-
tebrates, somites develop as epithelial blocks at a temporal and 
spatial periodicity that is controlled, in part, by Notch signaling 
(39). Given the phenotypic overlap between bbs morphants and 
segmentation mutants (mib, bea, des, and aei) (39), as well as our 
biochemical Notch observations in BBS4-deficient cultured mam-
malian cells, we wondered whether dysfunction of these proteins 
might influence Notch signaling. Upon injection of the estab-
lished bbs4 morpholino (5, 38) into 1- to 8-cell-stage embryos, 
and scoring at the 9 ± 1 somite stage (9 ± 1 ss), 92% of embryos 
exhibited an expansion of the anteroposterior midline expression 
domain of her4 (Supplemental Figure 5B), whose transcription is 
targeted directly by notch1 activation (40). To differentiate between 
ectopic expression at developmental stages, when Notch signal-
ing is already active, and the possibility that signaling is persistent 
throughout stages when it should be diminished, we performed 
an incremental developmental series of her4 in situ hybridization 
over the first 5 days of development. Scoring WT embryos (staged 
by number of somites and, later, by the presence of anatomical 
features such as the swim bladder to ensure that embryos of the 
same age were compared across experiments), we observed that the 
expression of her4 in neural structures of the head, including the 
developing forebrain, midbrain, hindbrain, and eye, was robust 
through 2.5 days post fertilization (dpf) and then began to wane. 
In bbs4 morphants, we saw persistent her4 expression through 
5 dpf, especially in the eye (Supplemental Figure 5C).
Given the availability of experimentally tractable signaling phe-
notypes, we asked whether overexpression of proteasomal subun-
its that were seen to mislocalize in BBS4- and OFD1-depleted cells 
might rescue the bbs4 and ofd1 morphant phenotype. Upon blind 
scoring for the effects of coinjecting human RPN10 , RPN13 , or 
RPT6 mRNA with the bbs4 or ofd1 morpholino, we measured sub-
stantial rescue of defective CE, somitic definition, and persistent 
her4 expression (Figure 5A).
Next, as an independent test, we examined bbs4 morphants 
coinjected with SFN, a known transcriptional activator of protea-
somal subunits (36). Upon blind scoring at the 9 ± 1 ss, there was 
a significant reduction of bbs4 morphants with CE and somitic 
defects (P < 0.001; Figure 5B). Moreover, coinjection of SFN with 
a bbs4 morpholino ameliorated the ectopic expression of her4 
in neural structures at 4.5 dpf (Figure 5B). We also observed a 
similar rescue of bbs1 and ofd1 morphants, in which coinjection 
of SFN gave rise to the same robust rescue of defective CE phe-
notypes, somitic defects, and persistent her4 expression as that 
observed in bbs4 loss-of-function models (Figure 5, C and D). 
Figure 3
Disruption of proteasomal degradation caused by loss of ciliopathy proteins. (A) Treatment of proteasomal agonist SFN ameliorated the accumu-
lation of GLI3FL, GLI2FL, and SUFU in T8-derived Ofd1KO neurons. (B) Suppression of BBS4 in HEK-293-FT cells led to a 1.57-fold increase in 
β-catenin protein levels that could be rescued by SFN. (C) Overexpression of BBS4 reduced NICD levels. MG132 treatment restored Flag-NICD 
levels. Samples in each panel in C were run on the same gel but were noncontiguous. Bar graphs showing SEM are plotted adjacent to each blot. 
*P < 0.05; **P < 0.01; ***P < 0.001.
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To substantiate the rescue effects of SFN, we used another pro-
teasomal agonist, mevalonolactone [known as mevalonic acid 
lactone, mevalonate, and (±)-β-hydroxy-β-methyl-δ-valerolactone 
and abbreviated hereafter as MVA], to ask whether broad acti-
vation of the proteasome can alleviate basal body–dependent 
phenotypes. We coinjected MVA with the bbs4 morpholino into 
zebrafish embryos, and upon blind scoring at 9 ± 1 ss, we found 
a reduction in bbs4 morphant zebrafish with CE defects from 
47.8% to 11.4% with MVA (Supplemental Figure 6). To investi-
gate the persistence of Notch signaling in bbs4 morphant zebraf-
ish coinjected with MVA, we performed in situ hybridization for 
her4. Coinjection of MVA with a bbs4 morpholino reduced her4 
Figure 4
Ciliopathy proteins interact with proteasomal components and regulate proteasome composition. (A) Immunoblots show interaction between 
endogenous OFD1 and Flag-tagged RPT6 and endogenous BBS4 and GFP-tagged RPN10. An endogenous interaction was detected between 
BBS1 and RPN10 from protein lysate isolated from the testis of C57BL/6 mice. (B) Immunoblots show that suppression of OFD1 in HEK-293 
cells reduced RPT2 protein levels in purified 26S proteasome. Densitometry measurements of proteasomal RPT2 protein levels were plotted 
(n = 3), and no significant difference in total RPT2 abundance was detected. Coomassie blue staining were carried out as a loading control and 
to measure the efficiency of the 26S proteasomal purification process. (C) Suppression of OFD1 in HEK-293 cells resulted in the reduction of 
pericentriolar RPN10 levels (normalized to cytoplasmic RPN10 levels) in OFD1-depleted cells. Scale bar: 10 μm. (D) HEK-293-FT cells transfected 
with pSuper control and pSuperOFD1 were subjected to sucrose gradient centrifugation. Fractions (fractions 6–12 of 13 fractions) were then 
analyzed by immunoblotting with antibodies against γ-tubulin and proteasomal subunits. In control cells, the fractions enriched with all proteasome 
subunits partially overlapped with fractions enriched with γ-tubulin (fraction 8), and when OFD1 was depleted, peak levels of RPN10, RPN13, 
RPT2, and RPT6 shifted significantly and resulted in a decrease in the overlap between γ-tubulin–enriched fractions and 19S subunit–enriched 
fractions. **P < 0.01; ***P < 0.001.
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expression levels in neural structures, especially the retina, to 
those in WT zebrafish by 4.5 dpf (Supplemental Figure 6).
NF-κB signaling defects in basal body ciliopathy mutants can be res-
cued by activation of the proteasome. Our findings indicate that Wnt, 
Notch, and Shh phenotypes generated upon loss of three basal 
body proteins might converge at the point of proteasomal degra-
dation. We therefore considered a model in which the basal body 
region serves as a broad regulator of paracrine signaling through 
proteasomal degradation. If this model is true, then (a) other para-
crine pathways not implicated previously in ciliary/basal body 
biology, but known to be regulated by the proteasome, should 
exhibit signaling defects upon depletion of BBS proteins or OFD1; 
and (b) the model should also be able to predict the direction of 
the phenotype (suppressed or excessive signaling). To test this, we 
turned to NF-κB signaling, a pathway involved in inflammatory 
responses and lymphoid organogenesis with no known link to 
basal body (dys)function. In response to stimuli, IκBs are degraded 
by the proteasome, releasing NF-κB to translocate to the nucleus 
and activate the transcription of target genes (41).
We transfected HEK-293-FT cells with an NF-κB luciferase 
reporter plasmid containing three copies of the κB response ele-
ments of the murine MHC class I promoter (3X-κB-L). Cells stimu-
lated by TNF-α and cotransfected with the pSuperBBS4, pSuperBBS1, 
and pSuperOFD1 plasmids displayed a 55%, 53%, and 72% reduction 
in NF-κB activity, respectively, compared with that of control cells; 
incubation with SFN for 6 hours restored NF-κB activity (Figure 6, 
A–C). In cells with depleted basal body proteins, the direction of 
the NF-κB activity change (suppressive signaling) is opposite that 
of Wnt and Notch activity change (excessive signaling) (5, 22). 
This inverse relationship is consistent with our model, since the 
predicted basal body–regulated proteasomal degradation sub-
strates are IκBs, which are negative regulators, while β-catenin and 
NICD are positive regulators. Also consistent with the luciferase 
assays, we observed accumulation of GFP-tagged IκBβ in BBS4-, 
BBS1-, or OFD1-suppressant cells, which can also be ameliorated by 
SFN treatment (Figure 6, D and E).
Finally, to probe the potential physiological relevance of the 
observed NF-κB data in vivo, we examined the expression and 
protein levels of the proteasomal substrate IκBβ in mice lack-
ing Ofd1. Immunoblot analysis showed no differences in IκBβ 
protein levels on protein lysates from E10.5 Ofd1Δ4–5/y mutant 
embryos and controls (data not shown). Since loss of Ofd1 in 
mice results in prenatal lethality, we generated and crossed 
Ofd1-floxed mice (Ofd1fl) with a CAG-Cre-ERTM–inducible gen-
eral deletor line to examine IκBβ protein levels in postnatal Ofd1 
knockout mice. In Ofd1fl/y CAG-Cre-ERTM (Ofd1fl/y CKO) mice, Ofd1 
inactivation was achieved at E18.5 by tamoxifen injection, and 
renal cysts were not observed at P8 (precystic stage). By P20, we 
observed a replacement of the renal parenchyma by cysts (cystic 
stage). Immunoblot analysis revealed an accumulation of IκBβ in 
protein lysates from kidney of Ofd1fl/y CKO male mice compared 
with controls; crucially, this phenotype was evident in both pre-
cystic and cystic stages (Figure 6F), suggesting that the accumu-
lation of IκBβ is not a by-product of tissue disorganization and 
cystogenesis. At the precystic stage, mRNA levels of the IκBβ gene 
(Nfkbib) were lower in Ofd1fl/y CKO mice compared with mRNA 
levels in WT animals (Figure 6G), confirming that the accumu-
lation of IκBβ is not due to increased mRNA transcription lev-
els. Nfkbib mRNA levels were comparable between Ofd1fl/y CKO 
and controls at the cystic stage (Figure 6G).
Discussion
The study of ciliary and basal body proteins has highlighted 
a complex role for this cellular region in the regulation of sig-
naling pathways. These observations have raised critical ques-
tions, including whether dedicated signaling transduction 
machinery aggregate around the cilium and basal body. Several 
transduction components have been localized to the basal body 
and/or the ciliary axoneme, including Smoothened, GLI pro-
teins, SUFU, β-catenin, adenomatosis polyposis coli (APC), and 
Notch3 (8, 10, 11, 13, 29). At the same time, a model in which 
the cilium facilitates each pathway independently is difficult to 
reconcile with the fact that (a) with the possible exception of 
the PCP transducer Fritz (17) and the Shh motor KIF7 (15, 16), 
none of the other 60-plus genes and proteins mutated in human 
ciliopathies are components of a specific paracrine signaling 
pathway; (b) the phenotype of ciliopathy patients is a mixture 
of defects more consistent with a context-specific pathway dys-
function; and (c) animal models ablated for specific ciliary or 
basal body proteins exhibit multiple signaling defects (1).
Our data suggest a simpler model, in which at least some basal 
body proteins play a role in signal transduction regulation by 
exerting their primary effect not on a given pathway per se, but 
by regulating context-dependent proteolytic degradation. The 
alternative would be that the observed phenotypes are the non-
specific consequence of generalized cellular malaise and that 
the observed rescue effects were reflective of broad improve-
ment in the ability of the cell to eliminate proteins targeted for 
degradation. Taken together, our experiments favor the former 
model. Cells and embryos suppressed or ablated for each of 
BBS1, BBS4, and OFD1 had defects in proteasomal clearance of 
both reporter proteins and specific signaling components that 
included β-catenin, NICD, JAG1, GLI2, GLI3, SUFU, and IκBβ. 
It is also notable that the pronounced defects in proteasomal 
activity were concomitant with overt anatomical pathology in 
our murine models of disease, such as in the retina of Bbs mice 
and the cystic kidneys of conditional Ofd1 animals, whereas no 
GFP accumulation was observed in Bbs mutant kidneys that, in 
our colony, never exhibited cyst formation.
We tested the robustness of the model in four ways: (a) by pre-
dicting that NF-κB signaling, which requires proteasomal deg-
radation (41), but has no known ciliary link, would be defective 
in the absence of our proteins of interest; (b) by predicting the 
direction of the defect in NF-κB signaling; (c) by ameliorating 
the signaling defects for each tested pathway in vivo through the 
chemical upregulation of proteasomal components; and (d) by 
demonstrating that in the absence of some basal body proteins, 
the centrosomal proteasome is partially depleted of the various 
regulatory subunits whose overexpression also has an ameliorat-
ing defect in vivo.
Notably, we observed sucrose fraction sedimentation changes in 
multiple proteasomal subunits in the absence of OFD1 or BBS4, 
arguing that ciliopathy phenotypes are unlikely to be driven by spe-
cific defects in only one subunit, consistent with the observations 
that the mice haploinsufficient for the subunit RPN10 are pheno-
typically normal, at least by gross pathology, while homozygous 
Rpn10 –/– mutants are embryonic lethal (42). An attractive mecha-
nism is one in which basal body proteins regulate the composition 
of multiple subunits in the proteasome holoenzyme in a context- 
dependent manner. This is known to occur during cellular stress 
(43), and it is plausible that ciliary signaling can have a similar effect.
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Moreover, it is likely that proteasomal dysfunction is only one 
contributor to the pathology of ciliopathies. The BBS proteins have 
been proposed to perforate vesicles and regulate vesicular trans-
port, possibly into the ciliary axoneme, in a GTPase-dependent 
fashion (44), while BBS4 has also been reported to bind to EXOC7 
(45). These data intimate additional layers of complexity, in which 
these proteins can either have both promoting and inhibitory func-
tions with regard to proteasomal targeting or other subcellular sur-
veying mechanisms, or might be themselves inhibited or activated 
by other ciliary and axonemal proteins in a spatiotemporal context. 
Emergent data suggest that the composition and function of pri-
mary cilia vary significantly across cell types (46). Such complex-
ity might account for conflicting observations, in which each of 
the major signaling pathways mapped to date on this subcellular 
region have been shown to be activated, suppressed, or irrelevant in 
different tissues (4–6, 46, 47).
Finally, our findings indicate potential therapeutic applica-
tions. SFN has shown no toxic effects in humans and is currently 
being tested in several anticancer trials (48, 49). Should this 
compound show therapeutic benefit in rodent ciliopathy mod-
Figure 5
Activation of proteasome ameliorates signaling defects in bbs and ofd1 morphant zebrafish embryos. (A) Coinjection of human RPN10, 
RPN13, and RPT6 mRNA into bbs4 and ofd1 morphant zebrafish embryos rescued somitic and CE defects at the 9 ± 1 ss and ectopic 
expression of her4 in the eye (arrowheads in lower row) at 4.5 dpf. CE defects were scored based on the body gap angle (arrowheads in 
upper row). Expression of her4 was detected by whole-mount RNA in situ hybridization. (B, C, and D) Coinjection of SFN rescued somitic 
and CE defects as well as ectopic her4 expression in bbs4 (B), bbs1 (C), and ofd1 (D) morphant zebrafish embryos, while injection of SFN 
alone did not give rise to any obvious phenotype (B). As shown in the top row (dorsal view), the somites (bars) were longer in bbs4 (B), bbs1 
(C), and ofd1 (D) morphants and were shortened in morphant zebrafish embryos coinjected with SFN. In the second row (lateral view), the 
body gap angle (arrowheads) was greater in morphants and reduced in the presence of SFN. Dashed boxes delimit the enlarged images 
in the third row, showing the effects of SFN treatment on somite boundary definition defects. Percentage of embryos with somite boundary 
definition and CE defects and sample size (n) are noted below the images of each condition. Scale bars: 100 μm. 
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els, it would be a candidate for clinical trials in some ciliopathy 
patients. More broadly, other SFN derivatives as well as unrelated 
proteasome agonists might also represent natural candidates. 
However, SFN is likely to confer a partial benefit that is possibly 
both genotype and subphenotype dependent. First, the observed 
rescue of embryos injected with the compound, although signifi-
cant, was not complete. Second, SFN is unlikely to be of benefit 
to all pathway defects. The proteasome is known to degrade the 
negative regulator SUFU and both the activator and the repres-
sor forms of GLI2/3; as such, it is likely that downstream Shh sig-
naling defects will not be rescued. Likewise, long-term exposure 
to SFN repressed NF-κB activity (data not shown), suggesting 
that delivery, dosage, and duration of exposure might be criti-
cal. Finally, if basal body ciliopathy proteins participate in other 
cellular processes that regulate signaling, proteasomal modifica-
tion will only be partially effective. Given our findings, however, 
a compound approach that includes targeting the proteasome 
may be of benefit.
Methods
Immunoblotting. Transfected cells and mouse tissues were lysed in modi-
fied RIPA buffer [150 mM sodium chloride, 50 mM Tris-HCl, pH7.4, 1% 
nonidet P-40, 0.1% sodium deoxycholate, 1 mM EDTA] with 1× protea-
some inhibitor (Roche) and centrifuged at 4°C for 15 minutes. Protein 
concentration was measured by Lowry assay using the DC Protein Assay 
Kit (Bio-Rad) on a DU 530 Life Science UV/Vis Spectrophotometer (Beck-
man Coulter). Total protein in each sample was separated by SDS-PAGE 
on 4% to 15% Mini-PROTEAN TGX Precast Gel (Bio-Rad) with a Spectra 
Multicolor Broad Range Protein Ladder (Fermentas) and transferred to 
an Immun-Blot PVDF Membrane (Bio-Rad). The membrane was blocked 
with 5% nonfat milk or 5% BSA (Sigma-Aldrich) and probed with the fol-
lowing commercial primary antibodies: anti-GAPDH (ab9484 from Abcam 
or sc-32233 from Santa Cruz Biotechnology Inc.); anti-GFP (sc-8334; Santa 
Cruz Biotechnology Inc. or ab13970; Abcam); anti-HSP90 (sc-7947; Santa 
Cruz Biotechnology Inc.); anti-GLI2 (AF3635; R&D Systems); anti-GLI3 
(AF3690; R&D Systems); anti-SUFU (sc-10934; Santa Cruz Biotechnology 
Inc.); anti-Flag (F7425; Sigma-Aldrich); anti-catenin (sc-7199; Santa Cruz 
Figure 6
NF-κB signaling defects in BBS4-, BBS1-, and OFD1-depleted cells, and Ofd1 conditional knockout mice. (A–C) Suppression of BBS4 (A), BBS1 
(B), or OFD1 (C) in HEK-293-FT cells led to decreased 3X-κB-L luciferase reporter responsiveness to a 12-hour TNF-α treatment. Incubation with 
SFN for 6 hours partially restored sensitivity to TNF-α stimulation (n = 3). (D and E) GFP-tagged IκBβ protein levels were higher in HEK-293-FT 
cells depleted of BBS4, BBS1 (D), or OFD1 (E) compared with those in control. SFN incubation rescued IκBβ-GFP accumulation. (F) Protein 
levels of IκBβ in kidney tissues isolated from Ofd1fl/y CAG-Cre-ERTM (Ofd1fl/y CKO) mice at P8 (precystic stage) and P20 (cystic stage) were higher 
than the levels in kidney tissues from WT littermates. (G) mRNA levels of IκBβ (Nfkbib) in kidney tissues were lower in Ofd1fl/y CKO compared 
with mRNA levels in WT animals at P8 and were comparable between Ofd1fl/y CAG-Cre-ERTM and controls at P20 (n = 3). Bar graphs showing 
SEM are plotted adjacent to each blot. *P < 0.05; **P < 0.01; ***P < 0.001.
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followed by incubation with protein G–coupled agarose beads (Santa Cruz 
Biotechnology Inc.) at 4°C for 1 hour, or directly with anti-Flag M2 beads 
(A2220 Sigma-Aldrich). The beads were collected and washed with IP buf-
fer (10% glycerol, 50 mM Tris-HCl [pH 7.5], 2.5 mM MgCl2, 1% NP40, and 
200 mM NaCl). Proteins conjugated with the beads were then denatured 
and separated from the beads by boiling at 95°C to 100°C for 5 minutes 
before processing for immunoblotting.
Affinity purification of proteasome complex. The 26S proteasome complex 
was purified following a previously described protocol (52) with mod-
ifications. Briefly, HEK-293-FT cells expressing stable HTBH-tagged 
hRPN11 (a gift from Lan Huang, University of California, Irvine, Cal-
ifornia, USA) were transfected with either pSuper control plasmid or 
pSuperBBS4 to knock down BBS4 expression. Seventy-two hours after 
transfection, cells were lysed in buffer A (100 mM NaCl, 50 mM Tris-HCl 
[pH 7.5], 10% glycerol, 2 mM ATP, 1 mM DTT, and 5 mM MgCl2) with 
1× proteasome inhibitor (Roche). Lysates were centrifuged at 4°C for 
15 minutes to remove cell debris. To purify proteasomes, an aliquot of 
the supernatant was incubated with streptavidin beads at 4°C overnight 
to precipitate HTBH-RPN11. The beads were then washed with buffer A 
three times, followed by one washing with TEB buffer (50 mM Tris-HCl, 
pH 7.5 and 10% glycerol). Finally, the beads were incubated in TEB buffer 
containing 1% TEV protease at 30°C for 1 hour, before SDS-PAGE and 
immunoblotting with anti-RPN10 (ab20239; Abcam).
Immunocytochemistry. HEK-293 cells cultured on coverslips were fixed 
in methanol, blocked in normal goat serum (1:10 in PBS containing 5% 
BSA), and then probed with anti-RPN10 and anti–γ-tubulin, followed by 
secondary antibodies Alexa Fluor 488 IgG and Alexa Fluor 568 IgG. Finally, 
nuclei were visualized with Hoechst 33258 (Sigma-Aldrich). Images were 
captured with a Zeiss LSM 710 confocal microscope and analyzed with 
ImageJ 1.44p software.
Sucrose gradient sedimentation. HEK-293-FT cells were transfected and 
treated with nocodazole (10 μg/ml) and cytochalasin B (5 μg/ml) for 
1 hour at 72 hours after transfection. To collect cytoplasmic lysates, cells 
were harvested in lysis buffer (1 mM HEPES [pH 7.3], 0.5% NP-40, 0.5 mM 
MgCl2, 0.1% β-ME, and 1× protease inhibitor), followed by centrifugation 
at 2,500 g for 10 minutes. After 10 mM HEPES and 5 U/ml DNase treat-
ment for 30 minutes on ice, 1 ml of cytoplasmic lysates was layered on a 
discontinued sucrose gradient (70%, 50%, and 40% sucrose in the buffer 
containing 10 mM PIPES [pH 7.2], 0.1% NP-40, and 0.1% β-ME) and cen-
trifuged for 1 hour at 195,000 g; 2% of lysates were kept before ultracentrif-
ugation and served as an input. After ultracentrifugation, 13 fractions were 
collected and analyzed by immunoblotting.
Microinjection of morpholinos, mRNA, and sulforaphane. Morpholi-
nos against bbs1 (5′-CACACGTCCATCACTAACCAATAGC-3′), bbs4 
(5′-CCGTTCTCATAGCGTCGTCCGCCAT-3′), and ofd1 (5′-ATCTTCTC-
TACTGCAACACACATAC-3′) were purchased from Gene Tools, LLC. 
Human RPN10 , RPN13 , and RPT6 mRNA were in vitro transcribed with 
an mMESSAGE mMACHINE SP6 Kit (Ambion). SFN was dissolved in 
DMSO (Sigma-Aldrich) at a stock concentration of 1 M and further 
diluted in water to 10 mM. The morpholino and mRNA or SFN were 
mixed, and a volume of 0.5 nl was microinjected.
Whole-mount RNA in situ hybridization. Zebrafish embryos were fixed 
overnight in 4% PFA at 4°C. Residual pigment was removed by bleach-
ing with 3% H2O2/0.5% KOH. Whole-mount RNA in situ hybridiza-
tion was performed with a digoxigenin-labeled anti-her4 RNA probe (a 
gift from Tohru Ishitani, Kyush University, Fukuoka, Kyushu, Japan) 
synthesized by in vitro transcription (Roche), followed by immuno-
logical detection with Anti-Digoxigenin-AP, Fab Fragments (Roche) 
and nitro blue tetrazolium/5-bromo-4-chloro-3-indolyl-phosphate 
staining (Roche).
Biotechnology Inc.); anti–α-tubulin (T6199; Sigma-Aldrich); anti-NICD 
(ab8925; Abcam); anti-hsOFD1 (rabbit polyclonal antisera against human 
full-length OFD1 NM_003611); anti-mmOFD1 (rabbit polyclonal antisera 
against a portion of murine OFD1 NM_177429 aa 461-884); anti-BBS4 
(AB15009; Millipore); anti-BBS1 (a166613; Abcam); anti–γ-tubulin (T7451; 
Sigma-Aldrich); anti-20S (NB600-1016; Novus); anti-PA28γ (NBP1-54587; 
Novus); anti-RPN10 (ab20239; Abcam); anti-RPN13 (H00011037-M01; 
Novus); anti-RPT2 (AP-107; Boston Biochem); anti-RPT6 (BML-PW9265; 
Enzo Life Sciences); anti-IκBβ (sc-9248; Santa Cruz Biotechnology Inc.); 
anti-Myc (m4439; Sigma-Aldrich); and anti-HA (ab16918; Abcam). Densi-
tometric analysis was performed with Image Lab (Bio-Rad), Quantity One 
(Bio-Rad), or ImageJ 1.44p (NIH) software.
Immunohistochemistry. Mouse eyes were fixed in 4% PFA, followed by 
immersion in sucrose (10%, 20%, and 30%) in PBS. With the lens removed, 
eyecups were embedded in Optimal Cutting Temperature Compound 
(Sakura) and flash frozen. Cryosections were blocked with 10% FBS in 
PBS and probed with primary antibodies anti-GFP (ab13970; Abcam) 
and anti–S-opsin (a gift from Jeremy Nathans, Johns Hopkins University, 
Baltimore, Maryland, USA), followed by secondary antibodies Alexa Fluor 
488 IgG (Invitrogen) and Alexa Fluor 594 IgG (Invitrogen). Nuclei were 
stained with DAPI (Roche). Images were captured with a Nikon Eclipse 
90i microscope.
Bioinformatic analyses. We selected a subset of 271 transcripts that 
included: (a) transcripts mutated in human ciliopathies; (b) transcripts 
that, when mutated in animal models, give rise to ciliary dysfunction; (c) a 
group of transcripts found in at least three of the available datasets of cil-
iary proteins (50); and (d) a subset of transcripts recently shown to be mod-
ulators of ciliogenesis and cilium length (51). The publicly available online 
tool (http://netview.tigem.it) was used to analyze the regulatory interac-
tions among genes from genome-scale measurements of gene expression 
profiles (microarrays) (32).
ES cell–derived in vitro neural differentiation. The Ofd1-deficient 
E14Tg2A.4 KOES line was obtained from BayGenomics. Both WT and 
Ofd1 KOESs were maintained in an undifferentiated state by culture on 
a monolayer of mitomycin C–inactivated fibroblasts in the presence of 
leukemia-inhibiting factor (LIF). To induce neural differentiation, we 
followed previously described protocols (33). Briefly, 48 hours after ES 
cells were seeded on gelatin-coated plates, they were dissociated and 
plated on gelatin-coated plates at 1,000 cells/cm2 on day 0 (T0). The cul-
ture medium for neuronal differentiation (serum-free KnockOut Serum 
Replacement–supplemented medium; Invitrogen) contained knockout 
DMEM supplemented with 15% KSR (Invitrogen), 2 mM L-glutamine, 
100 U/ml penicillin-streptomycin, and 0.1 mM β-mercaptoethanol and 
was replaced daily during the differentiation process.
Cell culture, DNA transfection, and drug treatment. HEK-293 or HEK-
293-FT cells and human dermal fibroblasts were grown in DMEM 
(Invitrogen) containing 10% FBS (Invitrogen) and 2 mM L-glutamine 
(Invitrogen), hTERT-RPE1 cells in DMEM and Ham’s F-12 Nutrient 
1:1 mixture (DMEM/F-12; Invitrogen) with 10% FBS and 2 mM L-glutamine. 
FuGene6 Transfection Reagent (Roche) was used for transfection of 
expression constructs (including the Notch1-NICD expression construct, 
a gift from Nicholas Gaiano, Johns Hopkins University, Baltimore, Mary-
land, USA), shRNA-expressing plasmids, and luciferase reporter plasmids; 
then cells were cultured for 72 hours. Drug treatment was carried out at 
a final concentration of 10 μM SFN (Sigma-Aldrich) for 6 to 24 hours, 
30 μm N-carbobenzoxyl-L-leucinyl-L-leucinyl-L-norleucinal (MG132; Cal-
biochem) for 5 hours, 20 μM lactacystin (EMD Bioscience) for 5 hours, 
and 50 ng/ml TNF-α (Sigma-Aldrich) for 12 hours.
IP. For IP, approximately 1 mg of whole-cell, embryo, or tissue lysate 
was incubated with anti-OFD1, anti-Flag, or anti-GFP at 4°C overnight, 
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Study approval. Zebrafish and mouse studies were approved by the 
IACUC of Duke University (protocol A229-12-08 and A251-12-09) and by 
the IACUC of Cardarelli Hospital (Naples, Italy), to which the Telethon 
Institute of Genetics and Medicine (TIGEM) refers, and were authorized by 
the Italian Ministry of Health. The Cardarelli Hospital Ethics Committee 
(Naples, Italy) approved this study.
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Luciferase reporter system assays. HEK-293-FT cells were seeded in 24-well 
plates at a density of 104 cells/well. After 24 hours, cells were transfected 
with expression constructs, short-hairpin plasmids, and a 3X-κB-L reporter 
(a gift from Tom Gilmore, Boston University, Boston, Massachusetts, USA) 
for NF-κB signaling. A pRL-SV40 plasmid expressing Renilla luciferase was 
used as an internal control. Seventy-two hours after transfection, cells were 
lysed with Passive Lysis Buffer (Promega). The luciferase activity of lysates 
was measured with the Dual Luciferase Reporter Assay System (Promega) 
on a FLUOstar Omega microplate reader (BMG LABTECH) and analyzed 
with MARS Data Analysis Software (BMG LABTECH).
Generation of Ofd1fl/y CAG-Cre-ERTM mice by tamoxifen injections. Ofd1fl/+ 
females were crossed with CAG-Cre-ERTM mice, a general deletor Cre line in 
which Cre-ER is ubiquitously expressed after tamoxifen injection. We treated 
pregnant mothers with a single i.p. injection of 100 μg tamoxifen/g of weight 
at E18.5. Tamoxifen (Sigma-Aldrich) was diluted in 10% ethanol and 90% 
sesame oil at a final concentration of 10 mg/ml. Quantification of Ofd1 inac-
tivation was assessed by quantitative RT-PCR (qRT-PCR) (data not shown).
Real-time qRT-PCR analyses. Total RNA was isolated with TRIzol (Invitrogen). 
The cDNA was synthesized from 5 μg of total RNA using SuperScript III 
(Invitrogen). qRT-PCR was performed with Power SYBR Green PCR Master 
Mix (Applied Biosystems) on a 7900HT Fast Real-Time PCR System (Applied 
Biosystems). The primers Nfkbib forward (5′-TTGGCTACGTCACTGAG-
GATG-3′) and Nfkbib reverse (5′-GCTCATGCTGATGAATCACAGC-3′) 
were used to test mRNA levels of Nfkbib, while the primers ofd1 forward 
(5′-TGGCAGACCACTTACAAAGATG-3′) and ofd1 reverse (AGACTGGAT-
GAGGGGTTAATC-3′) were used to examine the conditional knockout effi-
ciency, and the primers gapdh forward (5′-TCTTCTGGGTGGCAGTGAT-3′) 
and gapdh reverse (5′-TGCACCACCAACTGCTTAGC-3′) were used as inter-
nal controls. Real-time data were collected and analyzed with the Sequence 
Detection System software package, version 2.3 (Applied Biosystems).
Statistics. A one-tailed Student’s t test was performed to compare the means 
of two populations. In the bar graphs, data represent the mean ± SEM of 
multiple repeats (n ≥3). A χ2 test was performed to compare two popula-
tions with several subgroups of different proportions. Statistical significance 
of differences between samples are indicated by *P < 0.05, **P < 0.01, and 
***P < 0.001. A P value less than 0.05 was considered significant.
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